omeprazole has been researched along with ranitidine in 706 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 92 (13.03) | 18.7374 |
| 1990's | 370 (52.41) | 18.2507 |
| 2000's | 200 (28.33) | 29.6817 |
| 2010's | 38 (5.38) | 24.3611 |
| 2020's | 6 (0.85) | 2.80 |
| Authors | Studies |
|---|---|
| Hajos, ZG; Press, JB; Sanfilippo, PJ; Scott, CK; Shriver, DA; Urbanski, M | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fung, L; Greenberg, GR; Pokol-Daniel, S | 1 |
| Freston, JW | 1 |
| Brunner, GH; Thiesemann, C | 1 |
| Hetzel, DJ | 1 |
| Joelson, IB; Joelson, S; Lundborg, P; Walan, A; Wallander, MA | 1 |
| Jaup, BH | 2 |
| Alcón, A; Bisbe, E; Castaño, J; Escolano, F; López, R | 1 |
| Bianchi Porro, G; Lazzaroni, M; Sangaletti, O | 1 |
| Honda, N; Ikebe, H; Ito, K; Iwamoto, A; Iwasaka, H; Kitano, T; Oda, S; Okuno, Y; Taniguchi, K | 1 |
| Chattopadhyay, K; Goel, AK; Kumar, A; Sinha, S | 1 |
| Franzin, F; Lunazzi, G; Moretti, M; Pozzato, G; Stebel, M | 1 |
| Jönsson, B; Lindberg, G | 2 |
| Girma, K; Nilsson, G; Romell, B; Seensalu, R | 2 |
| Börsch, G; Gyenes, E; Labenz, J; Rühl, GH | 1 |
| Gudjónsson, H; Oddsson, E; Thjódleifsson, B | 1 |
| Bianchi Porro, G; Bonavina, L; Franceschi, M; Pace, F; Peracchia, A; Scialabba, A; Vigneri, S | 1 |
| Gardner, JD; Jensen, RT; Maton, PN; Metz, DC; Norton, JA; Pisegna, JR; Slimak, GG | 1 |
| Gin, T; Kan, AF; Oh, TE; Yau, G | 1 |
| Cagliola, AJ; Colon-Pagan, J; Graham, DY; Johnson, TL; Marks, JW; McCullough, AJ; Morse, RS; Sklar, M; Stone, RC; Walsh, JH | 1 |
| Collen, MJ; Strong, RM | 2 |
| Goldberg, J | 1 |
| Day, GM; Moore, JG; Sanders, SW; Tolman, KG | 1 |
| Alon, E; Atanassoff, PG; Pasch, T | 1 |
| Andersson, T; Boström, H; Jones, AW; Jönsson, KA | 1 |
| Acharya, M; Szalay, F; Tulassay, Z | 1 |
| Bloom, BS; Fendrick, AM; Hillman, AL; Schwartz, JS | 1 |
| Asada, S; Hirata, I; Matsumoto, A; Ohshiba, S; Okumura, Y; Takiuchi, H | 1 |
| Falknäs, AK; Fryklund, J; Helander, HF | 1 |
| Bardhan, KD; Bianchi Porro, G; Carroll, NJ; Daly, MJ; Hinchliffe, RF; Lazzaroni, M; Morris, P; Naesdal, J; Petrillo, M; Thompson, M | 1 |
| Feldman, M; Lin, HJ; McArthur, KE; Prince, MD; Redfern, JS | 1 |
| Guram, M; Holt, S; Howden, CW | 1 |
| Harding, M; Hayward, NJ; Hughes, J; Lloyd, SA; McKnight, AT; Woodruff, GN | 1 |
| Koop, H | 1 |
| Karmeli, F; Lysy, J; Rachmilewitz, D; Wengrower, D | 1 |
| Ayoubi Khajekini, M; Blasi, A; Brogna, A; Catalano, F; Inserra, G; Mangiameli, A; Monello, S; Rizzo, G; Sofia, M | 1 |
| Gail, K; Mihaljevic, L; Stolte, M | 1 |
| Brzozowski, T; Garlicki, J; Konturek, SJ; Majka, J; Nauert, C; Stachura, J | 1 |
| Farthing, MJ; Lennard-Jones, JE; Nightingale, JM; Walker, ER | 2 |
| Backman, L; Ekström, P; Enander, LK; Falkmer, S; Fausa, O; Grimelius, L; Havu, N; Lind, T; Lönroth, H; Lundell, L | 1 |
| Cederberg, C; Idström, JP; Lind, T; Lönroth, H; Lundell, L; Olbe, L | 1 |
| Barth, H; Dammann, HG; Hengels, KJ; Kleinert, R; Londong, W; Müller, P; Rohde, H; Simon, B | 1 |
| Bradstreet, DC; Simon, TJ | 1 |
| Danilewitz, MD; Garisch, JA; Marks, IN | 1 |
| Bode, JC; Klotz, U; Sarem-Aslani, A; Treiber, G; Walker, S | 1 |
| Belaïche, J | 1 |
| Diébold, MD; Duchateau, A; Thiéfin, G; Zeitoun, P | 1 |
| Cerf, M | 1 |
| Bamberg, P; Díaz de Rojas, F; Díaz Rubio, M; Malagelada, JR; Pajares, JM; Rodrigo, JM; Ruiz Ferrán, J; Sainz Samitier, R; Segura, J; Vilardell, F | 1 |
| Backman, L; Granström, L; Kager, L; Kollberg, B; Lindberg, G; Moberg, S; Nilsson, LH; Seensalu, R; Sidenvall, L; Sörstad, J | 1 |
| Bianchi-Porro, G; Bonavina, L; Pace, F; Peracchia, A; Sangaletti, O; Termini, R; Vigneri, S | 1 |
| Holt, S; Howden, CW | 1 |
| Fryklund, J; Wallmark, B | 1 |
| Axelson, J; Carlsson, E; Håkanson, R; Mattson, H; Ryberg, B; Sundler, F; Tielemans, Y; Willems, G | 1 |
| Eriksson, S; Helander, HF; Helander, KG; Rutgersson, K; Simonsson, M; Sundler, F | 1 |
| Backman, L; Ekström, P; Enander, LH; Fausa, O; Lind, T; Lönroth, H; Lundell, L; Sandmark, S; Sandzén, B; Unge, P | 1 |
| Hudson, M; Nwokolo, CU; Pounder, RE; Prewett, EJ; Sawyerr, AM | 1 |
| Carling, L; Engström, G; Glise, H; Hallerbäck, B; Martinson, J; Solhaug, JH; Unge, P | 1 |
| Branicki, FJ; Ho, J; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, MM | 1 |
| Berlin, RG; Cagliola, A; Colon-Pagan, J; Hirschowitz, BI; Johnson, TL; Morse, RS; Petrozza, J; Snape, WJ; Valenzuela, JE; Van Deventer, GM | 1 |
| Fryklund, J; Helander, HF; Larsson, H; Wallmark, B | 1 |
| Andersson, T; Bergstrand, R; Cederberg, C | 1 |
| Carlsson, E; Ekman, L; Havu, N; Mattsson, H | 1 |
| Andersson, K; Fryklund, J; Helander, HF; Larsson, H; Wallmark, B | 1 |
| Brunner, GH; Creutzfeldt, W; Lamberts, R | 1 |
| Lundell, L | 1 |
| Arnold, R | 1 |
| Berlin, RG; Karnes, WE; Maxwell, V; Root, JK; Sytnik, B; Walsh, JH | 1 |
| Mulder, CJ; Schipper, DL | 1 |
| Maki, Y; Nagaya, H; Satoh, H | 1 |
| Elm, G; Helander, HF; Mattsson, H; Ottosson, S | 1 |
| Brunner, G; Chang, J | 1 |
| Fiorucci, S; Morelli, A; Santucci, L | 1 |
| Rowbotham, DJ | 1 |
| Jansen, JB; Lamers, CB | 1 |
| Fändriks, L; Jönson, C | 1 |
| Axelson, J; Håkanson, R; Johnell, O; Persson, P; Sundler, F | 1 |
| Bardhan, KD; Carroll, NJ; Daly, MJ; Dhande, DS; Hinchliffe, RF; Jones, RB; Morris, P; Thompson, M | 1 |
| Ewart, MC; Gin, T; Kotur, CF; Oh, TE; Yau, G | 1 |
| Bateson, MC; Burke, GJ; Dickinson, RJ; Dronfield, MW; Green, JR; Keeling, PW; McFarland, RJ; O'Donoghue, DP; Peers, EM; Shreeve, DR | 1 |
| Branicki, FJ; Hui, WM; Lai, CL; Lam, SK; Lau, WY; Lok, AS; Ng, MM; Poon, GP | 1 |
| Ahmad, H; Chelvam, P; Goh, KL; Jalleh, R; Lee, HB; Leela, MP; Leong, YP; Mahendran, T; Wong, NW; Yin, TP | 1 |
| Flemström, G; Knutson, L; Lönnerholm, G; Wistrand, PJ | 1 |
| Brunner, G; Creutzfeldt, W | 1 |
| Cluysenaer, OJ; Gerrits, C; Hazenberg, BP; Meyer, WW; Mulder, CJ; Nicolai, JJ; Stuifbergen, WH; Tijtgat, GN; Vogten, AJ | 1 |
| Bory, M; Dupin, B | 1 |
| Bianchi Porro, G; Parente, F | 1 |
| Amoruso, A; Barone, M; Di Leo, A; Francavilla, A; Ingrosso, M; Makowka, L; Panella, C; Polimeno, L; Starzl, TE | 1 |
| Davis, MA; Decktor, DL; Kellner, AT; Pendleton, RG | 1 |
| de Bruijne, JW; Lamers, CB | 1 |
| De Natale, F; De Natale, G; Marino, A | 1 |
| Arnold, R; Klein, M; Koop, H; Koop, I; Massarrat, S; Stumpf, M | 1 |
| Bardram, L; Stadil, F | 1 |
| Gardner, JD; Jensen, RT; Maton, PN | 1 |
| Bate, CM | 1 |
| Bader, JP; Classen, M; Eriksson, S; Lamers, CB; Piper, DW; Rutgersson, K; Walan, A | 1 |
| Debas, HT; Mulholland, MW | 1 |
| Barbier, P; Carlsson, R; Eriksson, S; Isal, JP; Rampal, P; Zeitoun, P | 1 |
| Delchier, JC; Eriksson, S; Isal, JP; Soule, JC | 1 |
| Sölvell, L | 1 |
| Classen, M; Schepp, W | 2 |
| Zeitoun, P | 1 |
| de Bruijne, JW; Lamers, CB; Snel, P | 1 |
| Carlsson, E; Larsson, H; Mattsson, H; Ryberg, B | 1 |
| Bishop, AE; Bloom, SR; Carlsson, E; Håkanson, R; Larsson, H; Mattsson, H; Polak, JM; Ryberg, B; Sundler, F | 1 |
| Fryklund, J; Gedda, K; Wallmark, B | 1 |
| Batzri, S; Brugada, O; Harmon, JW; Rich, NM | 1 |
| Hendel, L; Kieffer, M; Stenderup, A; Svejgaard, E; Walsøe, I | 1 |
| Guslandi, M | 1 |
| Elder, JB | 1 |
| Bader, JP; Cortot, A; Delchier, JC; Goldfain, D; Isal, JP; Mignon, M; Soule, JC; Travers, B | 1 |
| Festen, HP; Jansen, JM; Klinkenberg-Knol, EC; Lamers, CB; Meuwissen, SG | 1 |
| Katz, LB; Shriver, DA; Tobia, AJ | 1 |
| Mahachai, V; Thomson, AB | 1 |
| Desjars De Keranroué, N; Isal, JP; Zeitoun, P | 1 |
| Arnold, R; Koop, H | 1 |
| Nio, CY; Tytgat, GN | 1 |
| Nielsen, ST; Palumbo, GJ | 1 |
| Fernández, AG; Massingham, R; Roberts, DJ | 1 |
| De Graef, J; Simoens, C; Woussen-Colle, MC | 1 |
| Pounder, R | 1 |
| Ball, S; Cederberg, C; Chronos, NA; Hamilton, MR; Lanzon-Miller, S; Olausson, M; Pounder, RE; Raymond, F | 1 |
| Festen, HP; Klinkenberg-Knol, EC; Meuwissen, SG | 1 |
| Dembiński, A; Drozdowicz, D; Gregory, H; Konturek, SJ; Warzecha, Z | 1 |
| Carlsson, R; Fausa, O; Lundell, L; Sandmark, S | 1 |
| Enbom, H; Lönroth, H; Lundell, L; Ruth, M; Sandberg, N; Sandmark, S | 1 |
| Dammann, HG; Müller, P; Simon, B | 2 |
| Dammann, HG; Kommerell, B; Müller, P; Simon, B | 1 |
| Andersen, BN; Fenger, C; Hanberg-Sørensen, F; Havelund, T; Jensen, KB; Lauritsen, K; Laursen, LS; Pedersen, SA; Skoubo-Kristensen, E | 1 |
| Carlsson, E; Håkanson, R; Larsson, H; Mattsson, H; Nilsson, G; Seensalu, R; Sundler, F; Wallmark, B | 1 |
| Carlsson, E; Håkanson, R; Larsson, H; Mattsson, H; Ryberg, B; Sundler, F | 1 |
| Arnold, R; Bauer, A; Klein, M; Koop, H | 1 |
| Bartelsman, JF; Depla, AC; Jansen, HM; Roos, CM; Tytgat, GN | 1 |
| Coenegrachts, JL; Rutgeerts, L; Schurmans, P; Vantrappen, G | 1 |
| Lucke, W; Marks, IN; Marotta, F; Newton, KA; O'Keefe, SJ; Winter, TA; Wright, JP | 1 |
| Axelson, J; Håkanson, R; Hedenbro, JL | 1 |
| Abbiati, R; Barbara, L; Blasi, A; Cheli, R; Corinaldesi, R; Dobrilla, G; Francavilla, A; Gradnik, R; Rinetti, M; Vezzaldini, P | 1 |
| Batzri, S; Dubois, A; Harmon, JW; Moskowitz, D; Rich, NM; Weichbrod, R | 1 |
| Blum, AL; Fimmel, CJ; Hinder, RA; Rickards, E; Svensson, LG; von Ritter, C | 1 |
| Brunner, G; Creutzfeldt, W; Jacubaschke, U; Lamberts, R; Maas, S; Stöckmann, F | 1 |
| Brunner, G; Creutzfeldt, W; Harke, U; Lamberts, R | 1 |
| Carlsson, E; Mattsson, H; Ryberg, B | 1 |
| Isaacs, PE; Lee, FI | 1 |
| Carlsson, E; Håkanson, R; Larsson, H; Mattsson, H; Sundler, F | 1 |
| Flemström, G; Gustavsson, S; Jedstedt, G; Knutson, L; Lönnerholm, G | 1 |
| Carlsson, E; Håkanson, R; Larsson, H; Lundell, L; Mattsson, H; Sundell, G; Sundler, F; Wallmark, B; Watanabe, T | 1 |
| Berger, J; Blum, AL; Dammann, HG; Lux, G; Rehner, M; Riecken, EO; Schiessel, R; Wienbeck, M; Witzel, L | 1 |
| Blum, AL; Dammann, HG; Lux, G; Rehner, M; Riecken, EO; Schiessel, R; Wienbeck, M; Witzel, L | 1 |
| Bardhan, KD; Bianchi Porro, G; Bose, K; Daly, M; Hinchliffe, RF; Jonsson, E; Lazzaroni, M; Naesdal, J; Rikner, L; Walan, A | 1 |
| Brodin, K; Elwin, CE; Goiny, M; Uvnäs-Moberg, K | 1 |
| Katz, LB; Schoof, RA; Shriver, DA | 1 |
| Burget, DW; Howden, CW; Hunt, RH; Jones, DB | 1 |
| Allen, JM; Bishop, AE; Bloom, SR; Carlsson, E; Daly, MJ; Larsson, H; Polak, JM | 1 |
| Berger, J; Classen, M; Dammann, HG; Domschke, W; Hengels, KJ; Hüttemann, W; Londong, W; Rehner, M; Simon, B; Witzel, L | 1 |
| Deveney, CW; Deveney, KE | 1 |
| Spenney, JG | 1 |
| Berger, J; Classen, M; Dammann, HG; Domschke, W; Hüttemann, W; Londong, W; Rehner, M; Scholten, T; Simon, B; Witzel, L | 1 |
| Berger, J; Classen, M; Dammann, HG; Domschke, W; Hüttemann, W; Londong, W; Rehner, M; Simon, B; Witzel, L | 1 |
| Spiro, HM | 1 |
| Bar-Meir, S; Jedwab, M; Missri, A; Sehayek, E | 1 |
| Gustavsson, S; Mårdh, S; Norberg, L; Nyrén, O; Wollert, S | 1 |
| Misiewicz, JJ | 1 |
| Delchier, JC | 1 |
| Demling, L | 1 |
| Levine, JB | 1 |
| Cieszkowsky, M; Dabroś, W; Konturek, J; Konturek, SJ; Stachura, J; Zakrzewska, J | 1 |
| Becker, HD | 1 |
| Pounder, RE | 1 |
| Barnert, J; Fleischmann, R; Hendrich, H; Prassler, R; Richter, G; Wienbeck, M | 1 |
| Bajaj, P; Singh, B; Somwanshi, M; Tripathi, A | 1 |
| Becker, T; Börsch, G; Köhl, H; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B | 1 |
| Dettmer, A; Domschke, W; Fenner, T; Gregor, M; Hesse, P; Holtmann, G; Miederer, SE; Schentke, KU; Schütz, E; van Husen, N | 1 |
| Balanzó, J; González, D; Sáinz, S; Soriano, G; Torras, X; Vilardell, F; Villanueva, C | 1 |
| Besancon, M; Gedda, K; Lorentzon, P; Sachs, G; Scott, D | 1 |
| Guthke, A; Hotz, J; Kark, W; Otten, O; Plein, K; Wiedbrauck, F | 1 |
| Badalamenti, S; Battaglia, G; Di Mario, F; Leandro, G; Mela, GS; Pantalena, M; Pilotto, A; Savarino, V; Termini, R; Vigneri, S | 1 |
| Freeman, J; Goldberg, M; Mendelsohn, M; Rival, R; Rosgen, S; Wong, R | 1 |
| Atkinson, BF; Brightman, SA; Jhala, NC; McFarland, MM; Morale, B; Rubin, W | 1 |
| Barbier, JP; Bergmann, JF; Hamelin, B | 1 |
| Fujio, Y; Hirohata, S; Honsako, Y; Kashio, Y; Konishi, M; Kumada, H; Miura, J; Miyamoto, M; Tamada, F; Yamamoto, T | 1 |
| Bardhan, KD; Brocklebank, D; Hawkey, CJ; Long, RG; Morgan, AG; Moules, IK; Wormsley, KG | 1 |
| Ariete, V; Canelles, P; Cuquerella, J; Medina, E; Ortí, E; Quiles, F; Tomé, A; Zapater, R | 1 |
| Carlsson, R; Eriksson, S; Långström, G; Naesdal, J; Rikner, L | 1 |
| Ahmed, W; Alam, SE; Qureshi, H; Zuberi, SJ | 2 |
| Klauser, AG; Müller-Lissner, SA; Schindlbeck, NE; Voderholzer, WA | 1 |
| Blandizzi, C; Carignani, D; Del Tacca, M; Gherardi, G; Marveggio, C; Natale, G | 1 |
| Maculotti, L; Pradella, P | 1 |
| al-Assi, MT; Cole, RA; el-Zimaity, H; Genta, RM; Graham, DY; Karttunen, TJ | 1 |
| Dehbashi, N; Etaati, H; Fattahi, M; Javan, A; Massarrat, S; Saberi-Firoozi, M; Zare, S | 1 |
| Havu, N; Hurwitz, A; Kimler, BF; Looney, GA; Mattsson, H; Pinson, DM; Sztern, MI | 1 |
| Hammar, CH; Jaspersen, D; Körner, T; Schorr, W | 1 |
| Alon, E; Atanassoff, PG; Brull, SJ; Landefeld, K; Rohling, R; Weiss, BM | 1 |
| Danon, SJ; Lee, A; Moss, ND; O'Rourke, JL | 1 |
| Chen, D; Ding, XQ; Håkanson, R; Norlén, P | 1 |
| Hotz, J; Plein, K; Rose, K; Schönekäs, H | 1 |
| Johnson, CD; Mole, DR; Pestridge, A | 1 |
| Bazin, B; Bigard, MA; Colin, R; Duhamel, C; Legoux, JL; Michel, P; Person, B; Raoul, JL; Sallerin, V | 1 |
| Piper, DW | 1 |
| Avner, D; Greski-Rose, PA; Jennings, DE; Jhala, N; Robinson, M; Sahba, B | 1 |
| Abitbol, V; Barbier, JP; Bergmann, JF; Hamelin, B | 1 |
| Helander, HF; Li, H | 1 |
| Agrawal, NM | 1 |
| Cremer, M; Delle Fave, G; Lambert, R; Lamers, CB; Maier, C | 1 |
| Celle, G; Mela, GS; Savarino, V; Vigneri, S | 1 |
| Alvarez Baleriola, I; Boixeda, D; De Rafael, L; Gisbert, JP; Hernández Ranz, F; Martín de Argila, C; Redondo, C | 1 |
| Classen, M; Dammann, HG; Koop, H; Lühmann, R; Schepp, W; Schneider, A | 1 |
| Dunjic, M; Gerzic, Z; Pesko, P; Rakic, S | 1 |
| Chari, ST; Scheid, J; Singer, MV; Teyssen, S | 1 |
| Kane, R; Karjoo, M | 1 |
| Bachmann, KA; Jauregui, L; Levine, L; Miller, K; Reese, J; Sullivan, TJ | 1 |
| Dominguez, HL; Freston, JW | 1 |
| Archimandritis, A; Balatsos, V; Delis, V; Kastanas, K; Mentis, A; Scandalis, N | 1 |
| Arizón Deza, P; García Tenorio, A; Gonzalo Til, A; Manero Ruiz, I; Mur Lalueza, MJ; Pascual Parrilla, MS | 1 |
| Elsborg, L; Kiilerich, S; Rannem, T | 1 |
| Cavina, E; De Negri, F; Goletti, O; Lippolis, PV; Sidoti, F | 1 |
| Goodlad, RA | 1 |
| Bertrams, J; Börsch, G; Labenz, J; Rühl, GH | 1 |
| Blandizzi, C; Del Tacca, M; Gherardi, G; Marveggio, C; Natale, G | 1 |
| Carling, L; Edwin, B; Glise, H; Hallerbäck, B; Havu, N; Lundberg, K; Lyrenäs, E; Unge, P | 1 |
| Bate, CM; Brown, P; Cockel, R; Dronfield, MW; Green, JR; Hislop, WS; Kerr, GD; Ross, BA; Smith, PM; Theodossi, A | 1 |
| Alarcón de la Lastra, C; La Casa, C; Martín, MJ; Motilva, V | 1 |
| Chhabra, B; Gombar, K; Gombar, S; Gupta, M; Kiran, S | 1 |
| Arber, N; Avni, Y; Eliakim, R; Konikoff, F; Melzer, E; Rachmilewitz, D; Swissa, A | 1 |
| Bar-Meir, S; Bardan, E | 1 |
| Blasco Colmenarejo, MM; Cabot Lozano, A; Caneiro Alcubilla, E; García Molinero, MJ; García-Rayo Somoza, M; Herrero Quirós, C; Pérez Flores, R | 1 |
| Blanloeil, Y; Boulay, K; Bourveau, M; Geay, G; Malinovsky, JM | 1 |
| Kirch, W; Krappweis, J; Petereit, G; Schentke, KU | 1 |
| Beton, RR; Brown, CL; Johnson, CS; Stahl, WG; Waring, JP | 1 |
| James, OF; Parry-Billings, KS | 1 |
| Abbühl, B; Halter, F; Hurlimann, S; Inauen, W | 1 |
| Ahlberg, J; Bardhan, KD; Hislop, WS; Lindholmer, C; Long, RG; Morgan, AG; Sjostedt, S; Smith, PM; Stig, R; Wormsley, KG | 1 |
| Havelund, T; Lauritsen, K; Laursen, LS | 1 |
| Jönsson, B | 2 |
| Eriksson, S; Walan, A | 1 |
| Hillman, AL | 1 |
| Goff, J; Greski-Rose, P; Jennings, D; Lanza, F; Scowcroft, C | 1 |
| Jones, AW; Jönsson, KA | 1 |
| Furusawa, A; Kaneko, H; Maeda, Y; Mitsuma, T; Morise, K; Nagai, H; Nakada, K; Uchida, K | 1 |
| Feldman, M; Fisher, RS; Greski-Rose, PA; Harford, WV; Jennings, DE; Murray, SB; Sampliner, RE | 1 |
| Bhasin, DK; Khosla, PP; Sachdev, A; Saha, N; Sankaranahyanan, A; Sharma, PL; Singh, K | 1 |
| Börsch, G; Labenz, J | 1 |
| Baker, SJ; Gerring, EL | 1 |
| Colin-Jones, DG; Singh, P; Taylor, RH | 1 |
| Car, D; Cvitanović, B; Dubracić, D; Georgijević, A; Katicić, M; Pulanić, R | 1 |
| Feigenbaum, KM; Jensen, RT; Koviack, PD; Metz, DC; Orbuch, M; Strader, DB | 1 |
| Stålhammar, NO | 1 |
| Bader, JP; Delchier, JC | 1 |
| Brunner, G; Harke, U | 1 |
| Bigard, MA; Bommelaer, G; Colin, R; Dupas, JL; Lemaire, M; Michel, P; Rambaud, JC; Verwaerd, JC | 1 |
| Judmaier, G; Koelz, HR | 1 |
| Brazer, SR; Maniatis, AG | 1 |
| Dent, J; Hetzel, DJ; Mackinnon, M; Narielvala, FM; Reed, W; Shearman, DJ; Solcia, E; Yeomans, ND | 1 |
| Hotta, K; Ichikawa, T; Ishihara, K; Saigenji, K | 1 |
| Bardhan, KD; Christian, J; Cochran, KM; Hawkey, CJ; Long, RG; Moules, IK; Wormsley, KG | 1 |
| Merki, HS; Wilder-Smith, CH | 1 |
| Auricchio, S; Campanozzi, A; Cucchiara, S; D'Armiento, F; Franceschi, M; Franco, MT; Iervolino, C; Minella, R | 1 |
| Triadafilopoulos, G | 1 |
| Arakawa, T; Fukuda, T; Higuchi, K; Kimura, S; Kobayashi, K; Uchida, T | 1 |
| Naveau, S | 1 |
| Bour, B; Garcia, E; Hamelin, B; Pariente, EA | 1 |
| Alhava, E; Hendolin, H; Suojaranta-Ylinen, R | 1 |
| Battaglia, G; Chiozzini, G; De Bona, M; De Boni, M; Di Mario, F; Grasso, GA; Pasquino, M; Saggioro, A; Vianello, F | 1 |
| Achem, SR; Burton, L; Kolts, BE; Richter, JE; Wears, R | 1 |
| Andres, JM; Baron, TH; Richter, JE; Singh, S; Tennyson, GS | 1 |
| Castro, FJ; Castro, LP; Chinzon, D; Eisig, JN; Ferrari Júnior, AP; Kendo, M; Massuda, H; Miszputen, S; Silva, AE; Zaterka, S | 1 |
| Decktor, DL; Kogut, D; Maton, PN; McCullough, A; Pardoll, P; Roberts, W; Robinson, M; Roufail, W; Sabesin, S; Saco, L | 1 |
| Neymour, R | 1 |
| Berstad, A; Hatlebakk, JG | 2 |
| Arnold, R; Brunner, G; Fuchs, W; Hennig, U | 1 |
| Bukhave, K; Hillingsø, J; Mertz-Nielsen, A; Rask-Madsen, J | 2 |
| Grey, MR | 1 |
| Grossman, MR; Mellow, MH; Orr, WC | 1 |
| Arroyo, MT; Artal, A; Blás, JM; Lanas, A; Lopez-Zaborras, J; Sáinz, R | 1 |
| Agostini, H; Lemaire, M; Poynard, T | 1 |
| Goebell, H; Holtmann, G; Layer, P | 2 |
| Maekawa, N; Mikawa, K; Nishina, K; Obara, H; Shiga, M; Takao, Y | 2 |
| Chen, D; Ding, XQ; Hakanson, R; Persson, L; Rosengren, E | 1 |
| Artal, A; Barrao, ME; Blas, JM; Lanas, A; López, J; Moliner, FJ | 1 |
| Asbury, AJ; Birrell, H; Bowie, RA; Braid, DP; Gillon, KR; Levack, ID; Marshall, RL; Slawson, KB | 1 |
| Arnestad, JS; Waldum, HL | 1 |
| Bischof, G; Feil, W; Riegler, M; Schiessel, R; Wenzl, E | 1 |
| Gin, T; Kan, AF; Rowbottom, SJ; Stuart, JC; Yau, G | 1 |
| Amagase, K; Kato, S; Okabe, S; Yamamoto, H | 1 |
| Auquier, P; Carrère, MO; Poynard, T; Sambuc, R | 1 |
| Caucheteur, B; De Koster, E; Deltenre, M; Jonas, C; Otero, J | 1 |
| Cantero, J; Gómez-Cedenilla, A; Grávalos, RG; Pajares, JM; Santander, C | 1 |
| Collen, MJ; Kerr, RM; Kogut, DG; Richter, JE; Sabesin, SM; Wruble, LD | 1 |
| Christian, J; Foster, CS; Garrett, AD; Gough, AL; Langworthy, CH; Swarbrick, ET | 1 |
| Hameeteman, W; Hooi, J; Houben, GM; Stockbrügger, RW | 1 |
| Dial, EJ; Illich, PA; Lichtenberger, LM; Romero, JJ; Ulloa, C; Vanous, AL | 1 |
| Cole, RA; el-Zimaity, HM; Genta, RM; Graham, DY; Yousfi, MM | 1 |
| Cooper, BT; Fosters, CS; Garrett, AD; Gough, AL; Langworthy, CH; Long, RG | 1 |
| Ansel, HJ; Farahmand, M; Ho, SB; Johnson, JA; Silvis, SE | 1 |
| Driman, DK; Riddell, RH; Tougas, G; Wright, C | 1 |
| De Fanis, C; Di Virgilio, M; Magnarini, C; Masciulli, V; Pantaleone, U; Pizzicannella, G; Sciampa, G; Spadaccini, A | 1 |
| Lambert, R | 1 |
| Brennenstuhl, M; Hammar, CH; Jaspersen, D; Raschka, C; Schorr, W; Schwacha, H | 1 |
| Lamers, CB | 1 |
| Brummer, RJ; Hooi, J; Houben, GM; Stobberingh, EE; Stockbrügger, RW | 1 |
| Bamford, KB; Collins, JS; Molloy, C; Sloan, JM; Tham, TC; Watson, RG | 1 |
| Dítĕ, P; Drazná, E; Dufek, V; Dvorák, M; Fric, P; Huslarová, A; Jirásek, V; Kunovská, M; Münzová, H; Pelech, T; Petrtýl, J; Roth, Z; Svoboda, J; Zádorová, Z; Zavoral, M | 1 |
| Asano, S; Inatomi, N; Murakami, I; Nagaya, H; Satoh, H; Yukishige, K | 1 |
| Asano, S; Inada, I; Inatomi, N; Murakami, I; Satoh, H | 1 |
| Campbell, DR; Castell, D; Fleischmann, R; Kogut, DG; Lehman, GA; McFarland, M; Richter, J; Robinson, M; Sabesin, S; Sontag, SJ | 1 |
| Chey, WD; DelValle, J; Nostrant, TT; Scheiman, JM; Woods, M | 1 |
| Chen, TL; Hsu, HW; Huang, CL; Lin, CJ | 1 |
| Kinoshita, M; Saito, N; Tamaki, H | 1 |
| Bargiggia, S; Bianchi Porro, G; Lazzaroni, M | 1 |
| Arnestad, JS; Kleveland, PM; Waldum, HL | 1 |
| Buljat, G; Gjurasin, M; Grabarević, Z; Hanzevacki, M; Jadrijević, S; Jagić, V; Jelovac, N; Jurina, L; Konjevoda, P; Marović, A; Miklić, P; Mikus, D; Mise, S; Perić, J; Perović, D; Petek, M; Rotkvić, I; Rucman, R; Seiwerth, S; Separović, J; Sikirić, P; Turković, B; Zoricić, I | 1 |
| Blum, AL; Börsch, G; Labenz, J; Leusing, C; Peitz, U; Tillenburg, B | 1 |
| Fölsch, UR; Katsoulis, S | 1 |
| Holm, L; Persson, AE; Synnerstad, I | 1 |
| Lee, SD; Lin, HJ; Lo, WC; Perng, CL; Wang, K | 1 |
| Levy, MJ; Ranney, JE; Robinson, NJ; Seelig, CB | 1 |
| Biemond, I; Götz, JM; Lamers, CB; Offerhaus, GJ; Thio, JL; Veenendaal, RA; Verspaget, HW | 1 |
| Ballesta, A; Gómez, F; Ortiz, JA; Romero, A; Sacristán, A; Villamayor, F | 1 |
| Murray, MJ | 1 |
| Carlsson, R; Dent, J; Frison, L; Galmiche, JP; Lundell, L | 1 |
| Ido, K; Kihira, K; Kimura, K; Saifuku, K; Satoh, K; Takimoto, T; Taniguchi, Y; Yamamoto, H; Yoshida, Y | 1 |
| Baxter, G; Jones, RH | 1 |
| Blum, AL; Börsch, G; Labenz, J; Peitz, U; Stolte, M; Tillenburg, B; Verdú, E | 1 |
| Fuchs, W; Müller, P; Simon, B | 1 |
| Isolauri, J; Nevalainen, J; Viljakka, M | 1 |
| Hirakawa, T | 1 |
| Lácha, J; Marecková, O; Matl, I; Skála, I; Vítko, S | 1 |
| Amadori, L; Arnone, F; Barillari, P; Bolognese, A; Cardi, M; Muttillo, IA; Sammartino, P; Signorelli, C | 1 |
| Alarcón de la Lastra, C; La Casa, M; López, A; Martin, MJ; Motilva, V | 1 |
| Ammon, S; Klotz, U; Treiber, G | 1 |
| Levy, N; Neeman, I; Stermer, E; Tabak, M | 1 |
| Dorlars, D; Kohler, B; Maier, M; Riemann, JF; Schauwecker, P; Schilling, D; Wehlen, G | 1 |
| Abucar, A; Armbrecht, U; Hameeteman, W; Schneider, A; Stockbrügger, RW | 1 |
| Hole, J; Newland, RD; Patel, AC; Turbitt, ML; Venables, TL; Wilcock, C | 1 |
| Blohmé, I; Mjörnstedt, L; Olausson, M; Wramner, L | 1 |
| Addis, A; Koren, G; Lalkin, A; Loebstein, R; Magee, L | 1 |
| Jick, H; Meier, CR | 1 |
| Harris, RA; Kuppermann, M; Richter, JE | 1 |
| Dixon, JS; Pipkin, GA; Williamson, R; Wood, JR | 1 |
| Florholmen, J; Løvhaug, N; Støa-Birketvedt, G; Vonen, B | 1 |
| Döbrönte, Z; Juhász, L; Lonovics, J; Papp, J | 1 |
| Bazzoli, F; Pozzato, P | 1 |
| Deltenre, M; Ilunga, KO | 1 |
| Fennerty, MB | 1 |
| Dall'Oglio, L; De Peppo, F; Federici di Abriola, G; Lucchetti, MC; Marchetti, P; Ponticelli, A; Rivosecchi, M; Zaccara, A | 1 |
| Dattilo, M; Russo, A | 1 |
| Comin, U; Cortelezzi, C; Curzio, M; Ferrara, A; Ferraris, L; Gullotta, R; Minoli, G; Prada, A; Rocca, F | 1 |
| Hawkey, CJ; Howard, JM; Juhász, L; Rácz, I; Swannell, AJ; Tulassay, Z; van Rensburg, CJ; Yeomans, ND | 1 |
| Dubois, D; Eggleston, A; Haycox, A; Huijghebaert, S; Wigerinck, A | 1 |
| Babul'ová, A; Bauer, V; Nosál'ová, V | 1 |
| Bardhan, KD; Bishop, A; Brooks, A; Cherian, P; D'Silva, J; Gillon, KR; Jones, RB; Manek, S; Morris, P; Parkin, S; Patterson, J; Polak, J; Thompson, M; Vaishnavi, A | 1 |
| Smout, AJ | 1 |
| King, VJ | 1 |
| Brown, KL; Fisher, RS; Knight, LC; Maurer, AH; Miller, MA; Parkman, HP; Trate, DM; Urbain, JL | 1 |
| Lanas Arbeloa, A; Serrano Aulló, MT | 1 |
| Das, AS; De, PK; Konar, A; Mazumder, DN; Roy, A | 1 |
| Bloom, BS; Cutler, AF; Schwartz, JS; Sonnenberg, A; Vakil, N | 1 |
| Evans, WM; Mason, I; Millar, LJ; Sheikh, RR; Taylor, MD; Todd, PL; Turbitt, ML | 1 |
| Talley, NJ | 1 |
| Lanza, FL | 1 |
| Jönsson, B; Wahlqvist, P | 1 |
| Harris, A | 1 |
| Fehér, A; Jármay, K; Kiss, I; Oláh, T; Rosztóczy, A; Szendrényi, V; Wittmann, T | 1 |
| Bardhan, KD; Bianchi Porro, G; Bigard, MA; Fulton, C; Gillon, K; Hosie, J; Müller-Lissner, S; Peacock, R; Ponce, J; Scott, M; Weir, D; Wiklund, I | 1 |
| Müller, P; Simon, B | 1 |
| Hetzel, D | 1 |
| Bianchi Porro, G; Cucino, C; Imbesi, V; Maconi, G; Manzionna, G; Parente, F; Vago, L | 1 |
| Crobach, LF; Geraedts, AA; Kolkman, JJ; Nicolai, JJ; Oudkerk Pool, M; Tan, TG; Timmerman, RJ; Van Der Laan, J; Van Kleef, WA; Wolff, AA | 1 |
| Alm, C; Grahnén, A; Hedenström, H; Kraft, M | 1 |
| Lambert, JR; Treiber, G | 1 |
| Field, SK; Sutherland, LR | 1 |
| Carvalho, AF; Da Silva, CM; De Nucci, G; Ferraz, JG; Fiorelli, LA; Jorge, VN; Pedrazzoli, J | 1 |
| Abighanem, O; Achard, JM; Brazier, M; Fournier, A; Hardy, P; Hottelart, C; Moriniere, P; Oprisiu, R; Pruna, A; Rasombololona, M; Said, S; Sechet, A | 1 |
| Girbes Pelechano, VJ; Llopis-González, A; Morales Suárez-Varela, MM; Pérez-Benajas, MA | 1 |
| Brown, AS; James, OF | 1 |
| Bentivegna, C; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R; Condorelli, G | 1 |
| Butruk, E; Dziurkowska-Marek, A; Hennig, E; Kohut, M; Marek, T; Nowak, A; Ostrowski, J; Przytulski, K; Regula, J | 1 |
| Dowling, RH; Gainsborough, N; Pereira, SP | 1 |
| Chan, FK; Sung, JJ | 1 |
| DeMarco, PJ; Schulman, S; Shikhman, AR | 1 |
| Alarcón, T; Domingo, D; López-Brea, M; Martínez, MJ; Sánchez, I; Sanz, JC | 1 |
| Chan, FK; Cheng, AF; Chung, SC; Lee, YT; Leung, WK; Ling, TK; Sung, JJ; Yung, MY | 1 |
| Kiel, G; Meining, A; Stolte, M | 1 |
| Balzanelli, MG; Catalano, A; Clemente, F; Coraggio, F; Marmo, R; Moccia, F; Parola, PC; Rotondano, G | 1 |
| Aran-Suau, R; Berenguer, J; Caswell, C; Clerch, L; Da Silveira, JC; Diaz de Rojas, F; Garcia Aparicio, P; Rodrigo, L | 1 |
| Dettmer, A; Fischer, R; Lühmann, R; Schneider, A; Sielaff, F; Vogt, R | 1 |
| De Fanis, C; Di Virgilio, M; Pantaleone, U; Pizzicanella, G; Russo, L; Sciampa, G; Silla, M; Spadaccini, A | 1 |
| Jeppesen, PB; Mortensen, PB; Staun, M; Tjellesen, L | 1 |
| Howden, CW; Hunt, RH | 1 |
| Chan, CK; Cheung, E; Ching, TY; Chu, KM; Kong, Y; Kou, M; Kumana, CR; Lam, SK; Seto, WH | 1 |
| Castell, DO; Katz, PO; Peghini, PL | 1 |
| Fendrick, AM; Scheiman, JM | 1 |
| Akiba, Y; Kaunitz, JD; Tanaka, S | 1 |
| Arai, H; Inoie, M; Marubuchi, S | 1 |
| Jansen, JB; Laheij, RJ; Severens, JL; Verbeek, AL | 1 |
| Aralica, G; Desković, S; Grabarević, Z; Jadrijević, S; Konjevoda, P; Marović, A; Perović, D; Petek, M; Rucman, R; Seiwerth, S; Sikirić, P; Sosa, T; Turković, B | 1 |
| Grabau, BJ; Hardy, KJ; Shulkes, A; Zavros, Y | 1 |
| Arnestad, JS; Brenna, E; Qvigstad, G; Waldum, HL | 1 |
| Freedman, MD | 1 |
| Collier, DS; Olsen, KM; Peddicord, TE | 1 |
| Bertaccini, G; Coppelli, G; Coruzzi, G; Frati, P | 1 |
| Gaia, C; Gut, A; Halter, F; Huluk, T; Hüsler, J; Inauen, W; Netzer, P; Sandoz, M | 1 |
| Bardhan, KD; Bianchi Porro, G; Bigard, MA; Fulton, C; Gillon, KR; Hosie, J; Müller-Lissner, S; Peacock, RA; Ponce, J; Scott, M; Weir, DG | 1 |
| Kihira, K; Kimura, K; Kumakura, Y; Sato, K; Sugano, K; Yoshida, Y | 1 |
| Kanayama, S | 1 |
| Albillos Martínez, A; Ortiz Berrocal, J; Pérez Páramo, M | 1 |
| Freston, JW; Haber, M; Heller, CA; Jennings, D; Rose, PA | 1 |
| Alander, V; Sintonen, H | 1 |
| Bate, CM; Richardson, PD | 1 |
| Bloom, BS | 1 |
| Bloom, BS; Hillman, AL; LaMont, B; Liss, C; Schwartz, JS; Stever, GJ | 1 |
| Brosolo, P; Damiani, D; de Pretis, G; Geromin, A; Grimaz, S; Skert, C | 1 |
| Festen, HP; Nelis, F; Schenk, E; Snel, P; Tan, G | 1 |
| Olson, CA; Sonnenberg, A; Zhang, J | 1 |
| Impicciatore, M; Letari, O; Makovec, F; Mennuni, L; Revel, L | 1 |
| García Rodríguez, LA; Ruigómez, A | 1 |
| Bisso, G; Celle, G; Mansi, C; Mela, GS; Mele, MR; Pivari, M; Savarino, V; Termini, R; Vigneri, S; Zentilin, P | 1 |
| Castell, DO; Hammod, R; Katz, PO; Khoury, RM | 1 |
| Newton, WP; Salzberg, SA | 1 |
| Busch, N; Handt, S; Heintz, B; Kierdorf, H; Marschall, H; Mertens, PR; Schönfelder, T; Sieberth, H | 1 |
| Levenson, SD; Pauly, MP; Schwartz, JS; Sonnenberg, A | 1 |
| Jacoby, EB; Porter, KB | 1 |
| Archimandritis, A; Balatsos, V; Delis, V; Manika, Z; Skandalis, N | 1 |
| Mulder, PG; Samsom, M; Smout, AJ; van Herwaarden, MA; van Nispen, CH | 1 |
| Joelsson, B; Maton, PN; Orlando, R | 1 |
| Bardhan, KD; Crouch, SL; Crowe, J; Keeling, PN; Thompson, RP; Trewby, PN; Weir, D | 1 |
| Cross, R; Grimley, CE; Illing, RC; Lismore, JR; Loft, DE; Nwokolo, CU; O'sullivan, M; Penny, A; Shebani, M | 1 |
| Ganesh, S; Kleibeuker, JH; Klinkenberg-Knol, EC; Kuipers, EJ; Lamers, CB; Peters, FT; Sluiter, WJ | 2 |
| Hawkey, CJ; Yeomans, ND | 1 |
| Itoh, M; Joh, T; Kurokawa, T; Sasakii, M; Seno, K; Tsuchida, K; Yokoyama, Y | 1 |
| Berstad, A; Hatlebakk, JG; Olafsson, S; Wilhelmsen, I | 1 |
| Bardhan, KD; Farley, A; French, PC; Paré, P; Roberts, PM; Romãozinho, JM | 1 |
| Castell, DO; Katz, PO; Khoury, RM | 1 |
| Agostinis, L; Cattaruzzi, C; García Rodríguez, LA; Johansson, S; Ruigómez, A; Troncon, MG; Wallander, MA | 1 |
| Bravo, LE; Campo, C; Correa, P; Mera, R; Realpe, JL | 1 |
| Arakawa, T; Ohara, T | 1 |
| Axon, A | 1 |
| Dave, B; Rubin, W | 1 |
| Wani, MK; Woodson, GE | 1 |
| Carpio, D; Gisbert, JL; Gisbert, JP; Grávalos, RG; Marcos, S; Pajares, JM | 1 |
| Jansen, JB; Van Oene, JC | 1 |
| Crawley, JA; Joelsson, BO; Levine, DS; Revicki, DA; Zodet, MW | 1 |
| Archambault, AP; Bailey, RJ; Bianchi Porro, G; Bolling, E; Brunner, G; Eriksson, S; Frison, L; Galmiche, JP; Gudjónsson, H; Havu, N; Lauritsen, K; Rutgersson, K; Thompson, AB; Walan, A | 1 |
| Chan, FK; Chung, SC; Ling, TK; Suen, R; Sung, JJ; Wu, JC | 1 |
| Chey, WD; Chien, NN; Chung, NQ; Connor, BA; Henley, KS; Hoan, PQ; Hop, TV; Lak, BV; Long, T; Mao, HV; Perez-Perez, GI; Stone, CD; Thang, DM | 1 |
| de Paula Castro, L; Lyra, LG; Malafaia, O; Meneghelli, UG; Zaterka, S | 1 |
| Abbasciano, V; Nielsen, I; Panzini, I; Sartori, S; Tassinari, D; Trevisani, L | 1 |
| Bardhan, KD; Bigard, MA; Carlsson, J; Fulton, C; Gillon, K; Hosie, J; Müller-Lissner, S; Peacock, R; Ponce, J; Porro, GB; Scott, M; Stålhammar, NO; Weir, DG | 1 |
| Bilardi, C; Bisso, G; Dulbecco, P; Mele, MR; Pivari, M; Savarino, V; Tracci, D; Vigneri, S; Zentilin, P | 1 |
| Ballardini, G; Boni, F; Bortoli, A; Colombo, E; Minoli, G; Spinzi, GC; Venturelli, R | 1 |
| Bethke, T; de K Grundling, H; Fischer, R; O'Keefe, SJ; Retief, FJ; Theron, I; van Rensburg, CJ; van Zyl, JH | 1 |
| Arroyo, MT; Lanas, A; Sáinz, R | 1 |
| Breiter, JR; Humphries, TJ; Riff, D | 1 |
| Armuzzi, A; Gasbarrini, A; Gasbarrini, G; Ghirlanda, G; Ojetti, V; Pitocco, D; Pola, P; Silveri, NG | 1 |
| Hara, M; Ono, H; Ooie, T; Saikawa, T; Sakata, T; Seike, M | 1 |
| Fujita, N; Kassai, K; Kondo, M; Naito, Y; Tanaka, Y; Yoshida, N; Yoshikawa, T | 1 |
| Agrawal, NM; Campbell, DR; Haber, MM; Huang, B; Lukasik, NL; Safdi, MA | 1 |
| Carpio, D; García Grávalos, R; Gisbert, JL; Gisbert, JP; Marcos, S; Pajares, JM | 1 |
| Pardi, DS | 1 |
| Balta, A; Bouzakis, H; Broutet, N; Kralios, N; Michopoulos, S; Tsibouris, P; Vougadiotis, J | 1 |
| Ammon, S; Kees, F; Klotz, U; Treiber, G | 1 |
| Bielanski, W; Brzozowski, T; Drozdowicz, D; Hahn, EG; Konturek, PC; Konturek, SJ; Kwiecieñ, S; Pajdo, R | 1 |
| Campbell, DR; Fludas, C; Huang, B; Kahrilas, PJ; Richter, JE | 1 |
| Kaplan-Machlis, B; Revicki, DA; Spiegler, GE; Zodet, MW | 1 |
| Arroyo, MT; Lanas, A | 1 |
| Coombes, JA; Leditschke, IA | 1 |
| Inauen, W; Netzer, P | 2 |
| Farley, A; Humphries, TJ; Wruble, LD | 1 |
| Castell, DO | 1 |
| Castellote, J; Porta, F | 1 |
| Velanovich, V | 1 |
| Buzás György, M; Illyés, G; Székely, E; Széles, I | 1 |
| Arnold, R; Blum, AL; Fischer, M; Koelz, HR; Stolte, M | 1 |
| Lelcuk, S; Menes, T; Spivak, H | 1 |
| Habu, Y; Inokuchi, H; Kawai, K; Kiyota, K; Oyasu, K; Sumitomo, Y; Wakamatsu, T | 1 |
| Bentivegna, C; Branciforte, G; Brogna, A; Catalano, F; Catanzaro, R; Cipolla, R | 1 |
| Bandyopadhyay, D; Bandyopadhyay, U; Banerjee, RK; Biswas, K; Reiter, RJ | 1 |
| Ippoliti, A; Lewin, K; Lieberman, D; Ofman, JJ; Ramers, C; Weinstein, W | 1 |
| Bezborodnyĭ, SD | 1 |
| Soto Alvarez, J | 1 |
| Dillon, JF; Johnston, DA; MacDonald, TM; Todd, JA; Weston, T | 1 |
| Graham, DY | 2 |
| Lanas, AI | 1 |
| Mégraud, F; Roberts, P; Williamson, R | 1 |
| Larson, LR; Ofman, JJ; Siddique, RM; Willian, MK; Yamashita, BD | 1 |
| de Jager-Krikken, A; Ganesh, S; Karrenbeld, A; Kleibeuker, JH; Klinkenberg-Knol, EC; Kuipers, EJ; Lamers, CB; Peters, FT; Sluiter, WJ | 1 |
| Chan, CK; Chu, KM; Fung, FM; Hu, WH; Lai, KC; Lam, SK; Lau, GK; Leung, SY; Wang, WH; Wong, BC; Wong, WM; Yuen, MF; Yuen, ST | 1 |
| Castell, DO; Katz, PO; Katzka, DA; Ramakrishnan, A; Srinivasan, R; Vela, MF | 1 |
| Anic, T; Aralica, G; Bilic, I; Buljat, G; Ivankovic, D; Mikus, D; Mise, S; Perovic, D; Petek, M; Prkacin, I; Rotkvic, I; Rucman, R; Seiwerth, S; Separovic, J; Sikiric, P; Stancic-Rokotov, D; Zoricic, I | 1 |
| Caffarelli, C; Caruana, P; de'Angelis, GL; Fornaroli, F; Magliani, W; Manfredi, M; Street, ME | 1 |
| Chuang, CH; Lin, XZ; Sheu, BS; Wu, JJ; Yang, HB | 1 |
| Christensen, JM; Hollingshead, N; Huber, M; Limsakun, T; Smith, BB | 1 |
| Biedermann, A; Kaspari, S; Mey, J | 1 |
| Bardou, M | 1 |
| Belmonte, A; Cavaliere, C; Ciliberto, E; Fiocca, R; Frandina, C; Giglio, A; Luzza, F; Pallone, F; Saccà, N; Trimboli, V | 1 |
| McGuigan, JE | 1 |
| Freston, JW; Henning, JM; Howden, CW; Huang, B; Lukasik, N | 1 |
| Andriulli, A; Annese, V; Niro, GA; Perri, F; Quitadamo, M; Villani, MR | 1 |
| Dixon, CA; Hopkins, RJ; Meyer, JM; Siepman, NY; Silliman, NP; Sugg, JE | 1 |
| Ell, C; Moser, W; Ridl, W; Schoerner, C; Solbach, W; Stolte, M; Vieth, M | 1 |
| Blandizzi, C; Del Tacca, M; Gherardi, G; Lazzeri, G; Lenzi, P; Natale, G; Pellegrini, A | 1 |
| Hojo, M; Miwa, H; Nagahara, A; Sato, N | 1 |
| Adamek, RJ; Behrendt, J; Wenzel, C | 1 |
| Buskens, E; de Wit, NJ; Lewin van den Broek, NT; Numans, ME; Smout, AJ; Verheij, TJ | 1 |
| Fedorov, AV; Sazhin, VP | 1 |
| Caro, JJ; Salas, M; Ward, A | 1 |
| Bujanda, L; Cosme, A; Iriondo, C; Muñoz, C; Sánchez, A; Santos, A | 1 |
| Ahmad, MM; Arefin, MS; Bardhan, P; Bauerfeind, P; Beglinger, C; Glatz-Krieger, K; Gyr, N; Hasan, M; Hildebrand, P; Khan, AK; Parvin, S; Rahman, A; Rossi, L; Terracciano, L | 1 |
| Cimmino, A; Melton, ST | 1 |
| Dudik, TV; Il'chenko, AA; Kaprel'yants, AS; Loginov, AS; Reshetnyak, VI; Vostroknutova, GN | 1 |
| Colwell, HH; Henning, JM; Mathias, SD; Miller, DP; Ofman, JJ; Pasta, DJ | 1 |
| Corder, FA; Howden, CW; Sahai, AV; Sharma, VK | 1 |
| Fasseas, P; Leybishkis, B; Rocca, G | 1 |
| De Francesco, V; Faleo, D; Hassan, C; Ierardi, E; Morini, S; Panella, C; Zullo, A | 1 |
| Ammon, S; Klotz, U; Treiber, G; van Doorn, LJ; Walker, S; Wittig, J | 1 |
| Ciociola, AA; Filinto, J; Gardner, JD; Miner, PB; Robinson, M; Rodriguez-Stanley, S; Zubaidi, S | 1 |
| Axon, A; Graham, DY; Hungin, AP; Jones, R; Malfertheiner, P; Mégraud, F; O'Morain, C; Tytgat, G | 1 |
| Beck, IT | 1 |
| Fackler, WK; Ours, TM; Richter, JE; Vaezi, MF | 2 |
| Astudillo, L; Bustamante, C; Rodríguez, JA; Schmeda-Hirschmann, G | 1 |
| Andriulli, A; Clemente, R; Festa, V; Merla, A; Perri, F; Quitadamo, M | 1 |
| Cross, LB; Justice, LN | 1 |
| Adachi, K; Kinoshita, Y | 1 |
| Astudillo, L; Rodriguez, JA; Schmeda-Hirschmann, G | 1 |
| Bowrey, DJ; Jurewicz, WA; Logan, AJ; Morris-Stiff, GJ | 1 |
| Muravtseva, OV; Vakhrushev, IaM | 1 |
| Almeida, JR; Boaventura, S; Castro, LP; Ferrari, AP; Fischer, R; Haddad, MT; Jorge, JL; Leitão, O; Magalhães, AF; Maguilnik, I; Meneghelli, UG; Moraes-Filho, JP; Silva, E; Tolentino, M | 1 |
| Mikawa, K; Morikawa, O; Nishina, K; Obara, H; Takao, Y; Uesugi, T | 1 |
| Bandyopadhyay, A; Bandyopadhyay, D; Das, PK; Reiter, RJ | 1 |
| Bowser, E; Francisco, MP; Novak, DA; Sherman, JM; Theriaque, D; Wagner, MH | 1 |
| Hiraishi, H; Ota, S; Terano, A | 1 |
| Hawkey, CJ; Långström, G; Naesdal, J; Peacock, RA; Swannell, AJ; Wilson, I; Yeomans, ND | 1 |
| Hawkey, CJ; Långström, G; Naesdal, J; Swannell, AJ; Wilson, I; Yeomans, ND | 1 |
| Cuena Boy, R | 1 |
| Campbell, DR; Collis, C; Goldstein, JL; Haber, MM; Huang, B; Lukasik, N; Sheldon, E | 1 |
| de la Porte, M; Reith, D; Tilyard, M | 1 |
| Katelaris, P; Moore, MG; Sprogis, A; Talley, NJ | 1 |
| Babkova, IV; Cherniakevich, SA; Mikhalev, AI | 1 |
| Bago, J; Bevanda, M; Bilić, A; Halle, ZB; Jandrić, D; Kućisec, N; Strinić, D; Tomić, M | 1 |
| Abraham, D; Saltoun, CA | 1 |
| Bochenek, WJ; Metz, DC | 1 |
| Yapicioglu, H; Yildizdas, D; Yilmaz, HL | 1 |
| Farup, PG; Høie, O; Lange, OJ; Tholfsen, J; Torp, R; Wetternus, S | 1 |
| Huggins, RM; Latour, JK; Scates, AC | 1 |
| Bianchi Porro, G; Pace, F; Pallotta, S | 1 |
| Biagini, R; Bilardi, C; Dulbecco, P; Gambaro, C; Iiritano, E; Mansi, C; Mele, MR; Savarino, V; Tessieri, L; Usai, P; Vigneri, S; Zentilin, P | 1 |
| Israel, D; Jacobson, K; Jevon, G; Ramaswamy, K | 1 |
| Hiramoto, JS; Norton, JA; Terdiman, JP | 1 |
| Bardhan, KD; Nayyar, AK; Royston, C | 1 |
| Kamolz, T; Pointner, R; Velanovich, V | 1 |
| Prasad, M; Rentz, AM; Revicki, DA | 1 |
| Ermolaev, IA; Nazarov, VE; Rukhliada, NV | 1 |
| Bernsand, M; Bjorkqvist, M; Ericsson, P; Hakanson, R; Norlen, P; Zhao, CM | 1 |
| Anic, T; Batelja, L; Bedekovic, V; Boban Blagaic, A; Drvis, P; Gjurasin, M; Kalogjera, L; Kopljar, M; Mise, S; Seiwerth, S; Sikiric, P; Staresinic, M | 1 |
| Barkun, A; Chiba, N; Cockeram, A; Dallaire, C; Fallone, C; Farley, A; Nicholls, B; Simms, L; Veldhuyzen van Zanten, S | 1 |
| Andriulli, A; Barberani, F; Festa, V; Merla, A; Perri, F; Pilotto, A | 1 |
| Balatsinou, C; Caldarella, MP; Cuccurullo, F; Di Bonaventura, G; Lapenna, D; Laterza, F; Milano, A; Neri, M; Piccolomini, R | 1 |
| Adachi, K; Amano, Y; Fujishiro, H; Karim Rumi, MA; Kawamura, A; Kinoshita, Y; Komazawa, Y; Mihara, T; Ono, M; Yuki, M | 1 |
| Karamanlioglu, B; Memiş, D; Pamukçu, Z; Saral, P; Turan, A; Türe, M | 1 |
| Gandhi, MS; Goswami, SS; Santani, D; Shah, MB; Shah, PJ | 1 |
| Crawley, JA; Joshua-Gotlib, S; Levine, D; Revicki, DA; Zodet, MW | 1 |
| Allakhverdian, AS; Isakov, VA; Mazurin, VS; Morozov, SV | 1 |
| Abu Farsakh, N | 1 |
| Vithayasai, N | 1 |
| Chu, CH; Hsu, TC; Huang, PC; Leu, SC; Su, CF; Wang, TE | 1 |
| Farup, PG | 1 |
| Baik, SK; Cho, MY; Kim, HS; Kim, JM; Kim, JW; Kwon, SO; Lee, DK; Suk, KT | 1 |
| Johnston, G; Lee, C; Stolle, J; Tolia, V | 1 |
| Badhe, A; Gouda, BB; Lydon, AM; Shorten, GD | 1 |
| Fischer, R; van Rensburg, C; van Zyl, J; Vieweg, W | 1 |
| Calvet, X; Gené, E; Güell, M; Montserrat, A; Vergara, M | 1 |
| Demir, N; Demir, Y; Nadaroğlu, H | 1 |
| Chan, HH; Hsu, PI; Lai, KH; Lin, CK; Lo, CC; Lo, GH; Shie, CB; Tsai, PM; Wang, WM; Wu, CJ; Wu, DC | 1 |
| Adejare, A; George, M; Madaras-Kelly, K; May, MP; Michas, P | 1 |
| Isakov, VA | 1 |
| Buzás, GM | 1 |
| Farcau, D; Leucuta, A; Nanulescu, M; Vlase, L | 1 |
| Furukawa, H; Hata, M; Hattori, T; Iida, M; Negishi, N; Sekino, H; Sezai, A; Sezai, Y; Shiono, M; Soeda, M; Taoka, M; Wakui, S; Yoshitake, I | 1 |
| Bloom, SR; Dhillo, WS; Jackson, JE; Jayasena, CN; Lynn, JA; Meeran, K; Todd, JF | 1 |
| Isakov, VA; Ivanova, OV; Paleev, NR | 1 |
| Färkkilä, MA; Heikkinen, MT; Koivisto, TT; Koskenpato, JP; Rautelin, HI; Voutilainen, ME | 1 |
| Allen, DG; Bersenas, AM; Conlon, PD; Mathews, KA | 1 |
| Filik, L; Köksal, AS; Odemiş, B; Ozden, A; Parlak, E; Sahin, B; Saşmaz, N; Ulker, A; Yolcu, OF | 1 |
| Armstrong, D; Barkun, AN; Chakraborty, B; Chiba, N; Sinclair, P; Smyth, S; Thomson, AB; Veldhuyzen van Zanten, SJ; White, RJ | 1 |
| Han, SY; Jee, SR; Kim, DH; Lee, JT; Park, SJ; Seol, SY; Urm, SH | 1 |
| Armstrong, D; Barkun, A; Chiba, N; Escobedo, S; Lee, J; Sinclair, P; Smyth, S; Thomson, A; Veldhuyzen van Zanten, SJ | 1 |
| Adem, A; Adeyemi, EO; Bastaki, SA; Chandranath, IS; Fahim, M; Hasan, MY | 1 |
| Bayeli, PF; Cerretani, D; Giorgi, G; Marzocca, G; Pellegrini, M; Urso, R | 1 |
| Brodsky, L; Ulualp, S | 1 |
| Lester, GD; Robertson, ID; Smith, RL | 1 |
| Habu, Y; Hayakumo, T; Hayashi, K; Kawai, K; Kusuda, T; Maeda, K; Shio, S; Watanabe, Y; Yamazaki, M; Yoshino, T | 1 |
| Sakaki, N | 1 |
| Baek, JT; Chung, IK; Jeong, HY; Kim, AN; Kim, SH; Kim, SJ; Lee, BS; Lee, DS; Lee, GS; Lee, JM; Lee, SH; Lee, TY; Nam, SW; Oh, JI; Shin, JE; Sung, JK; Yoon, SJ | 1 |
| Furukawa, H; Hata, M; Hattori, T; Iida, M; Negishi, N; Sekino, H; Sezai, A; Sezai, Y; Shiono, M; Taoka, M; Wakui, S; Yoshitake, I | 1 |
| Bryan, J; Dettmar, PW; Little, SL; Sykes, J | 1 |
| Carlsson, J; Carlsson, R; Glise, H; Wiklund, I | 1 |
| Lule, GN | 1 |
| Canani, RB; Cirillo, P; Guarino, A; Malamisura, B; Manguso, F; Morelli, L; Passariello, A; Roggero, P; Romano, C; Terrin, G | 1 |
| Kozak, FK; Ludemann, JP | 1 |
| Bozkurt, B; Demirkan, K; Kalyoncu, AF; Karakaya, G | 1 |
| Liu, FC; Pan, T; Wang, YP; Yang, JL | 1 |
| Garcia, I; Krishna, P; Rosen, CA | 1 |
| Cunha-Melo, JR; da Conceição, SA; da Luz, MM; de Araújo, GK; Lisboa, FA; Melo, JR; Moraes-Santos, T | 1 |
| Comer, GM; Jensen, DM; Pace, SC; Soffer, E | 1 |
| Hughes, SM | 1 |
| Apikoglu-Rabus, S; Besisik, F; Dulger, G; Izzettin, FV; Sancar, M; Tozun, N | 1 |
| Esplugues, JV; Martí-Cabrera, M; Ponce, J | 1 |
| De Marez, T; De Paepe, E; De Pauw, M; Hoetelmans, RM; Lefebvre, E; Parys, W; Sekar, VJ | 1 |
| Boccia, G; Buonavolontà, R; Manguso, F; Miele, E; Staiano, A | 1 |
| Lassen, AT | 1 |
| Kume, E; Nagasaki, M; Noto, T; Okuyama, K; Saito, N | 1 |
| Beketov, AS; Belousov, DIu; Belousov, IuB; Karpov, OI | 1 |
| Serebrova, SIu | 1 |
| Loshchakova, OIu; Vakhrushev, IaM | 1 |
| Junghard, O; Wiklund, IK | 1 |
| Mahachai, V; Thong-Ngam, D | 1 |
| Hassall, E | 1 |
| Hanemaaijer, R; Kubben, FJ; Lamers, CB; Schram, MT; Sier, CF; van Duijn, W; Veenendaal, RA; Verheijen, JH; Verspaget, HW; Witte, AM | 1 |
| Brühlmann, P; Distler, O; Fox, M; Fried, M; Halim, S; Janiak, P; Menne, D; Schwizer, W; Thumshirn, M | 1 |
| Miwa, H; Oshima, T; Tomita, T | 1 |
| Arçari, DP; Bartchewsky, W; Gambero, A; Hoehr, NF; Maróstica, M; Pedrazzoli, J; Ribeiro, ML; Trevisan, M | 1 |
| Gisbert, JL; Gisbert, JP; Jimenez-Alonso, I; Marcos, S; Moreno-Otero, R; Pajares, JM | 1 |
| Bauters, TG; Laureys, G; Robays, H; Verlooy, J | 1 |
| Beck, K; Cai, Y; Causemaker, SJ; Chiu, YL; Doan, T; Esslinger, HU; Hanna, GJ; King, KR; Klein, CE; Podsadecki, TJ | 1 |
| Giannoulis, E; Karamanolis, G; Ladas, SD; Theofanidou, I; Triantafyllou, K; Yiasemidou, M | 1 |
| Bouche, MP; De Smedt, G; Hoetelmans, RM; Kakuda, TN; Peeters, M; Schöller-Gyüre, M; Vanaken, H; Woodfall, B | 1 |
| Anic, T; Batelja, L; Berkopic, L; Blagaic Boban, A; Brcic, L; Cesarec, V; Coric, M; Dolovski, Z; Drmic, D; Ilic, S; Ivica, M; Klicek, R; Kocman, I; Kolenc, D; Lovric Bencic, M; Mise, S; Radic, B; Seiwerth, S; Sever, M; Sikiric, P; Skorjanec, S; Staresinic, M; Tonkic, A; Zoricic, I | 1 |
| Achem, SR | 1 |
| Medhi, B; Prakash, A | 1 |
| Ran, ZH; Shen, J; Tong, JL; Xiao, SD | 1 |
| Bandyopadhyay, U; Banerjee, RK; Biswas, K; Chattopadhyay, I; Maity, P | 1 |
| Alves, CC; Barbosa, NR; Dutra, RC; Fava, MB; Ferreira, AP | 1 |
| Chang, CH; Hsu, PI; Huang, YB; Lin, PC; Tseng, PL | 1 |
| Daneman, N; Kandel, CE; Lu, H; McAlister, FA; Redelmeier, DA | 1 |
| Abrahamsson, B; Albery, T; Dressman, J; Polentarutti, B | 1 |
| Hunt, R; Sachs, G; Shin, JM | 1 |
| Jonaitis, L; Kiudelis, G; Kupčinskas, J; Kupčinskas, L | 1 |
| Apikoglu-Rabus, S; Cevikbas, U; Izzettin, FV; Okuyan, B; Sancar, M | 1 |
| Këlliçi, I; Kraja, B; Mone, I; Prifti, S | 1 |
| Bergamaschi, R; Bernardi, F; Cazzato, S; Cicognani, A; di Palmo, E; Di Silverio Carulli, C; Lima, M; Mazzotta, A; Salfi, NC; Tursini, S | 1 |
| Nazir, Z | 1 |
| Eberlein, B; Gebhardt, E; Gilbertz, KP; Placzek, M; Przybilla, B | 1 |
| de Rooij, FW; Huisman, EJ; Renooij, W; Siersema, PD; van Erpecum, KJ; van Hoek, B; van Vlerken, LG | 1 |
| Czimmer, J; Mózsik, G; Szabó, IL; Szolcsányi, J | 1 |
| Bradbury, PA; Hilton, JF; Seymour, L; Shepherd, FA; Tu, D | 1 |
| Bech, N; Brennan, BJ; Morcos, PN; Moreira, SA; Navarro, MT; Quatkemeyer, A; Smith, PF | 1 |
| Amagase, K; Satoh, H; Takeuchi, K | 1 |
| Nani, FS; Tsuchie, SY; Vieira, JE | 1 |
| Johansson, S; Leese, PT; Li, Y; Lisbon, E; Martin, P; Mathews, D; Oliver, S; Read, J; Steinberg, M | 1 |
| Althaf, MM; Nadri, Q | 1 |
| Abt, M; Ducray, PS; Giraudon, M; Hamilton, M; Kletzl, H; Lum, BL | 1 |
| Abdul-Hussein, M; Castell, D; Freeman, J | 1 |
| Barbeau, G; Bertrand, OF; De Larochellière, R; Déry, JP; Déry, U; Gleeton, O; Harvey, A; Larose, É; Modak, A; Nguyen, CM; Noël, B; Paradis, JM; Proulx, G; Rinfret, S; Rodés-Cabau, J; Roy, L; Roy, M | 1 |
| D'Amico, EA; Filho, CC; Filho, RK; Freire, BT; Furtado, RHM; Giugliano, RP; Neto, PAL; Nicolau, JC; Pereira, AC; Ramires, JAF; Rocha, TR; Strunz, CMC | 1 |
| Arthur, RM; Knych, HK; McKemie, DS; Stanley, SD | 1 |
| Anderson, M; Bateman, DN; Cooper, G; Crawford, C; Eddleston, M; Jackson, G; Thomas, S; Thompson, J; Vale, A | 1 |
| Herrera-Mozo, I; Martí-Amengual, G; Sanz-Gallen, P | 1 |
| Boermeester, MA; de Vries, FEE; Dijksta, G; Haveman, JW; Kuin, W; Reeskamp, LF; Serlie, MJ; van Arum, I; van Ruler, O | 1 |
| Carroll, TL; Dezube, A; Nahikian, K; Roth, DF; Werner, A | 1 |
| Dağlı, Ü; Kalkan, İH | 1 |
| Ekhaguere, OA; Jensen, EA; Padula, MA | 1 |
| Chen, SJ; Fang, YF; Lian, QW; Qiu, LF; Wang, L; Xu, WL; Zhou, H | 1 |
| Higashi, Y; Kotani, K; Okazaki, Y | 1 |
| Arrebola, F; Gómez-Mateos, M; González, JM; Navarro, MC; Romero, MC; Valero, A | 1 |
| Ferreira, GC; Kemp, R; Pinheiro, LC; Sanches-Lopes, JM; Tanus-Santos, JE | 1 |
| Balaji, U; Chang, Y; Gu, J; Nelson, M; Odiase, E; Pan, Z; Souza, RF; Spechler, SJ; Zhang, Q; Zhang, X | 1 |
| Fass, R; Ganocy, SJ; Kim, YD; Poels, KE; Shibli, F; Wang, J | 1 |
| Afzal, NA; Andrews, E; Beattie, RM; Hayen, A; Liddicoat, I; Tighe, MP | 1 |
96 review(s) available for omeprazole and ranitidine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Clinical significance of hypergastrinaemia: relevance to gastrin monitoring during omeprazole therapy.
Topics: Colonic Neoplasms; Drug Monitoring; Fasting; Gastric Mucosa; Gastrins; Humans; Omeprazole; Ranitidine; Recurrence; Stomach Neoplasms; Vagotomy, Proximal Gastric | 1992 |
Controlled clinical trials of omeprazole in the long-term management of reflux disease.
Topics: Administration, Oral; Australia; Belgium; Biopsy; Double-Blind Method; Endoscopy, Gastrointestinal; Esophagitis, Peptic; France; Gastrins; Humans; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Scandinavian and Nordic Countries | 1992 |
Safety experience from long-term treatment with omeprazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cimetidine; Clinical Trials as Topic; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine | 1992 |
[New developments in drug therapy: omeprazole].
Topics: Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Ranitidine; Smoking; Stomach Ulcer | 1991 |
[Effects of gastric acid secretion inhibition on intrinsic factor secretion and cobalamin absorption].
Topics: Absorption; Cimetidine; Duodenal Ulcer; Gastrectomy; Gastric Acid; Gastritis, Atrophic; Humans; Intrinsic Factor; Omeprazole; Ranitidine; Reference Values; Vitamin B 12 | 1991 |
[Effects of antisecretory therapy on serum gastrin and argyrophil cells of the fundus mucosa].
Topics: Cimetidine; Duodenal Ulcer; Esophagitis; Gastric Mucosa; Gastrins; Humans; Omeprazole; Ranitidine; Vagotomy, Proximal Gastric | 1991 |
[Gastric anacidity. Effects on gastrointestinal microflora and physiopathological consequences].
Topics: Bacteria, Aerobic; Bacteria, Anaerobic; Cimetidine; Gastric Acid; Humans; Ileum; Jejunum; Nitrate Reductases; Omeprazole; Ranitidine; Stomach | 1991 |
Acid suppression as treatment for NSAID-related peptic ulcers.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Ranitidine; Recurrence | 1991 |
Gastrin and gastric enterochromaffin-like cell carcinoids in the rat.
Topics: Animals; Enterochromaffin Cells; Gastric Mucosa; Gastrins; Hyperplasia; Omeprazole; Ranitidine; Rats; Time Factors | 1990 |
[Ulcer disease--drug treatment and its limitations].
Topics: Campylobacter Infections; Duodenal Ulcer; Humans; Long-Term Care; Omeprazole; Organometallic Compounds; Ranitidine; Stomach Ulcer | 1990 |
Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials.
Topics: Duodenal Ulcer; Humans; Meta-Analysis as Topic; Omeprazole; Ranitidine | 1990 |
Omeprazole in the treatment of duodenal ulcer.
Topics: Adenosine Triphosphatases; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; H(+)-K(+)-Exchanging ATPase; Humans; Omeprazole; Parietal Cells, Gastric; Ranitidine | 1989 |
[Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Gastric Acid; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Random Allocation; Ranitidine | 1989 |
[Drugs used in the therapy of peptic ulcer with special reference to H2 receptor blockaders].
Topics: Antacids; Anti-Ulcer Agents; Cimetidine; Famotidine; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Peptic Ulcer; Pirenzepine; Ranitidine; Thiazoles | 1989 |
Recent advances in the management of gastric acid hypersecretion in patients with Zollinger-Ellison syndrome.
Topics: Cimetidine; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Nizatidine; Omeprazole; Parasympatholytics; Ranitidine; Thiazoles; Zollinger-Ellison Syndrome | 1989 |
Drug therapy in peptic ulcer disease.
Topics: Cimetidine; Histamine Antagonists; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Ranitidine | 1989 |
Omeprazole in the acute treatment of gastric ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Wound Healing | 1989 |
Efficacy of the H+/K+-adenosine triphosphatase inhibitor omeprazole in peptic ulcer.
Topics: Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Therapeutic Equivalency | 1989 |
Ulcer-healing drugs and endogenous prostaglandins.
Topics: Aluminum; Animals; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Carbenoxolone; Cimetidine; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Ranitidine; Somatostatin; Stimulation, Chemical; Sucralfate | 1985 |
Inhibition of acid and gastric carcinoids.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Humans; Male; Omeprazole; Ranitidine; Rats; Stomach Neoplasms; Triazoles | 1985 |
Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Topics: Alprostadil; Antacids; Anti-Ulcer Agents; Cimetidine; Drug Resistance; Enprostil; Famotidine; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Pirenzepine; Prostaglandins; Prostaglandins E, Synthetic; Ranitidine; Sucralfate; Thiazoles | 1987 |
The medical therapy of reflux oesophagitis.
Topics: Antacids; Bethanechol; Bethanechol Compounds; Cimetidine; Cisapride; Domperidone; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Metoclopramide; Omeprazole; Piperidines; Ranitidine; Sucralfate | 1987 |
Medical treatment of peptic ulcers.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Cimetidine; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins; Ranitidine; Recurrence; Sucralfate; Zollinger-Ellison Syndrome | 1985 |
Treatment of ulcer disease.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Clinical Trials as Topic; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Ranitidine; Sucralfate | 1985 |
Medical management of peptic ulcer.
Topics: Aluminum; Antacids; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Humans; Omeprazole; Parasympatholytics; Ranitidine; Recurrence; Stomach Ulcer; Sucralfate; Time Factors | 1984 |
Pharmacologic options for the control of peptic ulcer disease.
Topics: Antacids; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Carbenoxolone; Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Parasympatholytics; Peptic Ulcer; Prostaglandins, Synthetic; Ranitidine; Risk; Stomach Neoplasms; Surface-Active Agents | 1984 |
[Zollinger-Ellison syndrome].
Topics: Benzimidazoles; Calcium; Cimetidine; Diarrhea; Duodenal Ulcer; Female; Fluorouracil; Gastrectomy; Gastric Acid; Gastrins; Glucagon; Humans; Male; Middle Aged; Omeprazole; Pancreatic Neoplasms; Prognosis; Ranitidine; Secretin; Streptozocin; Zollinger-Ellison Syndrome | 1984 |
Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
Topics: Adult; Cimetidine; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine; Reproducibility of Results; Stomach Ulcer; Time Factors; Wound Healing | 1995 |
A comparative overview of the adverse effects of antiulcer drugs.
Topics: Antacids; Anti-Ulcer Agents; Carcinoid Tumor; Cimetidine; Humans; Misoprostol; Omeprazole; Ranitidine; Sucralfate | 1995 |
Epidemiology and prevention of non-steroidal anti-inflammatory drug effects in the gastrointestinal tract.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Duodenal Ulcer; Humans; Misoprostol; Omeprazole; Prevalence; Ranitidine; Risk Factors; Stomach Ulcer; Sucralfate | 1995 |
Acid suppression and claims of genotoxicity. What have we learned?
Topics: Animals; Cell Division; DNA; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Mutation; Omeprazole; Ranitidine; Rats | 1994 |
Efficacy of omeprazole in lower grades of gastro-oesophageal reflux disease.
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Gastroesophageal Reflux; Humans; Omeprazole; Ranitidine | 1994 |
Clinical efficacy of pantoprazole compared with ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Duodenal Ulcer; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Stomach Ulcer; Sulfoxides | 1994 |
Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Anti-Ulcer Agents; Esophagitis, Peptic; Humans; Lansoprazole; Omeprazole; Ranitidine | 1993 |
Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Time Factors; Wound Healing | 1995 |
[Reconsider management of Helicobacter pylori infections. Time to go over to the triple therapy].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clinical Trials as Topic; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine | 1996 |
[Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
Topics: Anti-Ulcer Agents; Enzyme Inhibitors; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 1996 |
[How to eradicate Helicobacter pylori in 1995? Critical review of available treatments].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Humans; Omeprazole; Penicillins; Ranitidine | 1996 |
The changing role of H2-receptor antagonists in acid-related diseases.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Dyspepsia; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1996 |
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidone; Famotidine; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Metoclopramide; Nizatidine; Omeprazole; Pantoprazole; Piperidines; Proton Pump Inhibitors; Ranitidine; Sucralfate; Sulfoxides | 1996 |
Suppression of gastric acidity in horses.
Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Horse Diseases; Horses; Omeprazole; Ranitidine; Stomach Ulcer | 1997 |
Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Anti-Ulcer Agents; Esophagitis; Esophagoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Prognosis; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Remission Induction; Smoking | 1997 |
[Diagnosis and treatment of Helicobacter pylori].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Bacteriological Techniques; Clarithromycin; Drug Therapy, Combination; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Polymerase Chain Reaction; Ranitidine | 1997 |
[Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal Ulcer; Female; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine | 1997 |
Clarithromycin dual therapy regimens for eradication of Helicobacter pylori: a review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Clinical Trials as Topic; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Ranitidine | 1997 |
Therapy of H. pylori infection.
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine; Tinidazole | 1997 |
Is the sensitivity to gastric acid inhibition Helicobacter pylori status-dependent?
Topics: Enzyme Inhibitors; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Omeprazole; Ranitidine | 1998 |
[Gastric lesion caused by NSAID and inflammation due to Helicobacter pylori. Is there potentiation or attenuation?].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Confidence Intervals; Duodenal Ulcer; Enzyme Inhibitors; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Multicenter Studies as Topic; Naproxen; Omeprazole; Peptic Ulcer; Prospective Studies; Ranitidine; Risk Factors; Stomach Ulcer | 1998 |
Healing of nonsteroidal anti-inflammatory drug-associated ulcers and erosions, and relief of dyspeptic symptoms: a commentary on the new data.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Dyspepsia; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Wound Healing | 1998 |
Prophylaxis against nonsteroidal anti-inflammatory drug-associated ulcers and erosions: a commentary on the new data.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Treatment Outcome | 1998 |
Management of nonsteroidal anti-inflammatory drug-associated lesions: a cost-effectiveness perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cost-Benefit Analysis; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Sweden | 1998 |
Current regimens for treatment of Helicobacter pylori infection.
Topics: Amoxicillin; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Diseases; Treatment Outcome | 1998 |
[Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Domperidone; Dose-Response Relationship, Drug; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Sucralfate | 1998 |
Acid pump inhibitors. The treatment of gastroesophageal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cisapride; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Pantoprazole; Piperidines; Ranitidine; Sulfoxides | 1998 |
The impact of Helicobacter pylori eradication on peptic ulcer healing.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Benzimidazoles; Duodenal Ulcer; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Odds Ratio; Omeprazole; Pantoprazole; Peptic Ulcer; Ranitidine; Stomach Ulcer; Sulfoxides; Treatment Outcome; Wound Healing | 1998 |
Does medical antireflux therapy improve asthma in asthmatics with gastroesophageal reflux?: a critical review of the literature.
Topics: Antacids; Anti-Asthmatic Agents; Anti-Ulcer Agents; Asthma; Cimetidine; Circadian Rhythm; Cisapride; Gastroesophageal Reflux; Humans; Lung; Omeprazole; Peak Expiratory Flow Rate; Piperidines; Placebos; Randomized Controlled Trials as Topic; Ranitidine; Spirometry | 1998 |
[Proton-pump inhibitors versus H2-receptor antagonists in triple therapy for Helicobacter pylori eradication].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine | 1999 |
[The breath test with labeled urea for the diagnosis of Helicobacter pylori infection].
Topics: Anti-Ulcer Agents; Bacterial Proteins; Breath Tests; Carbon Dioxide; Carbon Isotopes; Carbon Radioisotopes; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Radionuclide Imaging; Ranitidine; Reproducibility of Results; Urea; Urease | 1998 |
Safety profile of Lansoprazole: the US clinical trial experience.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Clinical Trials as Topic; Esophageal Diseases; Gastric Acid; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Ranitidine; United States | 1999 |
[Antisecretory drugs and prophylaxis of secondary gastrointestinal effects associated with the consumption of non steroid anti-inflammatory drugs].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Enzyme Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Male; Omeprazole; Peptic Ulcer; Ranitidine | 2000 |
Acid suppression therapy in Barrett's esophagus: the importance of pH monitoring.
Topics: Anti-Ulcer Agents; Barrett Esophagus; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Monitoring, Physiologic; Omeprazole; Ranitidine | 2000 |
Quality of life and severity of symptoms in gastro-oesophageal reflux disease: a clinical review.
Topics: Anti-Ulcer Agents; Gastroesophageal Reflux; Humans; Laparoscopy; Omeprazole; Patient Satisfaction; Quality of Life; Randomized Controlled Trials as Topic; Ranitidine; Severity of Illness Index; Surveys and Questionnaires | 2000 |
Pathogenesis and current management of gastrooesophageal-reflux-related asthma.
Topics: Asthma; Enzyme Inhibitors; Fundoplication; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine | 2000 |
[Cost-effectiveness of the treatment of reflux esophagitis: proton pump inhibitor versus histamine-2-receptor antagonist].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Cost-Benefit Analysis; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2000 |
Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2001 |
[H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Age Factors; Aged; Anti-Ulcer Agents; Benzimidazoles; Child; Child, Preschool; Duodenal Ulcer; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Infant; Infant, Newborn; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach Ulcer; Sulfoxides | 2001 |
Helicobacter pylori and early duodenal ulcer status post-treatment: a review.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Clinical Trials as Topic; Duodenal Ulcer; Follow-Up Studies; Helicobacter Infections; Humans; Lansoprazole; Odds Ratio; Omeprazole; Ranitidine; Research Design; Retrospective Studies; United States; United States Food and Drug Administration | 2001 |
Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection.
Topics: Abietanes; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Diterpenes; Drug Therapy, Combination; Evidence-Based Medicine; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Research Design; Tetracycline; Treatment Outcome | 2001 |
Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Gastroesophageal Reflux; Humans; Lansoprazole; Omeprazole; Pantoprazole; Rabeprazole; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides; Treatment Outcome | 2001 |
Helicobacter pylori eradication is superior to ulcer healing with or without maintenance therapy to prevent further ulcer haemorrhage.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; MEDLINE; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Risk Factors; Salicylates; Sensitivity and Specificity | 2001 |
Current concepts in the management of Helicobacter pylori infection--the Maastricht 2-2000 Consensus Report.
Topics: Adult; Anti-Ulcer Agents; Child; Duodenal Ulcer; Germany; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine; Stomach Neoplasms | 2002 |
Combination drug therapy for gastroesophageal reflux disease.
Topics: Anti-Ulcer Agents; Clinical Trials as Topic; Drug Therapy, Combination; Gastroesophageal Reflux; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Omeprazole; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2002 |
[Cause and prevention of nocturnal gastric acid breakthrough].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aryl Hydrocarbon Hydroxylases; Benzimidazoles; Circadian Rhythm; Cytochrome P-450 CYP2C19; Cytochrome P-450 Enzyme System; Esophagitis, Peptic; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Mixed Function Oxygenases; Omeprazole; Polymorphism, Genetic; Proton Pump Inhibitors; Proton Pumps; Rabeprazole; Ranitidine | 2002 |
[Treatment of NSAID-associated gastric ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Ranitidine; Stomach Ulcer | 2002 |
Intravenous proton-pump inhibitors versus H2-antagonists for treatment of GI bleeding.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cimetidine; Drug Administration Schedule; Enzyme Inhibitors; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Injections, Intravenous; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Sulfoxides | 2003 |
On-demand proton pump inhibitor therapy in patients with gastro-oesophageal reflux disease.
Topics: Esomeprazole; Gastroesophageal Reflux; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2002 |
Evidence-based analysis: postoperative gastric bleeding: etiology and prevention.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cost-Benefit Analysis; Drug Therapy, Combination; Duodenal Ulcer; Evidence-Based Medicine; Humans; Intensive Care Units; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Postoperative Complications; Ranitidine; Risk Factors; Stomach Neoplasms; Stomach Ulcer; Sucralfate; Sulfoxides; Treatment Outcome | 2003 |
The impact of gastroesophageal reflux disease on quality of life.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Combined Modality Therapy; Cross-Over Studies; Double-Blind Method; Esophagitis; Fundoplication; Gastroesophageal Reflux; Humans; Lansoprazole; Laparoscopy; Omeprazole; Prospective Studies; Quality of Life; Randomized Controlled Trials as Topic; Ranitidine; Retrospective Studies; Surveys and Questionnaires; Treatment Outcome | 2003 |
The impact of treatment for gastro-oesophageal reflux disease on health-related quality of life: a literature review.
Topics: Drug Evaluation; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pumps; Quality of Life; Ranitidine; Sickness Impact Profile; Treatment Outcome | 2003 |
[Proton pump inhibitors as the basis of anti-helicobacter therapeutic schemes].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2004 |
[Bronchial asthma and gastroesophageal reflux disease: are they interrelated by chance?].
Topics: Adult; Algorithms; Anti-Ulcer Agents; Asthma; Bronchodilator Agents; Cimetidine; Controlled Clinical Trials as Topic; Endoscopy, Digestive System; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Middle Aged; Omeprazole; Placebos; Ranitidine; Respiratory Function Tests; Time Factors | 2005 |
[Gastroduodenal erosions observed after Helicobacter pylori eradication].
Topics: Adult; Amoxicillin; Clarithromycin; Duodenitis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Omeprazole; Ranitidine | 2005 |
Anaphylactic reaction to drugs commonly used for gastrointestinal system diseases: 3 case reports and review of the literature.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anaphylaxis; Anti-Ulcer Agents; Benzimidazoles; Famotidine; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Skin Tests | 2006 |
Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough: a Cochrane systematic review.
Topics: Drug Administration Schedule; Gastric Acid; Histamine H2 Antagonists; Humans; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine | 2006 |
Canine gastrinoma: a case study and literature review of therapeutic options.
Topics: Animals; Anti-Ulcer Agents; Antineoplastic Agents; Dog Diseases; Dogs; Fatal Outcome; Female; Gastrinoma; Gastrins; Neoplasm Metastasis; Omeprazole; Pancreatic Neoplasms; Ranitidine; Sucralfate; Treatment Outcome | 2006 |
[Safety of proton pump inhibitors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Adult; Age Factors; Aged; Animals; Anti-Ulcer Agents; Cimetidine; Enzyme Inhibitors; Famotidine; Female; Fetus; Histamine H2 Antagonists; Humans; Lactation; Lansoprazole; Meta-Analysis as Topic; Nizatidine; Omeprazole; Pantoprazole; Pregnancy; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Safety; Time Factors | 2006 |
Acid-related disorders and use of antisecretory medication.
Topics: Anti-Ulcer Agents; Denmark; Drug Utilization; Enzyme Inhibitors; Esophagitis; Esophagoscopy; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Humans; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Proton Pumps; Randomized Controlled Trials as Topic; Ranitidine; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2007 |
Treatment of non-cardiac chest pain.
Topics: Anti-Ulcer Agents; Botulinum Toxins, Type A; Calcium Channel Blockers; Chest Pain; Diltiazem; Enzyme Inhibitors; Esophageal Motility Disorders; Esophageal Spasm, Diffuse; Gastroesophageal Reflux; Hyperalgesia; Neuromuscular Agents; Nifedipine; Nitrates; Omeprazole; Ranitidine; Transcutaneous Electric Nerve Stimulation | 2008 |
Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tinidazole; Treatment Outcome | 2009 |
The use of neem for controlling gastric hyperacidity and ulcer.
Topics: Animals; Anti-Ulcer Agents; Azadirachta; Gastric Acid; Omeprazole; Peptic Ulcer; Phytotherapy; Plant Bark; Plant Extracts; Ranitidine | 2009 |
The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Cimetidine; Critical Care; Histamine H2 Antagonists; Humans; Odds Ratio; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine; Risk; Stress, Psychological | 2010 |
A rare association of inlet patch with laryngospasm: a report of two children and literature review.
Topics: Alginates; Anti-Ulcer Agents; Child; Child, Preschool; Esophageal Diseases; Female; Gastric Mucosa; Glucuronic Acid; Hexuronic Acids; Humans; Laryngismus; Omeprazole; Ranitidine; Severity of Illness Index; Treatment Outcome | 2011 |
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine | 2013 |
Systematic review: pharmacotherapy for high-output enterostomies or enteral fistulas.
Topics: Enterostomy; Humans; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine; Somatostatin | 2017 |
Pharmacological treatment of gastro-oesophageal reflux in children.
Topics: Adolescent; Child; Esomeprazole; Gastroesophageal Reflux; Humans; Infant; Infant, Newborn; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine | 2023 |
320 trial(s) available for omeprazole and ranitidine
| Article | Year |
|---|---|
The potential clinical role of intravenous omeprazole.
Topics: Critical Illness; Decision Trees; Female; Gastric Acidity Determination; Gastrointestinal Hemorrhage; Humans; Infusions, Intravenous; Injections, Intravenous; Omeprazole; Peptic Ulcer; Ranitidine; Treatment Outcome; Wound Healing | 1992 |
Effects of omeprazole, ranitidine, famotidine and placebo on gastric secretion in patients undergoing elective surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Famotidine; Female; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Premedication; Ranitidine | 1992 |
Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
Topics: Adult; Double-Blind Method; Duodenal Ulcer; Female; Gastric Acid; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pepsin A; Ranitidine; Time Factors | 1992 |
[A comparison of the effects of omeprazole with those of ranitidine on intragastric pH and volume in patients for elective surgeries].
Topics: Gastric Acid; Humans; Omeprazole; Pneumonia, Aspiration; Ranitidine; Surgical Procedures, Operative | 1992 |
Two weeks treatment with amoxicillin/omeprazole for eradication of Helicobacter pylori.
Topics: Amoxicillin; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine | 1992 |
Comparison between ranitidine and omeprazole for protection against gastroduodenal damage caused by naproxen.
Topics: Acute Disease; Adult; Double-Blind Method; Duodenum; Endoscopy, Gastrointestinal; Female; Gastric Mucosa; Humans; Intestinal Mucosa; Male; Naproxen; Omeprazole; Ranitidine | 1992 |
Short-term treatment of refractory reflux esophagitis with different doses of omeprazole or ranitidine.
Topics: Adult; Chronic Disease; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Esophagitis, Peptic; Esophagus; Female; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Prognosis; Ranitidine; Time Factors; Treatment Outcome | 1992 |
Effects of curative gastrinoma resection on gastric secretory function and antisecretory drug requirement in the Zollinger-Ellison syndrome.
Topics: Adult; Aged; Cimetidine; Dose-Response Relationship, Drug; Duodenal Neoplasms; Famotidine; Female; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastrinoma; Gastrins; Humans; Male; Middle Aged; Omeprazole; Pancreatic Neoplasms; Postoperative Period; Prospective Studies; Ranitidine; Sex Factors; Time Factors; Zollinger-Ellison Syndrome | 1992 |
A comparison of omeprazole and ranitidine for prophylaxis against aspiration pneumonitis in emergency caesarean section.
Topics: Cesarean Section; Citrates; Citric Acid; Drug Therapy, Combination; Emergencies; Female; Humans; Hydrogen-Ion Concentration; Omeprazole; Pneumonia, Aspiration; Postoperative Complications; Pregnancy; Premedication; Ranitidine | 1992 |
Ulcer recurrence following duodenal ulcer healing with omeprazole, ranitidine, or placebo: a double-blind, multicenter, 6-month study. The Omeprazole Duodenal Ulcer Study Group.
Topics: Adult; Aged; Aged, 80 and over; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence | 1992 |
Comparison of omeprazole and ranitidine in treatment of refractory gastroesophageal reflux disease in patients with gastric acid hypersecretion.
Topics: Barrett Esophagus; Drug Administration Schedule; Esophagitis, Peptic; Female; Gastric Acid; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Prospective Studies; Ranitidine; Time Factors | 1992 |
Circadian differences in pharmacological blockade of meal-stimulated gastric acid secretion.
Topics: Adult; Anti-Ulcer Agents; Circadian Rhythm; Eating; Food; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Ranitidine | 1992 |
Effects of single-dose intravenous omeprazole and ranitidine on gastric pH during general anesthesia.
Topics: Adult; Anesthesia, General; Female; Gastric Acid; Gastric Acidity Determination; Genital Diseases, Female; Humans; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1992 |
Lack of effect of omeprazole, cimetidine, and ranitidine on the pharmacokinetics of ethanol in fasting male volunteers.
Topics: Adult; Cimetidine; Ethanol; Fasting; Humans; Male; Omeprazole; Ranitidine | 1992 |
Omeprazole versus ranitidine in the treatment of resistant duodenal ulcer.
Topics: Duodenal Ulcer; Humans; Omeprazole; Ranitidine | 1992 |
Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.
Topics: Adult; Aged; Aged, 80 and over; Clinical Protocols; Costs and Cost Analysis; Decision Trees; Follow-Up Studies; Gastroesophageal Reflux; Humans; Middle Aged; Models, Theoretical; Omeprazole; Ranitidine | 1992 |
Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Topics: Cimetidine; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Stomach Ulcer | 1991 |
Effect of duodenal ulcer healing induced by omeprazole and ranitidine on the generation of gastroduodenal eicosanoids, platelet-activating factor, pepsinogen A, and gastrin in duodenal ulcer patients.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Dinoprostone; Duodenal Ulcer; Eicosanoids; Female; Gastrins; Humans; Intestinal Mucosa; Leukotrienes; Male; Middle Aged; Omeprazole; Pepsinogens; Platelet Activating Factor; Random Allocation; Ranitidine | 1992 |
Omeprazole vs. ranitidine in short-term treatment of Helicobacter pylori positive duodenal ulcer patients.
Topics: Adult; Aged; Drug Administration Schedule; Duodenal Ulcer; Endoscopy; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pyloric Antrum; Random Allocation; Ranitidine; Treatment Outcome | 1991 |
Omeprazole 20 mg uid and ranitidine 150 mg bid in the treatment of benign gastric ulcer. Italian Cooperative Group on Omeprazole.
Topics: Double-Blind Method; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Time Factors; Wound Healing | 1991 |
Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Topics: Adult; Aged; Biopsy; Chi-Square Distribution; Esophagitis, Peptic; Esophagoscopy; Gastric Mucosa; Gastrins; Humans; Middle Aged; Omeprazole; Ranitidine; Recurrence | 1991 |
Dose-related healing of duodenal ulcer with the proton pump inhibitor lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Double-Blind Method; Duodenal Ulcer; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 1991 |
A comparison of omeprazole and ranitidine for duodenal ulcer in South African patients. A multiracial study.
Topics: Adult; Aged; Black People; Discriminant Analysis; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Prognosis; Ranitidine; South Africa; White People | 1991 |
[Comparative multicentric study of omeprazole versus ranitidine in the treatment of duodenal ulcer].
Topics: Adult; Aged; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Prognosis; Ranitidine; Spain | 1991 |
The effect of omeprazole and ranitidine on ulcer healing, relief of symptoms, and incidence of adverse events in the treatment of duodenal ulcer patients.
Topics: Duodenal Ulcer; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Multivariate Analysis; Omeprazole; Ranitidine; Wound Healing | 1991 |
High-dose famotidine in the maintenance treatment of refractory esophagitis: results of a "medium-term" open study.
Topics: Adult; Double-Blind Method; Esophagitis; Esophagoscopy; Famotidine; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Time Factors | 1991 |
Omeprazole or high-dose ranitidine in the treatment of patients with reflux oesophagitis not responding to 'standard doses' of H2-receptor antagonists.
Topics: Adult; Aged; Double-Blind Method; Endoscopy, Gastrointestinal; Esophagitis, Peptic; Female; Gastrins; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1990 |
Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole.
Topics: Adult; Circadian Rhythm; Double-Blind Method; Gastric Acid; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Peptic Ulcer; Ranitidine | 1991 |
Two and four weeks' treatment for duodenal ulcer. Symptom relief and clinical remission comparing omeprazole and ranitidine. Scandinavian Clinics for United Research.
Topics: Absenteeism; Activities of Daily Living; Adult; Aged; Aged, 80 and over; Antacids; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Omeprazole; Pain; Ranitidine; Recurrence; Remission Induction; Smoking | 1991 |
Effect of omeprazole on duodenal ulcer-associated antral gastritis and Helicobacter pylori.
Topics: Adult; Chronic Disease; Double-Blind Method; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pyloric Antrum; Ranitidine | 1991 |
U.S. experience with omeprazole in duodenal ulcer. Multicenter double-blind comparative study with ranitidine. The Omeprazole DU Comparative Study Group.
Topics: Double-Blind Method; Duodenal Ulcer; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing | 1991 |
Influence of acid secretory status on absorption of omeprazole from enteric coated granules.
Topics: Adult; Gastric Acid; Half-Life; Humans; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Tablets, Enteric-Coated | 1991 |
Prevention of relapse of reflux oesophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.
Topics: Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Gastric Acidity Determination; Gastric Mucosa; Humans; Omeprazole; Ranitidine; Recurrence | 1990 |
Prolonged inhibition of acid secretion causes hypergastrinaemia without altering pH inhibition of gastrin release in humans.
Topics: Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Fasting; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Peptones; Ranitidine | 1990 |
Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Topics: Aged; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine; Stomach Ulcer | 1990 |
Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial.
Topics: Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Randomized Controlled Trials as Topic; Ranitidine; Stomach Ulcer | 1990 |
A comparison of the effects of omeprazole and ranitidine on gastric secretion in women undergoing elective caesarean section.
Topics: Adult; Anesthesia, Obstetrical; Cesarean Section; Depression, Chemical; Female; Gastric Acidity Determination; Gastric Juice; Humans; Omeprazole; Pregnancy; Premedication; Preoperative Care; Random Allocation; Ranitidine; Secretory Rate | 1990 |
Omeprazole provides quicker symptom relief and duodenal ulcer healing than ranitidine.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Randomized Controlled Trials as Topic; Ranitidine; Time Factors | 1990 |
Omeprazole and ranitidine in duodenal ulcer healing and subsequent relapse: a randomized double-blind study with weekly endoscopic assessment.
Topics: Adult; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Omeprazole; Ranitidine; Recurrence | 1989 |
Omeprazole compared with ranitidine once daily in the treatment of duodenal ulcer.
Topics: Adult; Aged; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1989 |
Omeprazole in the long-term management of patients with acid-related diseases resistant to ranitidine.
Topics: Clinical Trials as Topic; Duodenal Ulcer; Esophagitis, Peptic; Follow-Up Studies; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Long-Term Care; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
Omeprazole (20 mg o.m.) versus ranitidine (150 mg b.d.) in duodenal ulcer healing and pain relief.
Topics: Adult; Aged; Antacids; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pain; Ranitidine; Smoking | 1989 |
Omeprazole in the treatment of duodenal ulcer.
Topics: Adenosine Triphosphatases; Cimetidine; Clinical Trials as Topic; Duodenal Ulcer; H(+)-K(+)-Exchanging ATPase; Humans; Omeprazole; Parietal Cells, Gastric; Ranitidine | 1989 |
[Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
Topics: Cimetidine; Clinical Trials as Topic; Double-Blind Method; Gastric Acid; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Random Allocation; Ranitidine | 1989 |
Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with benign gastric ulcer.
Topics: Adult; Aged; Analysis of Variance; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Ranitidine; Recurrence; Stomach Ulcer; Wound Healing | 1989 |
New drug effective.
Topics: Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
[Omeprazole (20 mg daily) compared to ranitidine (150 mg twice daily) in the treatment of esophagitis caused by reflux. Results of a double-blind randomized multicenter trial in France and Belgium].
Topics: Belgium; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; France; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Random Allocation; Ranitidine; Time Factors | 1989 |
Double blind multicentre comparison of omeprazole 20 mg once daily versus ranitidine 150 mg twice daily in the treatment of cimetidine or ranitidine resistant duodenal ulcers.
Topics: Adult; Cimetidine; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Duodenal Ulcer; Female; Humans; Male; Multicenter Studies as Topic; Omeprazole; Ranitidine | 1989 |
The clinical safety of omeprazole.
Topics: Cimetidine; Clinical Trials as Topic; Esophagitis, Peptic; Humans; Liver Function Tests; Omeprazole; Peptic Ulcer; Ranitidine; Thyroid Function Tests; Zollinger-Ellison Syndrome | 1989 |
Omeprazole in the acute treatment of gastric ulcer.
Topics: Cimetidine; Clinical Trials as Topic; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Wound Healing | 1989 |
Comparison of omeprazole with ranitidine in the treatment of reflux oesophagitis.
Topics: Dose-Response Relationship, Drug; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Ranitidine | 1989 |
Double-blind multicentre comparison of omeprazole and ranitidine in the treatment of reflux oesophagitis.
Topics: Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Time Factors | 1987 |
Omeprazole versus ranitidine in erosive oesophagitis.
Topics: Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1987 |
[Therapeutic achlorhydria: for which diseases, when and for how long?].
Topics: Achlorhydria; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Time Factors; Zollinger-Ellison Syndrome | 1988 |
The effects of omeprazole and ranitidine on 24-hour pH in the distal oesophagus of patients with reflux oesophagitis.
Topics: Adult; Aged; Circadian Rhythm; Double-Blind Method; Esophagitis, Peptic; Esophagus; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine | 1988 |
Omeprazole or ranitidine in the treatment of reflux esophagitis. Results of a double-blind, randomized, Scandinavian multicenter study.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Scandinavian and Nordic Countries | 1988 |
The effect of omeprazole or ranitidine treatment on 24-hour esophageal acidity in patients with reflux esophagitis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Circadian Rhythm; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1988 |
[Acute injury to the gastric mucosa by acetylsalicylic acid. A comparative endoscopic study in man with oral prostaglandin analogs, omeprazole and ranitidine].
Topics: Adult; Alprostadil; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Gastric Mucosa; Gastroscopy; Humans; Misoprostol; Omeprazole; Prostaglandins E; Prostaglandins, Synthetic; Random Allocation; Ranitidine; Rioprostil; Stomach Ulcer | 1986 |
[Drug therapy of peptic ulcer. What is coming up?].
Topics: Alprostadil; Anti-Ulcer Agents; Cimetidine; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Enprostil; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Prostaglandins E, Synthetic; Ranitidine | 1987 |
Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Esophagus; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1988 |
[Stomach tolerance of nonsteroidal antirheumatic drugs: comparative endoscopic study].
Topics: Adult; Alprostadil; Antacids; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Aspirin; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Gastroscopy; Humans; Indomethacin; Misoprostol; Omeprazole; Prostaglandins E; Ranitidine; Rioprostil; Stomach Ulcer | 1987 |
Omeprazole (40 mg) is superior to ranitidine in short-term treatment of ulcerative reflux esophagitis.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Time Factors | 1988 |
Omeprazole and ranitidine in duodenal ulcer healing.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Omeprazole; Random Allocation; Ranitidine; Smoking; Wound Healing | 1988 |
Omeprazole vs. ranitidine in the short-term treatment of duodenal ulcer: an Italian multicenter study.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Pain Measurement; Random Allocation; Ranitidine | 1987 |
[Different healing tendencies of reflux esophagitis following omeprazole and ranitidine. Results of a German-Austrian-Swiss multicenter study].
Topics: Administration, Oral; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1986 |
Comparison of omeprazole and ranitidine in the treatment of reflux esophagitis.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Omeprazole; Random Allocation; Ranitidine; Rats | 1986 |
A comparison of two different doses of omeprazole versus ranitidine in treatment of duodenal ulcers.
Topics: Adult; Aged; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Follow-Up Studies; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine | 1986 |
[Short-term therapy of duodenal ulcer with omeprazole and ranitidine. Results of a German multicenter study].
Topics: Adolescent; Adult; Aged; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Prognosis; Ranitidine; Smoking; Time Factors | 1985 |
Treatment of ulcer disease.
Topics: Aluminum; Antacids; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Clinical Trials as Topic; Gastric Acid; Humans; Omeprazole; Peptic Ulcer; Ranitidine; Sucralfate | 1985 |
[Healing rates following omeprazole and ranitidine treatment of gastric ulcer. Results of a German multicenter study].
Topics: Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Omeprazole; Random Allocation; Ranitidine; Smoking; Stomach Ulcer | 1985 |
Omeprazole heals duodenal, but not gastric ulcers more rapidly than ranitidine. Results of two German multicentre trials.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Clinical Trials as Topic; Duodenal Ulcer; Humans; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Time Factors | 1985 |
A comparison of intravenous ranitidine and omeprazole on gastric volume and pH in women undergoing emergency caesarean section.
Topics: Cesarean Section; Double-Blind Method; Emergencies; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Injections, Intravenous; Omeprazole; Pneumonia, Aspiration; Pregnancy; Proton Pump Inhibitors; Ranitidine; Stomach | 1995 |
Omeprazole/amoxicillin versus triple therapy for Helicobacter pylori in duodenal ulcer disease: two-year follow-up of a prospective randomized study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Female; Follow-Up Studies; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Outcome | 1995 |
Omeprazole versus ranitidine as adjunct therapy to endoscopic injection in actively bleeding ulcers: a prospective and randomized study.
Topics: Adult; Aged; Anti-Ulcer Agents; Confidence Intervals; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy; Female; Hemostasis, Endoscopic; Humans; Injections, Intralesional; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Stomach Ulcer; Treatment Outcome | 1995 |
[Treatment of acute peptic gastroduodenal ulcer: omeprazole is superior to ranitidine especially in the early phase of ulcer healing. A prospective controlled randomized serial endoscopy study].
Topics: Adult; Aged; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Endoscopy, Digestive System; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Ranitidine; Wound Healing | 1995 |
A comparison of five maintenance therapies for reflux esophagitis.
Topics: Adult; Anti-Ulcer Agents; Cisapride; Disease-Free Survival; Drug Therapy, Combination; Esophagitis, Peptic; Esophagoscopy; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Piperidines; Prospective Studies; Ranitidine; Recurrence; Severity of Illness Index; Single-Blind Method; Treatment Outcome | 1995 |
Pantoprazole and ranitidine in the treatment of acute duodenal ulcer. A multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Enzyme Inhibitors; Female; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides; Treatment Outcome | 1995 |
The effects of short-term lansoprazole therapy on Helicobacter pylori infection and antral gastritis in duodenal ulcer patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pyloric Antrum; Ranitidine | 1995 |
[Comparison of the cost-efficacy ratio of omeprazole and ranitidine in the treatment of reflux esophagitis].
Topics: Anti-Ulcer Agents; Endoscopy, Digestive System; Esophagitis, Peptic; Female; Health Care Costs; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Radiography; Ranitidine | 1995 |
Quantitative analysis of the gastric ulcer healing process using video endoscopic pseudocolor imaging systems.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Epithelium; Female; Hemoglobins; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Video Recording | 1995 |
Lansoprazole versus ranitidine for the treatment of reflux oesophagitis. UK Lansoprazole Clinical Research Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Double-Blind Method; Esophagitis, Peptic; Follow-Up Studies; H(+)-K(+)-Exchanging ATPase; Headache; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1995 |
[Does the antisecretory agent used affect the evolution of upper digestive hemorrhage?].
Topics: Adolescent; Adult; Aged; Combined Modality Therapy; Emergencies; Female; Gastrointestinal Hemorrhage; Hospital Mortality; Humans; Male; Middle Aged; Omeprazole; Prognosis; Prospective Studies; Ranitidine | 1995 |
Empiric therapy for gastroesophageal reflux disease.
Topics: Adult; Aged; Endoscopy, Digestive System; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Severity of Illness Index; Treatment Outcome | 1995 |
[Comparison between ranitidine, famotidine, and omeprazole in the treatment of bleeding duodenal ulcer].
Topics: Duodenal Ulcer; Famotidine; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine | 1995 |
Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin.
Topics: Amoxicillin; Biopsy; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Ranitidine; Reproducibility of Results; Sodium Bicarbonate | 1995 |
Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized
Topics: Adult; Amoxicillin; Bismuth; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Metronidazole; Nitrates; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Tetracycline; Time Factors; Tinidazole | 1995 |
Omeprazole in the management of sclerotherapy-induced esophageal ulcers resistant to H2 blocker treatment.
Topics: Adult; Aged; Aged, 80 and over; Drug Resistance; Esophageal and Gastric Varices; Esophageal Diseases; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Sclerotherapy; Ulcer | 1995 |
The time course of gastric pH changes induced by omeprazole and ranitidine: a 24-hour dose-response study.
Topics: Abdomen; Adult; Aged; Dose-Response Relationship, Drug; Female; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Middle Aged; Monitoring, Physiologic; Omeprazole; Prospective Studies; Ranitidine | 1995 |
Pantoprazole is superior to ranitidine in the treatment of acute gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Sulfoxides; Time Factors | 1995 |
[Lansoprazole versus ranitidine in the prevention of early recurrences of digestive hemorrhages from gastroduodenal ulcers. Randomized double-blind multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Stomach Ulcer; Time Factors | 1994 |
A comparison of lansoprazole and ranitidine in the treatment of erosive oesophagitis. Multicentre Investigational Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Alcohol Drinking; Anti-Ulcer Agents; Caffeine; Double-Blind Method; Drug Evaluation; Esophagitis, Peptic; Female; Gastroscopy; Humans; Lansoprazole; Longitudinal Studies; Male; Omeprazole; Proton Pump Inhibitors; Ranitidine; Smoking | 1995 |
[Prognostic factors of the speed of cicatrization in duodenal ulcer. Controlled trial of omeprazole versus ranitidine].
Topics: Adult; Aged; Aged, 80 and over; Cicatrix; Duodenal Ulcer; Endoscopy, Digestive System; Female; Humans; Male; Middle Aged; Omeprazole; Prognosis; Radiography; Ranitidine; Wound Healing | 1995 |
A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides; Time Factors | 1995 |
Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1995 |
Triple therapy eradicated H. pylori equally in patients pretreated with omeprazole or ranitidine. A 12-month follow-up.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Chi-Square Distribution; Confidence Intervals; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Recurrence; Statistics as Topic; Tetracycline | 1995 |
Effect of intravenous infusion of omeprazole and ranitidine on twenty-four-hour intragastric pH in patients with a history of duodenal ulcer.
Topics: Circadian Rhythm; Cross-Over Studies; Dose-Response Relationship, Drug; Duodenal Ulcer; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine | 1995 |
Omeprazole versus ranitidine plus somatostatin in the treatment of severe gastroduodenal bleeding: a prospective, randomized, controlled trial.
Topics: Acute Disease; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Somatostatin | 1994 |
Acid suppression and claims of genotoxicity. What have we learned?
Topics: Animals; Cell Division; DNA; Gastric Acid; Gastric Mucosa; Gastrins; Humans; Mutation; Omeprazole; Ranitidine; Rats | 1994 |
Omeprazole or ranitidine in long-term treatment of reflux esophagitis. The Scandinavian Clinics for United Research Group.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Esophagitis, Peptic; Female; Gastric Mucosa; Gastrins; Humans; Life Tables; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Prognosis; Prospective Studies; Ranitidine; Recurrence; Regression Analysis; Remission Induction; Scandinavian and Nordic Countries; Time Factors | 1994 |
A comparison of omeprazole and ranitidine in the prevention of recurrence of benign esophageal stricture. Restore Investigator Group.
Topics: Adult; Aged; Aged, 80 and over; Chi-Square Distribution; Dilatation; Double-Blind Method; Esophageal Stenosis; Esophagoscopy; Female; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; United Kingdom | 1994 |
Preanaesthetic oral ranitidine, omeprazole and metoclopramide for modifying gastric fluid volume and pH.
Topics: Administration, Oral; Adult; Anesthesia, General; Double-Blind Method; Gastric Acid; Gastrointestinal Contents; Humans; Hydrogen-Ion Concentration; Metoclopramide; Omeprazole; Placebos; Pneumonia, Aspiration; Premedication; Ranitidine | 1994 |
A multicenter, double-blind, randomized controlled study of omeprazole versus ranitidine in the treatment of duodenal ulcer in Israel.
Topics: Adult; Aged; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Israel; Male; Middle Aged; Omeprazole; Pain; Prospective Studies; Ranitidine; Safety; Smoking | 1994 |
[The treatment of upper digestive hemorrhage of peptic origin: intravenous ranitidine versus intravenous omeprazole].
Topics: Chi-Square Distribution; Duodenal Ulcer; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Statistics, Nonparametric; Stomach Ulcer; Treatment Failure | 1994 |
Effects of oral ranitidine, famotidine and omeprazole on gastric volume and pH at induction and recovery from general anaesthesia.
Topics: Administration, Oral; Adult; Aged; Anesthesia, General; Elective Surgical Procedures; Famotidine; Gastric Juice; Humans; Hydrogen-Ion Concentration; Middle Aged; Omeprazole; Pneumonia, Aspiration; Postoperative Complications; Preanesthetic Medication; Ranitidine | 1994 |
Comparison of omeprazole and histamine H2-receptor antagonists in the treatment of elderly and young patients with reflux oesophagitis.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Esophagoscopy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome; Wound Healing | 1994 |
Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole.
Topics: Administration, Oral; Circadian Rhythm; Double-Blind Method; Fasting; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Radioimmunoassay; Ranitidine; Reproducibility of Results | 1994 |
Rapid healing of gastric ulcers with lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Safety; Stomach Ulcer | 1994 |
Double-blind comparison of lansoprazole, ranitidine, and placebo in the treatment of acute duodenal ulcer. Lansoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Adult; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Gastric Mucosa; Gastrins; Helicobacter pylori; Humans; Lansoprazole; Male; Omeprazole; Ranitidine | 1994 |
Between-subject and within-subject variations in the pharmacokinetics of ethanol.
Topics: Administration, Oral; Adult; Analysis of Variance; Chromatography, Gas; Cimetidine; Ethanol; Half-Life; Humans; Intestinal Absorption; Male; Omeprazole; Random Allocation; Ranitidine | 1994 |
Treatment of reflux esophagitis resistant to H2-receptor antagonists with lansoprazole, a new H+/K(+)-ATPase inhibitor: a controlled, double-blind study. Lansoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Double-Blind Method; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Time Factors | 1993 |
Clinical evaluation of the effect of omeprazole, cimetidine, famotidine and ranitidine on histamine induced cutaneous wheal and flare response.
Topics: Adult; Cimetidine; Drug Hypersensitivity; Dyspepsia; Famotidine; Female; Histamine; Histamine H2 Antagonists; Humans; India; Male; Middle Aged; Omeprazole; Ranitidine | 1993 |
Use of omeprazole in Zollinger-Ellison syndrome: a prospective nine-year study of efficacy and safety.
Topics: Administration, Oral; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Gastric Acid; Gastrins; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Zollinger-Ellison Syndrome | 1993 |
Long-term therapy with pantoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Duodenal Ulcer; Enterochromaffin Cells; Esophagitis; Female; Gastrins; Humans; Longitudinal Studies; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Sulfoxides | 1994 |
Short report: treatment of gastric ulcer with lansoprazole or ranitidine: a multicentre clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer | 1994 |
Comparison of pantoprazole and ranitidine in the treatment of acute duodenal ulcer. Pantoprazole-Duodenal Ulcer-Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Benzimidazoles; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1994 |
Omeprazole v ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Esophagitis, Peptic; Esophagoscopy; Esophagus; Female; Humans; Hyperplasia; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Time Factors | 1994 |
Improved symptom relief and duodenal ulcer healing with lansoprazole, a new proton pump inhibitor, compared with ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1993 |
Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing?
Topics: Acids; Adult; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1994 |
Omeprazole and high dose ranitidine in the treatment of refractory reflux oesophagitis.
Topics: Adolescent; Child; Child, Preschool; Esophagitis, Peptic; Esophagus; Female; Gastric Acidity Determination; Gastrins; Humans; Infant; Male; Omeprazole; Ranitidine | 1993 |
Orally administered omeprazole versus injection therapy in the prevention of rebleeding from peptic ulcer with visible vessel. A multicenter randomized study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Drug Therapy, Combination; Duodenal Ulcer; Epinephrine; Female; Humans; Injections; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Polidocanol; Polyethylene Glycols; Ranitidine; Recurrence; Stomach Ulcer | 1993 |
Effect of single-dose omeprazole and ranitidine on gastric juice acidity and volume in patients undergoing laparotomy.
Topics: Abdomen; Administration, Oral; Adult; Aged; Gastric Acid; Gastric Juice; Humans; Middle Aged; Omeprazole; Ranitidine | 1993 |
Omeprazole vs ranitidine in the healing of duodenal ulcer.
Topics: Adolescent; Adult; Aged; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pain; Ranitidine | 1993 |
Chest pain associated with nutcracker esophagus: a preliminary study of the role of gastroesophageal reflux.
Topics: Adult; Aged; Chest Pain; Esophageal Motility Disorders; Esophagoscopy; Esophagus; Female; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Manometry; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 1993 |
Treatment of duodenal ulcer with omeprazole or ranitidine in a Brazilian population: a multicenter double-blind, parallel group study.
Topics: Adult; Brazil; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Multivariate Analysis; Omeprazole; Ranitidine; Risk Factors; Time Factors | 1993 |
Omeprazole is superior to ranitidine plus metoclopramide in the short-term treatment of erosive oesophagitis.
Topics: Adult; Antacids; Circadian Rhythm; Drug Therapy, Combination; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Metoclopramide; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1993 |
Lansoprazole in the treatment of reflux oesophagitis: a survey of clinical studies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Anti-Ulcer Agents; Esophagitis, Peptic; Humans; Lansoprazole; Omeprazole; Ranitidine | 1993 |
An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Duodenal Ulcer; Enterochromaffin Cells; Esophagitis; Female; Follicle Stimulating Hormone; Gastric Mucosa; Gastrins; Humans; Lansoprazole; Luteinizing Hormone; Male; Omeprazole; Peptic Ulcer; Pyloric Antrum; Ranitidine; Stomach Ulcer; Testosterone | 1993 |
Omeprazole promotes proximal duodenal mucosal bicarbonate secretion in humans.
Topics: Adult; Anti-Ulcer Agents; Bicarbonates; Duodenum; Female; Humans; Intestinal Secretions; Male; Middle Aged; Omeprazole; Ranitidine | 1996 |
Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.
Topics: Adult; Aged; Anti-Ulcer Agents; Esophagus; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 1995 |
Effect of parenteral omeprazole and ranitidine on gastric pH and the outcome of bleeding peptic ulcer.
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Stomach Ulcer | 1995 |
A comparison of lansoprazole, omeprazole, and ranitidine for reducing preoperative gastric secretion in adult patients undergoing elective surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Gastric Juice; Histamine H2 Antagonists; Humans; Lansoprazole; Middle Aged; Omeprazole; Preoperative Care; Ranitidine; Secretory Rate | 1996 |
[Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric ph-metry in duodenal ulcer hemorrhage].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal Ulcer; Gastric Acid; Gastric Acidity Determination; Humans; Middle Aged; Monitoring, Physiologic; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine; Time Factors | 1996 |
Comparison of the effect of two dose schedules of oral omeprazole with oral ranitidine on gastric aspirate pH and volume in patients undergoing elective surgery.
Topics: Adolescent; Adult; Aged; Antacids; Double-Blind Method; Drug Administration Schedule; Female; Gastric Acidity Determination; Gastrointestinal Contents; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Postoperative Complications; Preanesthetic Medication; Ranitidine | 1996 |
Acid aspiration prophylaxis for emergency Caesarean section.
Topics: Adult; Antacids; Anti-Ulcer Agents; Cesarean Section; Citrates; Citric Acid; Drug Therapy, Combination; Emergencies; Female; Gastric Acid; Gastrointestinal Contents; Humans; Hydrogen-Ion Concentration; Metoclopramide; Omeprazole; Pneumonia, Aspiration; Postoperative Complications; Pregnancy; Ranitidine | 1996 |
Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion treatment in the prevention of recurrent hemorrhage from peptic ulcer: prospective nonrandomized trial on 125 patients.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Stomach Ulcer; Time Factors | 1996 |
Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Topics: Dopamine Antagonists; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Metoclopramide; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1996 |
Prevention of recurrence of oesophageal stricture, a comparison of lansoprazole and high-dose ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Dilatation; Double-Blind Method; Drug Administration Schedule; Esophageal Stenosis; Humans; Lansoprazole; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Treatment Outcome | 1996 |
Twenty-four-hour intragastric acidity: 300 mg ranitidine b.d., 20 mg omeprazole o.m., 40 mg omeprazole o.m. vs. placebo.
Topics: Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Humans; Male; Omeprazole; Periodicity; Ranitidine | 1995 |
Lansoprazole versus ranitidine in the maintenance treatment of reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Diarrhea; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastritis; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine | 1996 |
A randomized blinded comparison of omeprazole and ranitidine in the treatment of chronic esophageal stricture secondary to acid peptic esophagitis.
Topics: Aged; Anti-Ulcer Agents; Chi-Square Distribution; Chronic Disease; Combined Modality Therapy; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Esophagus; Humans; Omeprazole; Radiography; Ranitidine | 1996 |
Omeprazole versus ranitidine: short-term triple-therapy in patients with Helicobacter pylori-positive duodenal ulcers.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Chi-Square Distribution; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole | 1996 |
Omeprazole in the treatment of patients with complicated gastro-oesophageal reflux disease.
Topics: Antacids; Anti-Ulcer Agents; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Female; Follow-Up Studies; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Time Factors | 1996 |
Are intragastric N-nitroso compounds elevated after short-term acid suppression?
Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Female; Gastric Acidity Determination; Gastric Juice; Humans; Hydrogen-Ion Concentration; Male; Monitoring, Physiologic; Nitroso Compounds; Omeprazole; Ranitidine; Time Factors | 1996 |
Randomised controlled trial of ranitidine versus omeprazole in combination with antibiotics for eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Single-Blind Method | 1996 |
[Treatment of duodenal ulcer with pantoprazole. A multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides | 1996 |
Lansoprazole heals erosive reflux esophagitis resistant to histamine H2-receptor antagonist therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Antacids; Anti-Ulcer Agents; Double-Blind Method; Drug Resistance; Esophagitis, Peptic; Esophagoscopy; Fasting; Female; Follow-Up Studies; Gastrins; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Safety; Sleep; Sleep Stages; Ulcer; Wound Healing | 1997 |
Prophylaxis against acid aspiration in regional anesthesia for elective cesarean section: a comparison between oral single-dose ranitidine, famotidine and omeprazole assessed with fiberoptic gastric aspiration.
Topics: Administration, Oral; Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Anti-Ulcer Agents; Cesarean Section; Double-Blind Method; Famotidine; Female; Humans; Omeprazole; Pneumonia, Aspiration; Pregnancy; Ranitidine | 1996 |
Triple therapy with ranitidine or lansoprazole in the treatment of Helicobacter pylori-associated duodenal ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Single-Blind Method; Time Factors | 1997 |
In single doses ranitidine effervescent is more effective than lansoprazole in decreasing gastric acidity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Capsules; Cross-Over Studies; Depression, Chemical; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine; Tablets | 1997 |
Efficacy of primed infusions with high dose ranitidine and omeprazole to maintain high intragastric pH in patients with peptic ulcer bleeding: a prospective randomised controlled study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal Ulcer; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Regression Analysis; Stomach Ulcer | 1997 |
[Maintenance therapy in reflux esophagitis].
Topics: Adult; Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Esophagitis, Peptic; Esophagoscopy; Female; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Piperidines; Ranitidine; Treatment Outcome | 1997 |
Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Nizatidine; Omeprazole; Organometallic Compounds; Penicillins; Ranitidine; Salicylates | 1997 |
Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.
Topics: Anti-Ulcer Agents; APACHE; Critical Illness; Feasibility Studies; Female; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Risk Factors; Stress, Physiological | 1997 |
Reappraisal of bicarbonate secretion by the human oesophagus.
Topics: Adult; Anti-Ulcer Agents; Bicarbonates; Esophagus; Female; Gastrointestinal Contents; Humans; Male; Omeprazole; Perfusion; Ranitidine; Saliva | 1997 |
Lansoprazole 30 mg daily versus ranitidine 150 mg b.d. in the treatment of acid-related dyspepsia in general practice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anti-Ulcer Agents; Double-Blind Method; Drug Therapy, Combination; Dyspepsia; Humans; Lansoprazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 1997 |
[Studies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Double-Blind Method; Duodenoscopy; Gastroscopy; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Peptic Ulcer; Platelet Aggregation Inhibitors; Ranitidine | 1997 |
Lifetime costs of surgical versus medical treatment of severe gastro-oesophageal reflux disease in Finland.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Distribution; Aged; Chronic Disease; Cost of Illness; Enzyme Inhibitors; Female; Finland; Follow-Up Studies; Fundoplication; Gastroesophageal Reflux; Health Care Costs; Humans; Lansoprazole; Life Expectancy; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Quality of Life; Ranitidine | 1997 |
Prophylaxis of acute gastroduodenal bleeding after renal transplantation.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastrointestinal Hemorrhage; Humans; Kidney Transplantation; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Stomach Ulcer; Transplantation Conditioning | 1997 |
[Intravenous omeprazole versus ranitidine in the treatment of hemorrhagic duodenal ulcer: a prospective randomized study].
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Duodenal Ulcer; Female; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine | 1997 |
Age-dependent eradication of Helicobacter pylori with dual therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Age Factors; Aged; Amoxicillin; Anti-Ulcer Agents; Area Under Curve; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastric Acid; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metabolic Clearance Rate; Middle Aged; Omeprazole; Penicillins; Proton Pump Inhibitors; Ranitidine | 1997 |
Cure with omeprazole plus amoxicillin versus long-term ranitidine therapy in Helicobacter pylori-associated peptic ulcer bleeding.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer Hemorrhage; Prognosis; Prospective Studies; Ranitidine; Secondary Prevention | 1997 |
Treatment of reflux oesophagitis of moderate and severe grade with ranitidine or pantoprazole--comparison of 24-hour intragastric and oesophageal pH.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Gastroscopy; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1997 |
Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of symptoms of gastro-oesophageal reflux disease in general practice.
Topics: Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1997 |
[Evaluation of the effectiveness of pantoprazole and ranitidine in the treatment of duodenal ulcer. Result of an international multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Humans; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides | 1997 |
Should we abandon metronidazole containing Helicobacter pylori treatment regimens? The clinical relevance of metronidazole resistance.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Metronidazole; Omeprazole; Penicillins; Placebos; Proton Pump Inhibitors; Ranitidine; Tetracycline | 1998 |
Bedtime administration of lansoprazole does not modify its greater efficacy vs ranitidine in the acute and long-term treatment of duodenal ulcer. Results from a multicentre, randomised, double blind clinical trial.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bed Rest; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Endoscopy, Digestive System; Female; Follow-Up Studies; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Treatment Outcome | 1997 |
Are we correctly using the inhibitors of gastric acid secretion and cytoprotective drugs? Results of a multicentre study.
Topics: Acute Disease; Anti-Ulcer Agents; Cohort Studies; Cytoprotection; Drug Prescriptions; Drug Utilization; Endoscopy, Digestive System; Gastric Acid; Histamine H2 Antagonists; Humans; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Sucralfate | 1997 |
A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs. Acid Suppression Trial: Ranitidine versus Omeprazole for NSAID-associated Ulcer Treatment (ASTRONAUT) Study Group.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prognosis; Proton Pump Inhibitors; Ranitidine; Remission Induction; Stomach Ulcer | 1998 |
Histamine H2 receptor antagonist-refractory oesophagitis: the efficacy of long-term omeprazole maintenance treatment.
Topics: Adult; Aged; Biopsy; Cimetidine; Drug Administration Schedule; Drug Resistance; Enzyme Inhibitors; Esophagitis, Peptic; Esophagus; Female; Follow-Up Studies; Gastric Mucosa; Gastrins; Gastroscopy; Histamine H2 Antagonists; Humans; Hyperplasia; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Treatment Outcome; Wound Healing | 1997 |
Effect of gastric acid suppressants on human gastric motility.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Cross-Over Studies; Electromyography; Famotidine; Female; Gastric Acid; Gastric Emptying; Gastrointestinal Motility; Histamine H2 Antagonists; Humans; Male; Manometry; Omeprazole; Postprandial Period; Radionuclide Imaging; Ranitidine; Stomach | 1998 |
Cost savings in duodenal ulcer therapy through Helicobacter pylori eradication compared with conventional therapies: results of a randomized, double-blind, multicenter trial. Gastrointestinal Utilization Trial Study Group.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Linear Models; Male; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 1998 |
The management of acid-related dyspepsia in general practice: a comparison of an omeprazole versus an antacid-alginate/ranitidine management strategy. Compete Research Group [corrected].
Topics: Abdominal Pain; Adolescent; Adult; Aged; Aged, 80 and over; Alginates; Anti-Ulcer Agents; Biocompatible Materials; Drug Therapy, Combination; Dyspepsia; Endoscopes; Female; Gastric Acid; Glucuronic Acid; Headache; Heartburn; Hexuronic Acids; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Outcome Assessment, Health Care; Patient Compliance; Patient Dropouts; Ranitidine; Severity of Illness Index; Treatment Outcome | 1998 |
[Drug therapy of gastroesophageal reflux (a prospective controlled clinical trial)].
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Domperidone; Dose-Response Relationship, Drug; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Sucralfate | 1998 |
Quality of life during acute and intermittent treatment of gastro-oesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial. The European Study Group.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Europe; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Ranitidine; Severity of Illness Index; Surveys and Questionnaires; Treatment Outcome | 1998 |
[The action of the proton pump inhibitor pantoprazol against acetylsalicylic acid-induced gastroduodenopathy in comparison to ranitidine. An endoscopic controlled, double blind comparison].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Aspirin; Benzimidazoles; Cyclooxygenase Inhibitors; Double-Blind Method; Endoscopy, Gastrointestinal; Enzyme Inhibitors; Humans; Male; Omeprazole; Pantoprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Sulfoxides | 1998 |
Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Dyspepsia; Female; Gastric Acid; Gastric Emptying; Gastrins; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pepsinogens; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 1998 |
Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Wound Healing | 1997 |
Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers.
Topics: Administration, Oral; Adult; Anti-Ulcer Agents; Capsules; Cross-Over Studies; Drug Administration Schedule; Famotidine; Fasting; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Ranitidine; Solubility; Tablets; Time Factors | 1997 |
Addition of bismuth subnitrate to omeprazole plus amoxycillin improves eradication of Helicobacter pylori.
Topics: Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Female; Follow-Up Studies; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Ranitidine; Stomach Ulcer | 1998 |
Inhibition of gastric secretion by omeprazole and efficiency of calcium carbonate on the control of hyperphosphatemia in patients on chronic hemodialysis.
Topics: Absorption; Anti-Ulcer Agents; Bicarbonates; Blood Proteins; Calcium; Calcium Carbonate; Creatinine; Cross-Over Studies; Female; Follow-Up Studies; Gastric Acid; Humans; Male; Middle Aged; Omeprazole; Parathyroid Hormone; Phosphates; Ranitidine; Renal Dialysis; Urea | 1998 |
Ranitidine bismuth citrate versus omeprazole triple therapy for the eradication of Helicobacter pylori and healing of duodenal ulcer.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 1998 |
Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clinical Protocols; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter pylori; Humans; Intubation, Gastrointestinal; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Pronase; Ranitidine | 1998 |
Drug-induced hypochlorhydria causes high duodenal bacterial counts in the elderly.
Topics: Achlorhydria; Age Factors; Aged; Aged, 80 and over; Anti-Ulcer Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Colony Count, Microbial; Duodenum; Female; Gastric Acid; Humans; Intestinal Absorption; Male; Middle Aged; Omeprazole; Ranitidine | 1998 |
One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Combined Modality Therapy; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Proton Pumps; Ranitidine; Single-Blind Method; Treatment Outcome | 1998 |
Changes in Helicobacter pylori-induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pyloric Antrum; Ranitidine; Treatment Outcome | 1998 |
Somatostatin in the prevention of recurrent bleeding after endoscopic haemostasis of peptic ulcer haemorrhage: a preliminary report.
Topics: Adult; Aged; Anti-Ulcer Agents; Female; Hemostasis, Endoscopic; Hemostatics; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Secondary Prevention; Somatostatin; Treatment Outcome | 1998 |
Omeprazole and ranitidine in long-term treatment of duodenal ulcer: a double-blind comparison of length of time in remission.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Duodenal Ulcer; Duodenoscopy; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Risk Factors; Survival Analysis; Treatment Outcome; Wound Healing | 1998 |
Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Treatment Outcome | 1998 |
Triple regimens using lansoprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Time Factors; Tinidazole | 1998 |
Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection.
Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Energy Metabolism; Feces; Female; Histamine H2 Antagonists; Humans; Ileostomy; Intestinal Absorption; Jejunostomy; Male; Middle Aged; Omeprazole; Ranitidine; Short Bowel Syndrome; Sodium, Dietary; Water | 1998 |
Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
Topics: Adult; Anti-Ulcer Agents; Circadian Rhythm; Cross-Over Studies; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Ranitidine | 1998 |
Healing and prevention of NSAID-associated ulcer disease: is seeing believing?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Endoscopy; Humans; Misoprostol; Omeprazole; Ranitidine; Secondary Prevention; Ulcer; Wound Healing | 1998 |
Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients.
Topics: Adult; Aged; Chromogranin A; Chromogranins; Drug Tolerance; Esophagitis; Female; Gastric Acid; Gastrins; Gastroesophageal Reflux; Gastrointestinal Agents; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Histamine Release; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine | 1998 |
Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours.
Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Injections, Intravenous; Male; Omeprazole; Ranitidine; Time Factors | 1999 |
Symptomatic gastro-oesophageal reflux disease: double blind controlled study of intermittent treatment with omeprazole or ranitidine. The European Study Group.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors; Treatment Outcome | 1999 |
[Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1999 |
Comparing the cost-effectiveness of drug regimens in the treatment of duodenal ulcers.
Topics: Clinical Trials as Topic; Cost-Benefit Analysis; Decision Trees; Direct Service Costs; Drug Evaluation; Duodenal Ulcer; Finland; Humans; Logistic Models; Omeprazole; Probability; Ranitidine; Sucralfate | 1990 |
Cost and quality effects of treating erosive oesophagitis. A re-evaluation.
Topics: Antacids; Anti-Ulcer Agents; Cost of Illness; Costs and Cost Analysis; Decision Trees; Esophagitis, Peptic; Humans; Insurance, Health; Omeprazole; Ranitidine; Treatment Outcome | 1995 |
Omeprazole or ranitidine plus metoclopramide for patients with severe erosive oesophagitis. A cost-effectiveness analysis.
Topics: Anti-Ulcer Agents; Antiemetics; Cost-Benefit Analysis; Double-Blind Method; Drug Combinations; Esophagitis; Esophagoscopy; Humans; Metoclopramide; Omeprazole; Prospective Studies; Ranitidine | 1995 |
Omeprazole versus high-dose ranitidine in mild gastroesophageal reflux disease: short- and long-term treatment. The Dutch Reflux Study Group.
Topics: Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Recurrence; Time Factors | 1999 |
The effect of antibiotic therapy on bleeding from duodenal ulcer.
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine; Risk Factors; Time Factors | 1999 |
Head-to-head comparison of 1-week triple regimens combining ranitidine or omeprazole with two antibiotics to eradicate Helicobacter pylori.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1999 |
Bedtime ranitidine does not eliminate the need for a second daily dose of omeprazole to suppress nocturnal gastric pH.
Topics: Adult; Anti-Ulcer Agents; Cross-Over Studies; Double-Blind Method; Female; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1999 |
Omeprazole or ranitidine for intermittent treatment of GERD?
Topics: Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 1999 |
Antibiotic therapy of Helicobacter pylori infection reduces healthcare expenditures related to duodenal ulcer.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Clarithromycin; Double-Blind Method; Drug Costs; Drug Therapy, Combination; Drug Utilization; Duodenal Ulcer; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Humans; Managed Care Programs; Omeprazole; Prospective Studies; Ranitidine; United States | 1999 |
"Reappearance" of Helicobacter pylori after eradication: implications on duodenal ulcer recurrence: a prospective 6 year study.
Topics: Adolescent; Adult; Aged; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Recurrence; Smoking; Time Factors | 1999 |
The effect of Helicobacter pylori eradication on intragastric pH during dosing with lansoprazole or ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine | 1999 |
Efficacy of omeprazole versus ranitidine for symptomatic treatment of poorly responsive acid reflux disease-a prospective, controlled trial.
Topics: Adult; Aged; Anti-Ulcer Agents; Double-Blind Method; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 1999 |
Lansoprazole is superior to ranitidine as maintenance treatment for the prevention of duodenal ulcer relapse.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Duodenal Ulcer; Female; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence | 1999 |
Comparison of two 3-day Helicobacter pylori eradication regimens with a standard 1-week regimen.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Biopsy; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Peptic Ulcer; Ranitidine; Treatment Outcome | 1999 |
The influence of Helicobacter pylori on oesophageal acid exposure in GERD during acid suppressive therapy.
Topics: Adult; Aged; Barrett Esophagus; Double-Blind Method; Esophagus; Female; Gastroesophageal Reflux; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Severity of Illness Index | 1999 |
The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Multivariate Analysis; Nizatidine; Omeprazole; Patient Dropouts; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Treatment Outcome | 1999 |
On demand therapy of reflux oesophagitis--a prospective study of symptoms, patient satisfaction and quality of life.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Esophagitis, Peptic; Famotidine; Female; Gastric Acidity Determination; Heartburn; Humans; Male; Middle Aged; Norway; Omeprazole; Patient Satisfaction; Prospective Studies; Quality of Life; Ranitidine; Socioeconomic Factors | 1999 |
Comparison of ranitidine bismuth citrate plus clarithromycin with omeprazole plus clarithromycin for the eradication of Helicobacter pylori.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Combinations; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Proton Pump Inhibitors; Ranitidine | 1999 |
Post-prandial ranitidine is superior to post-prandial omeprazole in control of gastric acidity in healthy volunteers.
Topics: Adolescent; Adult; Analysis of Variance; Anti-Ulcer Agents; Cross-Over Studies; Enzyme Inhibitors; Female; Gastric Juice; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Postprandial Period; Ranitidine; Reference Values; Time Factors | 1999 |
Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.
Topics: Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Double-Blind Method; Esophagoscopy; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 1999 |
Lansoprazole decreases peripheral blood monocytes and intercellular adhesion molecule-1-positive mononuclear cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Cell Count; Enzyme Inhibitors; Female; Humans; Intercellular Adhesion Molecule-1; Lansoprazole; Lymphocyte Subsets; Male; Monocytes; Omeprazole; Proton Pump Inhibitors; Ranitidine; Receptors, Interleukin-2 | 1999 |
Inhibition of gastric secretion relieves diarrhea and postprandial urgency associated with irritable bowel syndrome or functional diarrhea.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Chronic Disease; Colonic Diseases, Functional; Diarrhea; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine | 1999 |
Seven-day 'rescue' therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 1999 |
Standard-dose lansoprazole is more effective than high-dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. The Dutch Lansoprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Double-Blind Method; Endoscopy; Eructation; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pain; Ranitidine; Time Factors | 1999 |
Omeprazole and ranitidine in the prevention of relapse in patients with duodenal ulcer disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Double-Blind Method; Duodenal Ulcer; Enzyme Inhibitors; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proportional Hazards Models; Ranitidine; Remission Induction; Secondary Prevention | 1999 |
Salvage therapies after failure of Helicobacter pylori eradication with ranitidine bismuth citrate-based therapies.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Penicillins; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Salvage Therapy | 2000 |
Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Antigens, Bacterial; Bacterial Proteins; Bismuth; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin A; Male; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Urease; Vietnam | 2000 |
Pantoprazole versus ranitidine in the treatment of duodenal ulcer: a multicenter study in Brazil.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides | 2000 |
Randomized trial of omeprazole or ranitidine versus placebo in the prevention of chemotherapy-induced gastroduodenal injury.
Topics: Adult; Aged; Anti-Ulcer Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Duodenal Ulcer; Female; Fluorouracil; Gastric Mucosa; Histamine H2 Antagonists; Humans; Intestinal Mucosa; Male; Methotrexate; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer | 2000 |
Cost effectiveness of omeprazole and ranitidine in intermittent treatment of symptomatic gastro-oesophageal reflux disease.
Topics: Algorithms; Anti-Ulcer Agents; Cost-Benefit Analysis; Double-Blind Method; Drug Administration Schedule; Economics, Pharmaceutical; Europe; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 1999 |
A comparison of rabeprazole, lansoprazole, and ranitidine for improving preoperative gastric fluid property in adults undergoing elective surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Elective Surgical Procedures; Female; Gastric Juice; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pneumonia, Aspiration; Prospective Studies; Rabeprazole; Ranitidine | 2000 |
Effect of gastric acid suppression on 13C-urea breath test: comparison of ranitidine with omeprazole.
Topics: Anti-Ulcer Agents; Breath Tests; Depression, Chemical; Enzyme Inhibitors; False Negative Reactions; Female; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Urea | 2000 |
Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Prospective Studies; Ranitidine; Single-Blind Method | 2000 |
Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Severity of Illness Index; South Africa; Sulfoxides; Treatment Outcome | 2000 |
Rabeprazole is superior to ranitidine in the management of active duodenal ulcer disease: results of a double-blind, randomized North American study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Duodenoscopy; Female; Humans; Male; Middle Aged; Omeprazole; Pain Measurement; Rabeprazole; Ranitidine; Treatment Outcome | 2000 |
Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Clarithromycin; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Tinidazole | 2000 |
Superiority of lansoprazole vs ranitidine in healing nonsteroidal anti-inflammatory drug-associated gastric ulcers: results of a double-blind, randomized, multicenter study. NSAID-Associated Gastric Ulcer Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer; Wound Healing | 2000 |
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Logistic Models; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Prospective Studies; Ranitidine; Sulfoxides; Treatment Outcome | 2000 |
Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-line Helicobacter pylori eradication regimens.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Duodenitis; Female; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Ranitidine; Tetracycline; Treatment Outcome | 2000 |
Lansoprazole compared with ranitidine for the treatment of nonerosive gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adult; Aged; Aged, 80 and over; Antacids; Anti-Ulcer Agents; Diarrhea; Double-Blind Method; Drug Administration Schedule; Esophagoscopy; Female; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Risk Factors; Treatment Outcome | 2000 |
Effectiveness and costs of omeprazole vs ranitidine for treatment of symptomatic gastroesophageal reflux disease in primary care clinics in West Virginia.
Topics: Adult; Costs and Cost Analysis; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Primary Health Care; Proton Pump Inhibitors; Ranitidine; West Virginia | 2000 |
Rabeprazole versus ranitidine for the treatment of erosive gastroesophageal reflux disease: a double-blind, randomized clinical trial. Raberprazole Study Group.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Antacids; Benzimidazoles; Double-Blind Method; Female; Gastrins; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Treatment Outcome | 2000 |
[Combination of ranitidine and bismuth citrate plus 2 antibiotics in the eradication of Helicobacter pylori].
Topics: Amoxicillin; Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Organometallic Compounds; Penicillins; Prospective Studies; Ranitidine; Time Factors | 2000 |
[Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2000 |
Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group.
Topics: Adolescent; Adult; Aged; Algorithms; Anti-Ulcer Agents; Double-Blind Method; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Ranitidine; Recurrence; Regression Analysis; Treatment Outcome | 2000 |
Helicobacter pylori-positive duodenal ulcer: three-day antibiotic eradication regimen.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Costs and Cost Analysis; Duodenal Ulcer; Enzyme Inhibitors; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patient Compliance; Penicillins; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2000 |
The economic impact of the diagnosis of dysplasia in Barrett's esophagus.
Topics: Anti-Ulcer Agents; Barrett Esophagus; Biopsy; Cost-Benefit Analysis; Esophageal Neoplasms; Esophagoscopy; Esophagus; Female; Follow-Up Studies; Humans; Male; Middle Aged; Omeprazole; Precancerous Conditions; Prospective Studies; Ranitidine; Risk Assessment | 2000 |
Ranitidine bismuth citrate can help to overcome Helicobacter pylori resistance to clarithromycin in vivo.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Resistance, Microbial; Drug Synergism; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine | 2000 |
Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus.
Topics: Adult; Aged; Barrett Esophagus; Biopsy; Cell Division; Double-Blind Method; Enzyme Inhibitors; Gastric Mucosa; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Immunohistochemistry; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Statistics, Nonparametric | 2000 |
One-week ranitidine bismuth citrate-based triple therapy for the eradication of Helicobacter pylori in Hong Kong with high prevalence of metronidazole resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Hong Kong; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prevalence; Ranitidine; Treatment Outcome; Urea | 2001 |
Maximal acid reflux control for Barrett's oesophagus: feasible and effective.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Barrett Esophagus; Endoscopy, Digestive System; Epithelium; Esophagus; Female; Gastric Acid; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2001 |
Antibiotic resistance and antibiotic sensitivity based treatment in Helicobacter pylori infection: advantages and outcome.
Topics: Adolescent; Amoxicillin; Anti-Ulcer Agents; Child; Child, Preschool; Clarithromycin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Omeprazole; Ranitidine; Treatment Outcome | 2001 |
Ranitidine bismuth citrate or omeprazole-based triple therapy for Helicobacter pylori eradication in Helicobacter pylori-infected non-ulcer dyspepsia.
Topics: Adult; Amoxicillin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Probability; Ranitidine; Reference Values; Treatment Outcome | 2001 |
Pharmacokinetics and pharmacodynamics of antiulcer agents in llama.
Topics: Animals; Anti-Ulcer Agents; Area Under Curve; Camelids, New World; Dose-Response Relationship, Drug; Gastric Acidity Determination; Half-Life; Injections, Intravenous; Male; Omeprazole; Ranitidine; Ulcer | 2001 |
Comparison of pantoprazole 20 mg to ranitidine 150 mg b.i.d. in the treatment of mild gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Enzyme Inhibitors; Female; Follow-Up Studies; Gastroesophageal Reflux; Germany; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Sulfoxides; Treatment Outcome | 2001 |
Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Anti-Ulcer Agents; Bismuth; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Duodenal Ulcer; Dyspepsia; Female; Headache; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Pruritus; Ranitidine; Recurrence; Taste Disorders; Tinidazole; Treatment Outcome | 2001 |
Management of heartburn in a large, randomized, community-based study: comparison of four therapeutic strategies.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Cross-Over Studies; Double-Blind Method; Enzyme Inhibitors; Family Practice; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Time Factors | 2001 |
Ranitidine bismuth citrate-based triple therapies after failure of the standard 'Maastricht triple therapy': a promising alternative to the quadruple therapy?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Benzimidazoles; Bismuth; Breath Tests; Carbon Isotopes; Clarithromycin; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Helicobacter Infections; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Penicillins; Proton Pump Inhibitors; Ranitidine; Recurrence; Sulfoxides; Tinidazole; Treatment Outcome; Urea | 2001 |
The AMOR study: a randomized, double-blinded trial of omeprazole versus ranitidine together with amoxycillin and metronidazole for eradication of Helicobacter pylori.
Topics: Adolescent; Aged; Aged, 80 and over; Amoxicillin; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2001 |
Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Enzyme Inhibitors; Esophagitis, Peptic; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Secondary Prevention; Sulfoxides | 2001 |
A randomised controlled trial of four management strategies for dyspepsia: relationships between symptom subgroups and strategy outcome.
Topics: Anti-Ulcer Agents; Cimetidine; Cisapride; Clinical Protocols; Dyspepsia; Endoscopy, Gastrointestinal; Family Practice; Female; Humans; Male; Odds Ratio; Omeprazole; Practice Guidelines as Topic; Ranitidine; Retrospective Studies; Treatment Outcome | 2001 |
[Comparative study of the eradication of Helicobacter pylori: ranitidine bismuth citrate versus omeprazole plus two antibiotics for seven days].
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 2001 |
Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Female; Gastroesophageal Reflux; Humans; Lansoprazole; Male; Omeprazole; Patient Satisfaction; Quality of Life; Ranitidine; Socioeconomic Factors; Surveys and Questionnaires | 2001 |
Omeprazole versus ranitidine in the medical treatment of acute upper gastrointestinal bleeding: assessment by early repeat endoscopy.
Topics: Acute Disease; Adult; Aged; Anti-Ulcer Agents; Endoscopy, Digestive System; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine; Single-Blind Method | 2001 |
Two new treatment regimens for Helicobacter pylori eradication: a randomised study.
Topics: Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tinidazole; Treatment Outcome | 2001 |
Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication: a randomized controlled trial (MACLOR study).
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Regression Analysis; Treatment Outcome | 2002 |
Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.
Topics: Anti-Ulcer Agents; Cross-Over Studies; Drug Administration Schedule; Female; Gastric Acid; Gastric Acidity Determination; Gastroesophageal Reflux; Heartburn; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Ranitidine; Single-Blind Method | 2002 |
Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Supine Position; Treatment Outcome | 2002 |
Amoxicillin/tetracycline combinations are inadequate as alternative therapies for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Doxycycline; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Penicillins; Prospective Studies; Ranitidine; Tetracycline; Treatment Failure | 2002 |
Upper gastrointestinal complications after renal transplantation: a 3-yr sequential study.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Child; Child, Preschool; Cyclosporine; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tacrolimus; Treatment Outcome | 2002 |
Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Aged, 80 and over; Benzimidazoles; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Esophagitis, Peptic; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Probability; Ranitidine; Risk Assessment; Sulfoxides; Treatment Outcome; Wound Healing | 2002 |
The efficacy of lafutidine in improving preoperative gastric fluid property: a comparison with ranitidine and rabeprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acetamides; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Enzyme Inhibitors; Female; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Intraoperative Complications; Intubation, Gastrointestinal; Male; Middle Aged; Omeprazole; Piperidines; Preoperative Care; Proton Pump Inhibitors; Pyridines; Rabeprazole; Ranitidine; Risk Assessment; Stomach | 2002 |
Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis.
Topics: Adolescent; Adult; Child; Cross-Over Studies; Cystic Fibrosis; Dietary Fats; Double-Blind Method; Female; Gastric Acid; Humans; Intestinal Absorption; Male; Omeprazole; Pancrelipase; Placebos; Ranitidine | 2002 |
Effect of H. pylori status on gastric ulcer healing in patients continuing nonsteroidal anti-inflammatory therapy and receiving treatment with lansoprazole or ranitidine.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Double-Blind Method; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Peptic Ulcer; Prospective Studies; Ranitidine; Time Factors; Wound Healing | 2002 |
Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Heartburn; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Sulfoxides; Treatment Outcome | 2002 |
The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance; Drug Therapy, Combination; Dyspepsia; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2002 |
Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aluminum Hydroxide; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Drug Combinations; Esophagitis; Female; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Pantoprazole; Ranitidine; Recurrence; Silicic Acid; Sulfoxides; Treatment Outcome | 2003 |
Occurrence of ventilator-associated pneumonia in mechanically ventilated pediatric intensive care patients during stress ulcer prophylaxis with sucralfate, ranitidine, and omeprazole.
Topics: Anti-Ulcer Agents; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Omeprazole; Peptic Ulcer Hemorrhage; Pneumonia, Bacterial; Prospective Studies; Ranitidine; Respiration, Artificial; Stomach Ulcer; Sucralfate; Turkey | 2002 |
Comparison of three triple regimens with omeprazole or ranitidine bismuth citrate for Helicobacter pylori eradication.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Patient Compliance; Ranitidine; Tetracycline | 2002 |
Impact of long-term ranitidine and pantoprazole on accuracy of [13C]urea breath test.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzimidazoles; Breath Tests; Dose-Response Relationship, Drug; Drug Administration Schedule; Dyspepsia; False Negative Reactions; Female; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Male; Middle Aged; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Reference Values; Risk Assessment; Sensitivity and Specificity; Sulfoxides | 2003 |
Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.
Topics: Adult; Aged; Anti-Ulcer Agents; Drug Administration Schedule; Drug Therapy, Combination; Esophagus; Female; Gastric Acid; Gastric Mucosa; Gastroesophageal Reflux; Humans; Male; Manometry; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Surveys and Questionnaires; Treatment Outcome | 2003 |
A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Ranitidine; Time Factors; Urea | 2003 |
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy'.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Infective Agents; Anti-Ulcer Agents; Benzimidazoles; Bismuth; Breath Tests; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Male; Metronidazole; Middle Aged; Ofloxacin; Omeprazole; Pantoprazole; Prospective Studies; Ranitidine; Sulfoxides; Tinidazole; Treatment Failure; Urea | 2003 |
Role of antibiotic sensitivity testing before first-line Helicobacter pylori eradication treatments.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Omeprazole; Ranitidine; Tinidazole; Treatment Outcome | 2003 |
Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Chronotherapy; Cross-Over Studies; Drug Therapy, Combination; Gastric Acid; Helicobacter pylori; Humans; Male; Monitoring, Ambulatory; Omeprazole; Rabeprazole; Ranitidine; Reference Values | 2003 |
The effect of intravenous pantoprazole and ranitidine for improving preoperative gastric fluid properties in adults undergoing elective surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastric Acid; Gastric Acidity Determination; Gastric Mucosa; Humans; Hydrogen-Ion Concentration; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Pneumonia, Aspiration; Postoperative Period; Ranitidine; Risk Assessment; Stomach; Sulfoxides | 2003 |
[Antisecretory therapy for prevention of stenoses of bougienage after-burn of esophageal strictures].
Topics: Adult; Aged; Anti-Ulcer Agents; Burns, Chemical; Esophageal Stenosis; Esophagoscopy; Esophagus; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pumps; Ranitidine; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
Omeprazole is more effective than a histamine H2-receptor blocker for maintaining a persistent elevation of gastric pH after colon resection for cancer.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cimetidine; Colonic Neoplasms; Female; Gastric Acidity Determination; Gastric Mucosa; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Stomach | 2004 |
[Treatment of Helicobacter pylori infection--results and experiences with an Internet-based collaboration trial].
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Internet; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Tetracycline | 2003 |
[Therapeutic effect of low-dose omeprazole vs. standard-dose ranitidine in mild to moderate reflux esophagitis].
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 2004 |
A comparison of the effects of ranitidine and omeprazole on volume and pH of gastric contents in elective surgical patients.
Topics: Administration, Oral; Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Anti-Ulcer Agents; Elective Surgical Procedures; Female; Gastrointestinal Contents; Humans; Hydrogen-Ion Concentration; Intubation, Gastrointestinal; Isoflurane; Middle Aged; Nitrous Oxide; Omeprazole; Pneumonia, Aspiration; Premedication; Ranitidine; Statistics, Nonparametric; Thiopental | 2004 |
Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Odds Ratio; Omeprazole; Pantoprazole; Placebos; Ranitidine; Severity of Illness Index; Sulfoxides; Treatment Outcome | 2004 |
Ranitidine-bismuth citrate, tetracycline and metronidazole followed by triple therapy as alternative strategy for Helicobacter pylori treatment: a pilot study.
Topics: Adult; Aged; Amoxicillin; Anti-Infective Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Gastritis; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Pilot Projects; Ranitidine; Tetracycline; Treatment Outcome | 2004 |
Intravenous pantoprazole versus ranitidine for prevention of rebleeding after endoscopic hemostasis of bleeding peptic ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Combined Modality Therapy; Female; Hemostasis, Endoscopic; Humans; Injections, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Pilot Projects; Prospective Studies; Ranitidine; Secondary Prevention; Sulfoxides | 2004 |
A randomized crossover study investigating the influence of ranitidine or omeprazole on the pharmacokinetics of cephalexin monohydrate.
Topics: Adult; Area Under Curve; Cephalexin; Cross-Over Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Microbial Sensitivity Tests; Omeprazole; Ranitidine; Staphylococcus aureus; Streptococcus pyogenes | 2004 |
Prospective randomized trial for optimal prophylactic treatment of the upper gastrointestinal complications after open heart surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Benzimidazoles; Cardiac Surgical Procedures; Diterpenes; Endoscopy, Gastrointestinal; Gastritis; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Incidence; Omeprazole; Postoperative Complications; Premedication; Proton-Translocating ATPases; Rabeprazole; Ranitidine; Ulcer; Upper Gastrointestinal Tract | 2005 |
First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance: results of three eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Ranitidine; Risk Factors | 2005 |
Ranitidine bismuth citrate-based triple therapies as a second-line therapy for Helicobacter pylori in Turkish patients.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Breath Tests; Chi-Square Distribution; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Tetracycline; Treatment Outcome; Turkey | 2005 |
Heartburn-dominant, uninvestigated dyspepsia: a comparison of 'PPI-start' and 'H2-RA-start' management strategies in primary care--the CADET-HR Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Double-Blind Method; Drug Administration Schedule; Dyspepsia; Female; Heartburn; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quality of Life; Ranitidine; Recurrence; Treatment Outcome | 2005 |
[A randomized, comparative study of rabeprazole vs. ranitidine maintenance therapies for reflux esophagitis--multicenter study].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Humans; Male; Middle Aged; Omeprazole; Rabeprazole; Ranitidine | 2005 |
A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Topics: Adult; Aged; Cisapride; Cost-Benefit Analysis; Drug Costs; Dyspepsia; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Omeprazole; Quality of Life; Ranitidine; Time Factors; Treatment Outcome | 2005 |
Is a long-term ranitidine-based triple therapy against Helicobacter pylori only a heritage of the past? A prospective, randomized clinicopharmacological study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Chromatography, High Pressure Liquid; Clarithromycin; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Long-Term Care; Male; Metronidazole; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2005 |
Effects of treatment with omeprazole or ranitidine on gastric squamous ulceration in racing Thoroughbreds.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cross-Over Studies; Female; Horse Diseases; Horses; Male; Omeprazole; Physical Conditioning, Animal; Ranitidine; Severity of Illness Index; Stomach Ulcer; Time Factors; Treatment Outcome | 2005 |
[A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Benzimidazoles; Esophagitis, Peptic; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Proton-Translocating ATPases; Rabeprazole; Ranitidine | 2006 |
Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
Topics: Adolescent; Adult; Aged; Alginates; Antacids; Cross-Over Studies; Female; Gastroesophageal Reflux; Glucuronic Acid; Hexuronic Acids; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2006 |
Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Benzimidazoles; Double-Blind Method; Duodenal Ulcer; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Pantoprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine; Secondary Prevention; Sulfoxides; Treatment Outcome; United States | 2006 |
Pharmacoeconomic comparison of Helicobacter pylori eradication regimens.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adolescent; Adult; Amoxicillin; Anti-Infective Agents; Clarithromycin; Cost-Benefit Analysis; Drug Therapy, Combination; Economics, Pharmaceutical; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Melena; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Taste Disorders; Time Factors; Treatment Outcome | 2006 |
Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers.
Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Ulcer Agents; Antiviral Agents; Area Under Curve; Darunavir; Drug Interactions; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Ritonavir; Sulfonamides | 2007 |
Maintenance therapy for erosive esophagitis in children after healing by omeprazole: is it advisable?
Topics: Adolescent; Anti-Ulcer Agents; Child; Child, Preschool; Esophagitis, Peptic; Female; Gastroesophageal Reflux; Humans; Male; Omeprazole; Ranitidine; Recurrence | 2007 |
Effect of baseline symptom severity on patient-reported outcomes in gastroesophageal reflux disease.
Topics: Adult; Aged; Anti-Ulcer Agents; Esomeprazole; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Prognosis; Quality of Life; Randomized Controlled Trials as Topic; Ranitidine; Severity of Illness Index; Treatment Outcome | 2007 |
Eradication of Helicobacter pylori infection favourably affects altered gastric mucosal MMP-9 levels.
Topics: Adult; Aged; Anti-Infective Agents; Anti-Ulcer Agents; Biopsy; Clarithromycin; Drug Therapy, Combination; Endoscopy, Gastrointestinal; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Treatment Outcome | 2007 |
Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Topics: Aged; Anti-Ulcer Agents; Cross-Over Studies; Drug Therapy, Combination; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Scleroderma, Systemic; Treatment Outcome | 2007 |
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients.
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Breath Tests; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Prospective Studies; Ranitidine; Rifabutin; Tetracycline; Treatment Failure | 2008 |
Effects of acid-reducing agents on the pharmacokinetics of lopinavir/ritonavir and ritonavir-boosted atazanavir.
Topics: Adult; Anti-HIV Agents; Anti-Ulcer Agents; Area Under Curve; Atazanavir Sulfate; Biological Availability; Dose-Response Relationship, Drug; Drug Interactions; Female; Histamine H2 Antagonists; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Oligopeptides; Omeprazole; Pyridines; Pyrimidinones; Ranitidine; Ritonavir | 2008 |
A glass of water immediately increases gastric pH in healthy subjects.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Antacids; Anti-Ulcer Agents; Cross-Over Studies; Esomeprazole; Female; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Stomach; Time Factors; Water | 2008 |
A pharmacokinetic study of etravirine (TMC125) co-administered with ranitidine and omeprazole in HIV-negative volunteers.
Topics: Adolescent; Adult; Anti-HIV Agents; Anti-Ulcer Agents; Drug Administration Schedule; Drug Combinations; Drug Interactions; Epidemiologic Methods; Female; Humans; Male; Middle Aged; Nitriles; Omeprazole; Proton Pump Inhibitors; Pyridazines; Pyrimidines; Ranitidine; Reverse Transcriptase Inhibitors; Treatment Outcome | 2008 |
Role of intravenous omeprazole on non-variceal upper gastrointestinal bleeding after endoscopic treatment: a comparative study.
Topics: Antacids; Anti-Ulcer Agents; Endoscopy, Gastrointestinal; Female; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence | 2010 |
Molecular pharmacological approaches to effects of capsaicinoids and of classical antisecretory drugs on gastric basal acid secretion and on indomethacin-induced gastric mucosal damage in human healthy subjects (mini review).
Topics: Adult; Afferent Pathways; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Atropine; Capsaicin; Cimetidine; Dose-Response Relationship, Drug; Famotidine; Female; Gastric Acid; Gastric Mucosa; Humans; Indomethacin; Male; Omeprazole; Peptic Ulcer; Ranitidine | 2013 |
Effect of meal and antisecretory agents on the pharmacokinetics of danoprevir/ritonavir in healthy volunteers.
Topics: Adult; Area Under Curve; Cross-Over Studies; Cyclopropanes; Female; Food-Drug Interactions; Healthy Volunteers; Humans; Isoindoles; Lactams; Lactams, Macrocyclic; Male; Meals; Neuropeptides; Omeprazole; Proline; Ranitidine; Ritonavir; Sulfonamides; Young Adult | 2014 |
Pharmacokinetic evaluations of the co-administrations of vandetanib and metformin, digoxin, midazolam, omeprazole or ranitidine.
Topics: Adolescent; Adult; Area Under Curve; Digoxin; Drug Interactions; Female; Humans; Male; Metformin; Midazolam; Middle Aged; Omeprazole; Piperidines; Quinazolines; Ranitidine; Young Adult | 2014 |
Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Cross-Over Studies; Drug Administration Schedule; Drug Interactions; Erlotinib Hydrochloride; Female; Gastric Acid; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinazolines; Ranitidine; Young Adult | 2015 |
Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.
Topics: Adult; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Female; Gastric Acid; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Male; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2015 |
Changes in CYP2C19 enzyme activity evaluated by the [(13)C]-pantoprazole breath test after co-administration of clopidogrel and proton pump inhibitors following percutaneous coronary intervention and correlation to platelet reactivity.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Blood Platelets; Breath Tests; Clopidogrel; Cytochrome P-450 CYP2C19; Drug Interactions; Esomeprazole; Humans; Omeprazole; Pantoprazole; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platelet Function Tests; Proton Pump Inhibitors; Ranitidine; Ticlopidine | 2016 |
Drug Interaction Between Clopidogrel and Ranitidine or Omeprazole in Stable Coronary Artery Disease: A Double-Blind, Double Dummy, Randomized Study.
Topics: Aged; Blood Platelets; Clopidogrel; Coronary Artery Disease; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Omeprazole; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Ticlopidine | 2016 |
299 other study(ies) available for omeprazole and ranitidine
| Article | Year |
|---|---|
Synthesis of (aryloxy)alkylamines. 1. Novel antisecretory agents with H+K+-ATPase inhibitory activity.
Topics: Adenosine Triphosphatases; Amines; Aminopyrine; Animals; Benzothiazoles; Benzoxazoles; Bucladesine; Chemical Phenomena; Chemistry; Cimetidine; Gastric Acid; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Histamine; Ligation; Male; Omeprazole; Parietal Cells, Gastric; Pyloric Antrum; Ranitidine; Rats; Structure-Activity Relationship; Thiazoles | 1988 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Influence of gastric acid on circulating somatostatin-14 and -28 released after insulin-induced hypoglycemia in conscious dogs.
Topics: Animals; Atropine; Blood Glucose; Chromatography, Gel; Dogs; Gastric Acid; Hypoglycemia; Insulin; Omeprazole; Pancreatic Polypeptide; Ranitidine; Somatostatin; Somatostatin-28; Time Factors | 1992 |
[A study on reflux esophagitis--clinical nonsense].
Topics: Cost-Benefit Analysis; Esophagitis, Peptic; Humans; Omeprazole; Ranitidine | 1992 |
Total gastrectomy in Zollinger Ellison syndrome: does it have no role today?
Topics: Cost-Benefit Analysis; Developing Countries; Gastrectomy; Humans; India; Omeprazole; Patient Compliance; Ranitidine; Zollinger-Ellison Syndrome | 1992 |
Influence of acid-secretion blockers on gastric and hepatic alcohol dehydrogenase in rat.
Topics: Alcohol Dehydrogenase; Animals; Cimetidine; Gastric Mucosa; Isoenzymes; Kinetics; Liver; Male; Omeprazole; Ranitidine; Rats; Rats, Wistar | 1992 |
[Prognostic markers in reflux esophagitis better than wrapped up recommendations].
Topics: Biomarkers; Esophagitis, Peptic; Humans; Omeprazole; Prognosis; Ranitidine | 1992 |
Effects of omeprazole and ranitidine on plasma gastrin concentration and stomach gastrin content in rats.
Topics: Analysis of Variance; Animals; Gastric Acidity Determination; Gastric Mucosa; Gastrins; Hydrogen-Ion Concentration; Male; Methylcellulose; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach | 1992 |
[Omeprazole is more cost-effective than ranitidine in reflux esophagitis].
Topics: Cost-Benefit Analysis; Drug Costs; Esophagitis, Peptic; Humans; Omeprazole; Ranitidine | 1992 |
Cisapride and gastroesophageal reflux disease.
Topics: Cisapride; Drug Therapy, Combination; Gastroesophageal Reflux; Omeprazole; Piperidines; Ranitidine | 1992 |
Effects of anti-acid secretory agents on various types of gastric mucus.
Topics: Animals; Anti-Ulcer Agents; Gastric Juice; Gastric Mucosa; Hydrogen-Ion Concentration; Male; Mucus; Omeprazole; Pirenzepine; Prostaglandins E; Ranitidine; Rats | 1992 |
Omeprazole does not cause unscheduled DNA synthesis in rabbit parietal cells in vitro.
Topics: Animals; Autoradiography; DNA; Glucose; Histamine; Hydroxyurea; In Vitro Techniques; Male; Methylnitronitrosoguanidine; Omeprazole; Oxidation-Reduction; Parietal Cells, Gastric; Rabbits; Ranitidine; Thymidine; Ultraviolet Rays | 1992 |
Gastric acid and pepsin hypersecretion in conscious rabbits.
Topics: Animals; Atropine; Bethanechol; Bethanechol Compounds; Gastric Acid; Gastric Juice; Histamine; Male; Omeprazole; Pepsin A; Rabbits; Ranitidine; Stimulation, Chemical; Vagotomy | 1991 |
Further evidence for an interaction between alcohol and certain H2-receptor antagonists.
Topics: Adult; Alcoholic Intoxication; Cimetidine; Ethanol; Famotidine; Histamine H2 Antagonists; Humans; Male; Nizatidine; Omeprazole; Ranitidine | 1991 |
The effect of CCKB/gastrin antagonists on stimulated gastric acid secretion in the anaesthetized rat.
Topics: Animals; Anti-Anxiety Agents; Atropine; Benzodiazepinones; Bethanechol Compounds; Cholecystokinin; Dose-Response Relationship, Drug; Gastric Acid; Gastrins; Histamine; Indoles; Male; Meglumine; Omeprazole; Phenylurea Compounds; Ranitidine; Rats; Rats, Inbred Strains; Receptors, Cholecystokinin | 1991 |
Failure of ranitidine and omeprazole treatment in eosinophilic gastritis with ulceration.
Topics: Adult; Eosinophilia; Female; Gastritis; Gastroscopy; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine; Stomach Ulcer | 1991 |
Intragastric pH in the gastroprotective and ulcer-healing activity of aluminum-containing antacids.
Topics: Acute Disease; Aluminum Hydroxide; Animals; Antacids; Chronic Disease; Drug Combinations; Ethanol; Female; Gastric Acid; Gastric Mucosa; Hydrogen-Ion Concentration; Indomethacin; Magnesium Hydroxide; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Stomach Ulcer | 1991 |
Effect of omeprazole on intestinal output in the short bowel syndrome.
Topics: Anastomosis, Surgical; Humans; Intestines; Jejunostomy; Jejunum; Octreotide; Omeprazole; Potassium; Ranitidine; Rectum; Short Bowel Syndrome | 1991 |
24-hour intragastric acidity and plasma gastrin during long-term treatment with omeprazole or ranitidine in patients with reflux esophagitis.
Topics: Adult; Aged; Aged, 80 and over; Circadian Rhythm; Esophagitis, Peptic; Female; Gastric Acidity Determination; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1991 |
Comparative tolerability profile of omeprazole in clinical trials.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Aspartate Aminotransferases; Cimetidine; Clinical Trials as Topic; Drug Interactions; Duodenal Ulcer; Follow-Up Studies; Gastroesophageal Reflux; Humans; Middle Aged; Omeprazole; Ranitidine; Zollinger-Ellison Syndrome | 1991 |
Effect of omeprazole on nocturnal intragastric pH in cirrhotics with inadequate antisecretory response to ranitidine.
Topics: Female; Gastric Acid; Gastric Acidity Determination; Gastritis; Humans; Hydrogen-Ion Concentration; Liver Cirrhosis; Male; Middle Aged; Monitoring, Physiologic; Omeprazole; Peptic Ulcer; Ranitidine | 1991 |
Pharmacological agents of gastric acid secretion: receptor antagonists and pump inhibitors.
Topics: Adenosine Triphosphatases; Aminopyrine; Animals; Carbachol; Carbon Radioisotopes; Cell Separation; Cimetidine; Epithelial Cells; Epithelium; Gastric Acid; Gastric Mucosa; Guinea Pigs; H(+)-K(+)-Exchanging ATPase; Histamine; Male; Models, Biological; Omeprazole; Parietal Cells, Gastric; Pepsinogens; Radioisotope Dilution Technique; Ranitidine; Rats; Receptors, Cell Surface | 1990 |
Gastrin stimulates the self-replication rate of enterochromaffinlike cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats.
Topics: Animals; Cell Division; Chromaffin System; Enterochromaffin Cells; Female; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Hormones; Omeprazole; Pyloric Antrum; Ranitidine; Rats; Rats, Inbred Strains; Somatostatin; Stem Cells | 1990 |
Jejunal efflux in short bowel syndrome.
Topics: Administration, Oral; Adult; Female; Food; Humans; Injections, Intravenous; Intestinal Absorption; Jejunostomy; Jejunum; Malabsorption Syndromes; Male; Middle Aged; Octreotide; Omeprazole; Parenteral Nutrition; Potassium; Ranitidine; Short Bowel Syndrome; Sodium | 1990 |
Histology of gastric biopsies from peptic ulcer patients before and after short-term treatment with omeprazole or H2-receptor antagonists.
Topics: Adult; Cimetidine; Female; Gastric Mucosa; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine | 1990 |
Partial pronase digestion of rat gastric mucosa isolates cells undergoing replicative DNA synthesis.
Topics: Administration, Oral; Animals; Autoradiography; Cell Separation; DNA Replication; Fasting; Gastric Mucosa; Hydroxyurea; Male; Methylnitronitrosoguanidine; Mutagenicity Tests; Omeprazole; Pronase; Ranitidine; Rats; Rats, Inbred Strains; S Phase | 1991 |
Tritiated thymidine incorporation into DNA in rat gastric mucosal cells.
Topics: Animals; Cell Division; DNA; Male; Methylnitronitrosoguanidine; Mutagenicity Tests; Omeprazole; Parietal Cells, Gastric; Pronase; Ranitidine; Rats; Rats, Inbred Strains; Thymidine | 1990 |
Efficacy and safety of omeprazole in the long-term treatment of peptic ulcer and reflux oesophagitis resistant to ranitidine.
Topics: Drug Resistance; Esophagitis, Peptic; Gastrins; Humans; Omeprazole; Peptic Ulcer; Ranitidine; Time Factors | 1990 |
Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphate; Animals; Bucladesine; Carbachol; Cycloheximide; Dogs; Female; Gastric Acid; Histamine Antagonists; Lansoprazole; Male; Omeprazole; Parietal Cells, Gastric; Puromycin; Ranitidine | 1990 |
Structure and function of rat parietal cells during treatment with omeprazole, SCH 28080, SCH 32651, or ranitidine.
Topics: Adenosine Triphosphatases; Animals; Anti-Ulcer Agents; Female; H(+)-K(+)-Exchanging ATPase; Imidazoles; Microscopy, Electron; Omeprazole; Parietal Cells, Gastric; Pyrazines; Ranitidine; Rats; Rats, Inbred Strains; Time Factors | 1990 |
Effect of omeprazole and high doses of ranitidine on gastric acidity and gastroesophageal reflux in patients with moderate-severe esophagitis.
Topics: Adult; Esophagitis, Peptic; Esophagus; Female; Gastric Acidity Determination; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Stomach; Time Factors | 1990 |
Omeprazole--a useful new agent?
Topics: Administration, Oral; Antacids; Cimetidine; Gastric Acid; Gastric Juice; Humans; Omeprazole; Preanesthetic Medication; Ranitidine | 1990 |
High doses of ranitidine in patients with reflux oesophagitis.
Topics: Adult; Aged; Esophagitis, Peptic; Female; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1990 |
Effects of acute administration of omeprazole or ranitidine on basal and vagally stimulated gastric acid secretion and alkalinization of the duodenum in anaesthetized cats.
Topics: Anesthesia; Animals; Bicarbonates; Cats; Duodenum; Electric Stimulation; Female; Gastric Acid; Gastric Mucosa; Male; Omeprazole; Polyethylene Glycols; Ranitidine; Sodium Chloride; Vagus Nerve | 1990 |
Evidence that gastrin enhances 45Ca uptake into bone through release of a gastric hormone.
Topics: Animals; Bone and Bones; Calcium; Female; Gastrectomy; Gastrins; Kinetics; Male; Omeprazole; Radioimmunoassay; Radius; Ranitidine; Rats; Rats, Inbred Strains; Sternum; Time Factors | 1990 |
Time course of inhibition of gastric acid secretion by omeprazole and ranitidine in gastric fistula rats.
Topics: Animals; Fistula; Gastric Acid; Gastrins; Histamine; In Vitro Techniques; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Stomach | 1990 |
Omeprazole in the treatment of erosive oesophagitis refractory to high dose cimetidine and ranitidine.
Topics: Adult; Aged; Aged, 80 and over; Cimetidine; Esophagitis; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1990 |
Carbonic anhydrase in the normal rat stomach and duodenum and after treatment with omeprazole and ranitidine.
Topics: Animals; Carbonic Anhydrases; Duodenum; Fluorescent Antibody Technique; Gastric Mucosa; Histocytochemistry; Intestinal Mucosa; Male; Omeprazole; Parietal Cells, Gastric; Ranitidine; Rats; Rats, Inbred Strains; Stomach | 1989 |
[Angina-like chest pain of esophageal origin].
Topics: Catheterization; Chest Pain; Esophageal Diseases; Humans; Hydrochloric Acid; Hydrogen-Ion Concentration; Manometry; Methylergonovine; Omeprazole; Parasympatholytics; Ranitidine | 1989 |
Effect of cimetidine, ranitidine, famotidine and omeprazole on hepatocyte proliferation in vitro.
Topics: Animals; Cell Division; Cells, Cultured; Cimetidine; DNA; Famotidine; Hepatectomy; Histamine H2 Antagonists; Hormones; Liver; Omeprazole; Osmolar Concentration; Ranitidine; Rats; Rats, Inbred F344; Thiazoles | 1989 |
Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.
Topics: Animals; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Acidity Determination; Gastrins; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Thiazoles | 1989 |
Irradiation-induced duodenal ulcer disease refractory to ranitidine: healing by omeprazole.
Topics: Aged; Carcinoma, Renal Cell; Duodenal Ulcer; Female; Histamine H2 Antagonists; Humans; Kidney Neoplasms; Male; Middle Aged; Omeprazole; Radiotherapy, High-Energy; Ranitidine | 1989 |
Effects of omeprazole on acid secretion and acid-related symptoms in patients with Zollinger-Ellison syndrome.
Topics: Adult; Aged; Cimetidine; Female; Gastric Acid; Gastrins; Humans; Long-Term Care; Male; Middle Aged; Multiple Endocrine Neoplasia; Omeprazole; Ranitidine; Zollinger-Ellison Syndrome | 1989 |
Omeprazole v ranitidine.
Topics: Duodenal Ulcer; Humans; Omeprazole; Ranitidine | 1989 |
Correlation between inhibition of gastric acid secretion, plasma gastrin, and oxyntic mucosal histidine decarboxylase activity in the rat.
Topics: Animals; Carboxy-Lyases; Dose-Response Relationship, Drug; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histidine Decarboxylase; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains | 1989 |
Omeprazole versus ranitidine for gastric ulcer.
Topics: Humans; Omeprazole; Ranitidine; Stomach Ulcer | 1989 |
Omeprazole and ranitidine, antisecretagogues with different modes of action, are equally effective in causing hyperplasia of enterochromaffin-like cells in rat stomach.
Topics: Animals; Chromaffin System; Enterochromaffin Cells; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Hyperplasia; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains | 1989 |
Specific labelling of gastric H+,K+-ATPase by omeprazole.
Topics: Adenosine Triphosphatases; Animals; Gastric Juice; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; In Vitro Techniques; Omeprazole; Oxygen Consumption; Protein Binding; Rabbits; Ranitidine; Secretory Rate; Sulfhydryl Compounds | 1988 |
Inhibition of acid secretion in guinea pigs by tricyclic antidepressants: comparison with ranitidine and omeprazole.
Topics: Adenosine Triphosphatases; Animals; Atropine; Gastric Acid; Guinea Pigs; H(+)-K(+)-Exchanging ATPase; Imipramine; In Vitro Techniques; Male; Omeprazole; Parietal Cells, Gastric; Promethazine; Ranitidine | 1988 |
Esophageal candidosis in progressive systemic sclerosis: occurrence, significance, and treatment with fluconazole.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Fluconazole; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Scleroderma, Systemic; Triazoles | 1988 |
Effectiveness of omeprazole in seven patients with Zollinger-Ellison syndrome resistant to histamine H2-receptor antagonists.
Topics: Adult; Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Cimetidine; Drug Resistance; Drug Therapy, Combination; Female; Gastric Acid; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Pirenzepine; Ranitidine; Zollinger-Ellison Syndrome | 1986 |
Effects of ORF 17583, other histamine H2-receptor antagonists and omeprazole on gastric acid secretory states in rats and dogs.
Topics: Animals; Dogs; Female; Gastric Acid; Histamine H2 Antagonists; Ligation; Male; Omeprazole; Pylorus; Ranitidine; Rats; Rats, Inbred Strains; Time Factors | 1987 |
The effect of secretagogue selection on potency determinations for gastric acid antisecretory agents.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Dogs; Female; Food; Gastric Acid; Histamine; Histamine H2 Antagonists; Omeprazole; Ranitidine | 1988 |
Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride.
Topics: Animals; Benzamides; Cimetidine; Drug Synergism; Gastric Acid; Histamine H2 Antagonists; Male; Omeprazole; Pirenzepine; Pylorus; Ranitidine; Rats; Rats, Inbred Strains | 1988 |
Effect of cimetidine, ranitidine and omeprazole on postprandial gastrin and somatostatin release in conscious dogs.
Topics: Animals; Cimetidine; Dogs; Food; Gastric Juice; Gastrins; Omeprazole; Ranitidine; Somatostatin; Wakefulness | 1988 |
Duodenal ulcers that are difficult to heal.
Topics: Anti-Ulcer Agents; Cimetidine; Duodenal Ulcer; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine | 1988 |
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole.
Topics: Adult; Circadian Rhythm; Duodenal Ulcer; Gastric Acid; Gastric Acidity Determination; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1987 |
Inhibition of acid formation by epidermal growth factor in the isolated rabbit gastric glands.
Topics: Aminopyrine; Animals; Bucladesine; Depression, Chemical; Dinoprostone; Epidermal Growth Factor; Gastric Acid; Gastric Mucosa; Histamine; In Vitro Techniques; Male; Omeprazole; Parietal Cells, Gastric; Potassium; Prostaglandins E; Rabbits; Ranitidine | 1986 |
Time-course of development and reversal of gastric endocrine cell hyperplasia after inhibition of acid secretion. Studies with omeprazole and ranitidine in intact and antrectomized rats.
Topics: Animals; Cell Count; Chromaffin System; Enterochromaffin Cells; Female; Gastric Acid; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Hyperplasia; Omeprazole; Parietal Cells, Gastric; Pyloric Antrum; Ranitidine; Rats; Rats, Inbred Strains; Time Factors | 1988 |
Omeprazole: its influence on gastric acid secretion, gastrin and ECL cells.
Topics: Animals; Chromaffin System; Dogs; Enterochromaffin Cells; Gastric Acid; Gastric Mucosa; Gastrins; Hyperplasia; Mice; Omeprazole; Ranitidine; Rats; Species Specificity | 1988 |
[Reduced suppression of gastric acid by ranitidine in severe reflux esophagitis. A pilot study].
Topics: Adult; Aged; Dose-Response Relationship, Drug; Esophagitis, Peptic; Female; Gastric Acidity Determination; Humans; Male; Middle Aged; Omeprazole; Pilot Projects; Ranitidine | 1988 |
Beneficial effect of omeprazole in a patient with severe bronchial asthma and gastro-oesophageal reflux.
Topics: Adult; Asthma; Domperidone; Gastroesophageal Reflux; Humans; Male; Omeprazole; Ranitidine; Recurrence | 1988 |
Insulin-induced gastric ulcers in the rat.
Topics: Animals; Gastric Mucosa; Insulin; Male; Omeprazole; Pyloric Antrum; Ranitidine; Rats; Rats, Inbred Strains; Sodium Chloride; Stomach Ulcer; Sucralfate; Vagotomy | 1987 |
A new in vivo method for repeatedly studying gastric acid secretion and other secretory parameters in awake guinea pig.
Topics: Animals; Catheters, Indwelling; Cimetidine; Depression, Chemical; Dye Dilution Technique; Gastric Acid; Guinea Pigs; Histamine; Histamine Antagonists; Male; Omeprazole; Ranitidine; Stimulation, Chemical | 1987 |
Stimulation of gastric acid secretion increases mucosal blood flow in immediate vicinity of parietal cells in baboons.
Topics: Animals; Depression, Chemical; Female; Gastric Acid; Gastric Mucosa; Histamine; Male; Omeprazole; Papio; Parietal Cells, Gastric; Ranitidine; Regional Blood Flow; Stimulation, Chemical | 1988 |
Long-term omeprazole treatment in man: effects on gastric endocrine cell populations.
Topics: Female; Gastric Mucosa; Gastrins; Humans; Male; Omeprazole; Parietal Cells, Gastric; Peptic Ulcer; Ranitidine; Stomach Ulcer; Time Factors | 1988 |
Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment.
Topics: Adult; Aged; Duodenal Ulcer; Esophagitis, Peptic; Female; Gastrins; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer; Time Factors | 1988 |
Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats.
Topics: Animals; DNA; Dogs; Female; Gastric Acid; Gastrins; Male; Omeprazole; Parietal Cells, Gastric; Ranitidine; Rats; Thymidine | 1988 |
Barrett's ulcer: response to standard dose ranitidine, high dose ranitidine, and omeprazole.
Topics: Barrett Esophagus; Drug Administration Schedule; Drug Therapy, Combination; Esophageal Diseases; Esophagoscopy; Female; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Omeprazole; Ranitidine | 1988 |
Inhibition of gastric acid secretion by omeprazole and ranitidine. Effects on plasma gastrin and gastric histamine, histidine decarboxylase activity and ECL cell density in normal and antrectomized rats.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Female; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Omeprazole; Parietal Cells, Gastric; Pyloric Antrum; Ranitidine; Rats; Rats, Inbred Strains | 1986 |
HCO3- secretion in rat duodenum after treatment with omeprazole and ranitidine.
Topics: Animals; Bicarbonates; Dinoprostone; Duodenum; Intestinal Mucosa; Intestinal Secretions; Male; Omeprazole; Prostaglandins E; Ranitidine; Rats; Rats, Inbred Strains | 1987 |
Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Studies with omeprazole and ranitidine in intact and antrectomized rats.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Cell Count; Cell Division; Chromaffin System; Enterochromaffin Cells; Female; Fluorescent Antibody Technique; Gastric Mucosa; Gastrins; Histamine; Histidine Decarboxylase; Omeprazole; Parietal Cells, Gastric; Pyloric Antrum; Ranitidine; Rats; Rats, Inbred Strains | 1986 |
A long lasting gastrin response to apomorphine revealed by inhibitors of gastric acid secretion.
Topics: Animals; Apomorphine; Cimetidine; Dogs; Domperidone; Female; Gastric Acid; Gastrins; Haloperidol; Male; Omeprazole; Ranitidine; Vagotomy | 1987 |
Use of a five-day test to predict the long-term effects of gastric antisecretory agents on serum gastrin in rats.
Topics: Animals; Anti-Ulcer Agents; Female; Gastric Acid; Gastrins; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Time Factors | 1987 |
Comparison of the effects of gastric antisecretory agents in healthy volunteers and patients with duodenal ulcer.
Topics: Anti-Ulcer Agents; Cimetidine; Drug Administration Schedule; Duodenal Ulcer; Famotidine; Gastric Acidity Determination; Humans; Imidazoles; Omeprazole; Ranitidine; Thiazoles | 1986 |
Gastric regulatory peptides in rats with reduced acid secretion.
Topics: Achlorhydria; Animals; Gastrectomy; Gastric Acid; Gastric Fundus; Gastrins; Gastrointestinal Hormones; Histocytochemistry; Omeprazole; Radioimmunoassay; Ranitidine; Rats | 1986 |
Duodenal ulcer disease.
Topics: Anti-Ulcer Agents; Benzimidazoles; Campylobacter Infections; Cimetidine; Duodenal Ulcer; Duodenoscopy; Female; Gastric Mucosa; Humans; Male; Omeprazole; Pain; Prostaglandins; Ranitidine; Recurrence; Sex Factors; Stress, Psychological | 1985 |
Effect of cimetidine, ranitidine and omeprazole on hepatic flow of the artificially perfused rat liver.
Topics: Animals; Anti-Ulcer Agents; Benzimidazoles; Cimetidine; Liver Circulation; Male; Omeprazole; Perfusion; Ranitidine; Rats; Rats, Inbred Strains | 1985 |
Omeprazole, cimetidine, and ranitidine: inhibition of acid production in isolated human parietal cells.
Topics: Adult; Aged; Benzimidazoles; Cimetidine; Female; Gastric Acid; Humans; In Vitro Techniques; Male; Middle Aged; Omeprazole; Parietal Cells, Gastric; Ranitidine; Receptors, Histamine H2; Time Factors | 1985 |
[New antisecretory agents].
Topics: Anti-Ulcer Agents; Benzimidazoles; Benzodiazepinones; Humans; Omeprazole; Pirenzepine; Ranitidine | 1984 |
[Changes in therapy of duodenal ulcers. The European Gastro-Club 1983 discusses new pathophysiologic and epidemiologic data referring to drug and surgical therapy].
Topics: Amino Acids; Benzimidazoles; Carbenoxolone; Cimetidine; Duodenal Ulcer; Gastric Acid; Histamine; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Neoplasms | 1983 |
Comparison of the effect of omeprazole--a substituted benzimidazole--and ranitidine--a potent H2-receptor antagonist--on histamine-induced gastric acid secretion and the ultrastructure of canine parietal cells.
Topics: Animals; Benzimidazoles; Dogs; Gastric Acid; Histamine; Omeprazole; Parietal Cells, Gastric; Ranitidine | 1983 |
Duodenal ulcers that will not heal.
Topics: Anti-Ulcer Agents; Benzimidazoles; Bismuth; Cimetidine; Drug Resistance; Duodenal Ulcer; Humans; Omeprazole; Organometallic Compounds; Ranitidine | 1984 |
[Do proton pump inhibitors after endoscopic control of acute ulcer hemorrhage have an advantage over H2 receptor antagonists?].
Topics: Adult; Aged; Anti-Ulcer Agents; Combined Modality Therapy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastroscopy; Hemostatic Techniques; Histamine H2 Antagonists; Humans; Infusions, Intravenous; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Ranitidine; Recurrence | 1995 |
[Helicobacter pylori and peptic ulcer--1995 therapeutic indications and recommendations of a Munster Expert Group].
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine; Salicylates; Tetracycline | 1995 |
Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion.
Topics: Animals; Anti-Ulcer Agents; Female; Gastric Acid; H(+)-K(+)-Exchanging ATPase; Half-Life; Ion Pumps; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach | 1995 |
Role of gastroesophageal reflux disease in patients with cervical symptoms.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Barium Sulfate; Biopsy; Cineradiography; Deglutition Disorders; Diagnosis, Differential; Esophagoscopy; Female; Fluoroscopy; Follow-Up Studies; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Hydrochloric Acid; Male; Manometry; Metoclopramide; Middle Aged; Omeprazole; Peristalsis; Pharyngeal Diseases; Pharyngitis; Pilot Projects; Ranitidine | 1995 |
Healing and relapse rates of duodenal ulcer with omeprazole vs ranitidine.
Topics: Adolescent; Adult; Aged; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Treatment Outcome | 1995 |
Mechanisms of protection by omeprazole against experimental gastric mucosal damage in rats.
Topics: Animals; Ethanol; Gastric Acid; Gastric Mucosa; Gastritis; Hydrochloric Acid; Male; Misoprostol; Mucus; Necrosis; Omeprazole; Ranitidine; Rats; Rats, Wistar | 1995 |
Drug-induced hypergastrinemia: absence of trophic effects on colonic carcinoma in rats.
Topics: Analysis of Variance; Animals; Colonic Neoplasms; Gastrins; Intestinal Mucosa; Male; Methylazoxymethanol Acetate; Neoplasm Invasiveness; Omeprazole; Random Allocation; Ranitidine; Rats; Rats, Sprague-Dawley | 1995 |
Treatment of pyrosis does not insure adequate control of gastric acid reflux.
Topics: Barrett Esophagus; Chronic Disease; Esophagitis; Gastroesophageal Reflux; Heartburn; Humans; Hydrogen-Ion Concentration; Monitoring, Physiologic; Omeprazole; Ranitidine; Treatment Outcome | 1995 |
The importance of local acid production in the distribution of Helicobacter felis in the mouse stomach.
Topics: Animals; Cardia; Cell Count; Female; Gastric Acid; Gastric Mucosa; Helicobacter; Mice; Mice, Inbred BALB C; Omeprazole; Parietal Cells, Gastric; Pyloric Antrum; Ranitidine; Specific Pathogen-Free Organisms; Stomach | 1995 |
Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach.
Topics: Adrenalectomy; Animals; Chromogranin A; Enterochromaffin Cells; Gastrectomy; Gastrins; Male; Omeprazole; Pancreatic Hormones; Radioimmunoassay; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach | 1995 |
Postprandial alkaline tide: does it exist?
Topics: Adult; Carbon Dioxide; Dietary Proteins; Eating; Gastric Acid; Humans; Hydrogen-Ion Concentration; Male; Omeprazole; Ranitidine; Respiration; Urine | 1995 |
Parietal cell kinetics after administration of omeprazole and ranitidine in the rat.
Topics: Animals; Autoradiography; Cell Cycle; Female; Gastric Acid; Omeprazole; Parietal Cells, Gastric; Ranitidine; Rats; Rats, Sprague-Dawley; Thymidine; Time Factors; Tritium | 1995 |
Helicobacter pylori eradication and reinfection.
Topics: Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Nitroimidazoles; Omeprazole; Peptic Ulcer; Ranitidine | 1995 |
[Course of histological lesions of the gastric mucosa after eradication of H. pylori in patients with duodenal ulcer. Initial study and 6-month follow-up].
Topics: Adult; Aged; Anti-Bacterial Agents; Biopsy; Drug Therapy, Combination; Duodenal Ulcer; Female; Follow-Up Studies; Gastric Mucosa; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine; Time Factors | 1995 |
Acid-suppression did not enhance healing of gastric ulcer associated with paraesophageal hernia after hernial reduction.
Topics: Esophageal Diseases; Gastric Acid; Hernia; Herniorrhaphy; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer | 1995 |
Effect of repeated boluses of intravenous omeprazole and primed infusions of ranitidine on 24-hour intragastric pH in healthy human subjects.
Topics: Adult; Analysis of Variance; Circadian Rhythm; Female; Gastric Acidity Determination; Gastric Juice; Humans; Hydrogen-Ion Concentration; Infusions, Intravenous; Injections, Intravenous; Male; Omeprazole; Ranitidine; Reference Values; Time Factors | 1995 |
Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy.
Topics: Abdominal Pain; Adolescent; Child; Chronic Disease; Drug Resistance; Esophagitis, Peptic; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Prospective Studies; Ranitidine | 1995 |
Drug interactions of H2-receptor antagonists.
Topics: Adolescent; Adult; Aged; Antacids; Biological Availability; Cimetidine; Drug Interactions; Famotidine; Histamine H2 Antagonists; Humans; Middle Aged; Nizatidine; Omeprazole; Phenytoin; Ranitidine; Theophylline | 1994 |
Peptic ulcer disease in adolescence: changing concepts in the age of Helicobacter pylori.
Topics: Adolescent; Adult; Anti-Ulcer Agents; Duodenal Ulcer; Famotidine; Helicobacter Infections; Helicobacter pylori; Humans; Male; Omeprazole; Ranitidine; Recurrence; Sucralfate | 1994 |
[Maintenance therapy with antiulcer drugs: review of 71 cases].
Topics: Aluminum Hydroxide; Antacids; Anti-Ulcer Agents; Carbonates; Cross-Over Studies; Duodenal Ulcer; Famotidine; Female; Humans; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Risk Factors; Time Factors | 1995 |
Effective treatment after failure of omeprazole plus amoxycillin to eradicate Helicobacter pylori infection in peptic ulcer disease.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Prospective Studies; Ranitidine; Recurrence; Salicylates; Tetracycline; Treatment Failure; Treatment Outcome | 1994 |
Protective action of omeprazole against gastric mucosal injury induced by hemorrhagic shock in rats.
Topics: Animals; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Gastric Acid; Gastric Mucosa; Male; Omeprazole; Ranitidine; Rats; Rats, Wistar; Shock, Hemorrhagic; Stomach Ulcer; Stress, Physiological | 1994 |
Antiulcerogenicity of the flavonoid fraction from Bidens aurea: comparison with ranitidine and omeprazole.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Cold Temperature; Disease Models, Animal; Female; Flavonoids; Gastric Mucosa; Glycoproteins; Male; Mucus; Omeprazole; Plant Extracts; Plants, Medicinal; Ranitidine; Rats; Rats, Wistar; Restraint, Physical; Stomach Ulcer | 1994 |
Omeprazole--a more potent suppressor of gastric acid secretion: is it better?
Topics: Duodenal Ulcer; Gastric Acid; Humans; Omeprazole; Ranitidine | 1994 |
[Reversible thrombocytopenia due to digitoxin overdose].
Topics: Aged; Digitoxin; Drug Overdose; Female; Gastritis; Gastroscopy; Heart Failure; Humans; Nausea; Omeprazole; Platelet Count; Ranitidine; Stomach Ulcer; Thrombocytopenia; Vomiting | 1994 |
Diagnosis and treatment of patients with gastroesophageal reflux and noncardiac chest pain.
Topics: Adult; Aged; Aged, 80 and over; Barium Sulfate; Chest Pain; Diagnosis, Differential; Esophagoscopy; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omeprazole; Ranitidine | 1994 |
Economic evaluation of new medical technology.
Topics: Canada; Cost-Benefit Analysis; Drug Costs; Europe; Health Expenditures; Hospital Costs; Humans; Japan; Omeprazole; Peptic Ulcer; Ranitidine; Technology Assessment, Biomedical; Turkey; United States | 1994 |
Long-term consequences with regard to clinical outcome and cost-effectiveness of episodic treatment with omeprazole or ranitidine for healing of duodenal ulcer.
Topics: Cost-Benefit Analysis; Drug Costs; Duodenal Ulcer; Humans; Omeprazole; Probability; Prognosis; Ranitidine; Scandinavian and Nordic Countries; Treatment Outcome | 1994 |
Economic analysis of alternative treatments for persistent gastro-oesophageal reflux disease.
Topics: Cost-Benefit Analysis; Decision Trees; Drug Costs; Gastroesophageal Reflux; Humans; Omeprazole; Ranitidine; Treatment Outcome | 1994 |
The role of thyrotropin-releasing hormone (TRH) in the pathogenesis of water-immersion stress in rats--inhibition of TRH release from the stomach by atropine, ranitidine or omeprazole.
Topics: Animals; Atropine; Bethanechol; Bethanechol Compounds; Gastric Acid; Gastric Juice; Gastric Mucosa; Immersion; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Physiological; Thyrotropin-Releasing Hormone | 1993 |
Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse.
Topics: Adult; Aged; Aged, 80 and over; Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Organometallic Compounds; Peptic Ulcer; Peptic Ulcer Hemorrhage; Prospective Studies; Ranitidine; Recurrence; Salicylates; Stomach Ulcer | 1994 |
Effects of single intravenously administered doses of omeprazole and ranitidine on intragastric pH and plasma gastrin concentration in nonfed ponies.
Topics: Analysis of Variance; Animals; Dose-Response Relationship, Drug; Fasting; Female; Gastric Acidity Determination; Gastric Juice; Gastrins; Horses; Hydrogen-Ion Concentration; Injections, Intravenous; Omeprazole; Ranitidine; Time Factors | 1993 |
Prolonged remission of oesophagitis does not alter the magnitude of oesophageal acid exposure.
Topics: Adult; Aged; Esophagitis; Esophagitis, Peptic; Esophagus; Female; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1994 |
[Hemostasis and treatment of stress hemorrhage in the upper gastrointestinal tract of trauma patients].
Topics: Cimetidine; Combined Modality Therapy; Croatia; Endoscopy, Gastrointestinal; Gastrectomy; Humans; Military Personnel; Omeprazole; Peptic Ulcer Hemorrhage; Postoperative Complications; Ranitidine; Recurrence; Sclerotherapy; Stress, Physiological; Survival Rate; Suture Techniques; Vagotomy, Truncal; Warfare; Wounds, Gunshot | 1993 |
Assessing the cost-effectiveness of medical treatments in acid-related diseases. The Markov chain approach applied to a comparison between intermittent and maintenance treatment of reflux esophagitis.
Topics: Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Esophagitis, Peptic; Humans; Markov Chains; Omeprazole; Ranitidine; Recurrence; Sweden | 1993 |
Omeprazole/amoxicillin versus ranitidine/triple therapy for duodenal ulcer: when is the "same" the same?
Topics: Amoxicillin; Bismuth; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Metronidazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Tetracycline | 1994 |
Stimulation of mucus glycoprotein biosynthesis in rat gastric mucosa by gastrin.
Topics: Animals; Benzodiazepinones; Carbon Radioisotopes; Diphenhydramine; Gastric Mucosa; Glucosamine; Glycoproteins; Male; Omeprazole; Organ Culture Techniques; Phenylurea Compounds; Ranitidine; Rats; Rats, Wistar; Sulfates; Sulfur Radioisotopes; Tetragastrin; Threonine; Tritium; Up-Regulation | 1993 |
Clinical and pathologic features of the nodular duodenum.
Topics: Adult; Aged; Aged, 80 and over; Biopsy; Duodenal Diseases; Duodenitis; Duodenoscopy; Duodenum; Humans; Male; Middle Aged; Omeprazole; Prospective Studies; Ranitidine | 1993 |
Proton-pump inhibitor-refractory gastric ulcer and Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Ulcer Agents; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine; Stomach Ulcer | 1993 |
[Inhibitors of proton pump, a new target: the visible vessel].
Topics: Combined Modality Therapy; Humans; Omeprazole; Peptic Ulcer Hemorrhage; Proton Pumps; Ranitidine; Recurrence; Sclerotherapy | 1993 |
[Evaluation of the cost of maintenance therapy (6 months) with 150 mg ranitidine vs 20 mg omeprazole vs 20 mg omeprazole every other day in duodenal ulcer].
Topics: Adult; Aged; Aged, 80 and over; Cost-Benefit Analysis; Drug Administration Schedule; Duodenal Ulcer; Female; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Time Factors | 1993 |
Unusual presentation of mucosal hypersensitivity secondary to gastroesophageal reflux disease.
Topics: Adolescent; Deglutition Disorders; Enteral Nutrition; Eosinophils; Esophagitis, Peptic; Esophagus; Follow-Up Studies; Gastroesophageal Reflux; Humans; Male; Mucous Membrane; Omeprazole; Ranitidine; Vomiting | 1993 |
Gastric pH and stomach contents.
Topics: Clinical Trials as Topic; Female; Gastric Acid; Gastric Acidity Determination; Gastrointestinal Contents; Humans; Omeprazole; Prospective Studies; Ranitidine; Single-Blind Method | 1993 |
Maintenance therapies for reflux esophagitis.
Topics: Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Esophagitis, Peptic; Humans; Omeprazole; Patient Compliance; Piperidines; Ranitidine | 1996 |
Proton-pump inhibitors or H2-receptor antagonists for Helicobacter pylori eradication-a meta-analysis.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter pylori; Histamine H2 Antagonists; Humans; Meta-Analysis as Topic; Omeprazole; Peptic Ulcer; Proton Pumps; Ranitidine | 1996 |
Comparison between activation of ornithine decarboxylase and histidine decarboxylase in rat stomach.
Topics: Analgesics; Animals; Benzodiazepinones; Cholecystokinin; Duodenum; Eating; Enzyme Activation; Fasting; Gastrectomy; Gastric Mucosa; Gastrins; Histidine Decarboxylase; Infusions, Intravenous; Kinetics; Male; Omeprazole; Ornithine Decarboxylase; Phenylurea Compounds; Pyloric Antrum; Ranitidine; Rats; Rats, Sprague-Dawley; Saline Solution, Hypertonic; Sodium Bicarbonate; Somatostatin; Time Factors | 1996 |
[Treatment with anti-secretory agents for symptomatic relief].
Topics: Anti-Ulcer Agents; Gastric Acid; Humans; Omeprazole; Palliative Care; Ranitidine | 1996 |
Peptic esophageal stricture: is surgery still necessary?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cimetidine; Combined Modality Therapy; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Female; Follow-Up Studies; Fundoplication; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence; Retrospective Studies; Survival Analysis; Treatment Outcome | 1996 |
Effects of the novel histamine H2-receptor antagonist (+/-)-(E)-1-[2-hydroxy-2-(4-hydroxyphenyl)ethyl]-3-[2-[[[5- (methylamino)methyl-2-furyl]methyl]thio]ethyl]-2-(methylsulfonyl) guanidine on gastric secretion and gastroduodenal ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Epirizole; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Pepsin A; Peptic Ulcer; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Stress, Psychological; Sulfones | 1996 |
Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Cost-Benefit Analysis; Costs and Cost Analysis; Drug Therapy, Combination; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine; Recurrence; Time Factors | 1996 |
[Medico-economic aspects of the treatment of duodenal ulcer: from antisecretory treatment to eradication of Helicobacter pylori].
Topics: Anti-Ulcer Agents; Combined Modality Therapy; Cost-Benefit Analysis; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 1995 |
Nonsteroidal anti-inflammatory drug and phospholipid prodrugs: combination therapy with antisecretory agents in rats.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cimetidine; Digestive System; Drug Therapy, Combination; Male; Omeprazole; Prodrugs; Ranitidine; Rats; Rats, Sprague-Dawley | 1996 |
Resolution of a metaplastic duodenal polyp after cure of Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Duodenal Neoplasms; Helicobacter Infections; Helicobacter pylori; Humans; Intestinal Polyps; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Time Factors | 1996 |
Omeprazole produces parietal cell hypertrophy and hyperplasia in humans.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Cell Count; Cell Size; Humans; Hyperplasia; Hypertrophy; Middle Aged; Omeprazole; Parietal Cells, Gastric; Ranitidine | 1996 |
Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
Topics: Antacids; Anti-Ulcer Agents; Dilatation; Esophageal Stenosis; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Randomized Controlled Trials as Topic; Ranitidine | 1996 |
[Effects of lansoprazole on indomethacin-induced gastric bleeding and mucosal lesions in rats].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Famotidine; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Indomethacin; Lansoprazole; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley | 1996 |
[Effects of intravenous lansoprazole on acute gastric mucosal lesions and acid secretion].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Animals; Anti-Ulcer Agents; Famotidine; Gastric Acid; Gastric Mucosa; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Injections, Intravenous; Lansoprazole; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stress, Physiological | 1996 |
Lansoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; False Negative Reactions; Female; Forecasting; Gastric Acid; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Male; Middle Aged; Monitoring, Ambulatory; Omeprazole; Ranitidine; Stomach; Urea | 1997 |
Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats.
Topics: Animals; Anti-Ulcer Agents; Enzyme Inhibitors; Esophagitis, Peptic; Gastric Acid; Gastric Fistula; Gastric Mucosa; Histamine H2 Antagonists; Imidazoles; Male; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Pyridines; Ranitidine; Rats; Rats, Sprague-Dawley | 1997 |
Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectromized rats: a model for cytoprotective studies.
Topics: Animals; Anti-Ulcer Agents; Atropine; Bromocriptine; Cimetidine; Cysteamine; Duodenal Ulcer; Female; Gastrectomy; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar | 1997 |
Effect of inhibition of pentagastrin-stimulated acid secretion on gastric mucosal gland luminal pressure.
Topics: Animals; Anti-Ulcer Agents; Gastric Acid; Gastric Mucosa; Hydrostatic Pressure; Omeprazole; Pentagastrin; Ranitidine; Rats; Rats, Inbred Lew; Rats, Sprague-Dawley | 1997 |
Treatment of Helicobacter pylori infection favourably affects gastric mucosal superoxide dismutases.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Antitrichomonal Agents; Clarithromycin; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Ranitidine; Superoxide Dismutase | 1997 |
Comparative study of plasma gastrin levels in rats after two months of ebrotidine administration.
Topics: Animals; Benzenesulfonates; Cimetidine; Gastrins; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Specific Pathogen-Free Organisms; Thiazoles | 1997 |
Comparison of ranitidine and lansoprazole in short-term low-dose triple therapy for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Bacterial Agents; Anti-Ulcer Agents; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Ranitidine | 1997 |
Effect of curing Helicobacter pylori infection on intragastric acidity during treatment with ranitidine in patients with duodenal ulcer.
Topics: Adult; Aged; Anti-Ulcer Agents; Duodenal Ulcer; Female; Gastric Acid; Gastric Acidity Determination; Helicobacter Infections; Helicobacter pylori; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Omeprazole; Ranitidine | 1997 |
Effects of cisapride on ulcer formation and gastric secretion in rats: comparison with ranitidine and omeprazol.
Topics: Animals; Anti-Ulcer Agents; Cisapride; Gastric Juice; Gastric Mucosa; Histamine Release; Ligation; Male; Mucus; Omeprazole; Pepsin A; Piperidines; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer; Stress, Physiological | 1996 |
Lanzoprazole and ranitidine affect the accuracy of the 14C-urea breath test by a pH-dependent mechanism.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Breath Tests; Carbon Dioxide; Carbon Radioisotopes; False Negative Reactions; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Radiopharmaceuticals; Ranitidine; Urea | 1997 |
Heart allograft rejection in rats triggered by H2 inhibitors.
Topics: Animals; Antilymphocyte Serum; Cimetidine; Female; Graft Rejection; Graft Survival; Heart Transplantation; Histamine H2 Antagonists; Immunosuppressive Agents; Male; Omeprazole; Ranitidine; Rats; Rats, Inbred Strains; Transplantation, Homologous | 1997 |
Acid-suppressing drugs during pregnancy.
Topics: Abnormalities, Drug-Induced; Anti-Ulcer Agents; Cohort Studies; Female; Fetus; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant, Newborn; Omeprazole; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Prospective Studies; Ranitidine | 1997 |
Omeprazole, H2 blockers, and polyarthralgia: case-control study.
Topics: Adult; Anti-Ulcer Agents; Arthralgia; Case-Control Studies; Cimetidine; Cohort Studies; Histamine H2 Antagonists; Humans; Middle Aged; Omeprazole; Ranitidine; Risk Factors | 1997 |
Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Case-Control Studies; Cost-Benefit Analysis; Decision Support Techniques; Delphi Technique; Drug Costs; Enzyme Inhibitors; Esophagitis, Peptic; Follow-Up Studies; Gastroenterology; Histamine H2 Antagonists; Humans; Lansoprazole; Medicare; Omeprazole; Probability; Proton Pump Inhibitors; Quality of Life; Randomized Controlled Trials as Topic; Ranitidine; Recurrence; Relative Value Scales; Sensitivity and Specificity; United States; Value of Life | 1997 |
H2-receptor antagonist reduces food intake and weight gain in rats by non-gastric acid secretory mechanisms.
Topics: Animals; Anti-Ulcer Agents; Cimetidine; Eating; Famotidine; Gastric Acid; Histamine H2 Antagonists; Male; Omeprazole; Ranitidine; Rats; Rats, Wistar; Weight Gain | 1997 |
Helicobacter pylori eradication in duodenal ulcer disease is cost-beneficial: a Belgian model.
Topics: Anti-Ulcer Agents; Belgium; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy; Duodenal Ulcer; Helicobacter Infections; Helicobacter pylori; Humans; Markov Chains; Omeprazole; Prospective Studies; Ranitidine | 1997 |
Stenting for caustic strictures: esophageal replacement replaced.
Topics: Anti-Bacterial Agents; Burns, Chemical; Case-Control Studies; Catheterization; Child, Preschool; Dexamethasone; Drug Therapy, Combination; Esophageal Stenosis; Female; Humans; Male; Omeprazole; Ranitidine; Silicone Elastomers; Stents; Treatment Outcome | 1998 |
Cost effectiveness of treatment for gastro-oesophageal reflux disease in clinical practice: a clinical database analysis.
Topics: Anti-Ulcer Agents; Cisapride; Cost-Benefit Analysis; Databases, Factual; Family Practice; Gastroesophageal Reflux; Humans; Omeprazole; Piperidines; Practice Patterns, Physicians'; Ranitidine; Retrospective Studies; Treatment Outcome | 1998 |
Gastric transmucosal potential difference: effect of antisecretory and gastroprotective drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Carbamates; Dinoprostone; Electrophysiology; Ethanol; Female; Gastric Mucosa; Omeprazole; Ranitidine; Rats; Rats, Wistar; Stomach Diseases | 1998 |
PPIs vs H2RAs for erosive reflux esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Acute Disease; Cost-Benefit Analysis; Enzyme Inhibitors; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Lansoprazole; Markov Chains; Omeprazole; Ranitidine; Recurrence; Reproducibility of Results | 1998 |
Natural history of severe duodenal ulcer disease.
Topics: Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Drug Therapy, Combination; Duodenal Ulcer; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Ranitidine; Recurrence | 1998 |
Antacid (A02A) and antiulcer (A02B) drug prescription patterns: predicting factors, dosage and treatment duration.
Topics: Adolescent; Adult; Age Distribution; Aged; Aluminum Hydroxide; Analysis of Variance; Antacids; Anti-Ulcer Agents; Carbonates; Data Collection; Digestive System Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Prescriptions; Drug Utilization; Female; Humans; Logistic Models; Magnesium Hydroxide; Male; Middle Aged; Omeprazole; Peptic Ulcer; Pharmacoepidemiology; Ranitidine; Sampling Studies; Sex Distribution; Spain | 1998 |
Omeprazole, ranitidine, and cimetidine have no effect on peak blood ethanol concentrations, first pass metabolism or area under the time-ethanol curve under 'real-life' drinking conditions.
Topics: Adult; Alcohol Drinking; Area Under Curve; Central Nervous System Depressants; Cimetidine; Ethanol; Female; Histamine H2 Antagonists; Humans; Male; Omeprazole; Ranitidine; Reference Values | 1998 |
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Histamine H2 Antagonists; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine; Severity of Illness Index | 1998 |
Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Humans; Omeprazole; Peptic Ulcer; Ranitidine | 1998 |
In vitro activity of ebrotidine, ranitidine, omeprazole, lansoprazole, and bismuth citrate against clinical isolates of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Ulcer Agents; Benzenesulfonates; Helicobacter pylori; Lansoprazole; Microbial Sensitivity Tests; Omeprazole; Organometallic Compounds; Ranitidine; Thiazoles | 1998 |
Treating Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Combinations; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Penicillins; Peptic Ulcer; Ranitidine | 1998 |
Antiulcer drug prescribing in hospital successfully influenced by "immediate concurrent feedback".
Topics: Administration, Oral; Anti-Ulcer Agents; Cimetidine; Cost-Benefit Analysis; Drug Utilization; Famotidine; Feedback; Hong Kong; Hospitals, Teaching; Humans; Infusions, Intravenous; Medical Audit; Nizatidine; Omeprazole; Practice Patterns, Physicians'; Ranitidine | 1998 |
Pentagastrin gastroprotection against acid is related to H2 receptor activation but not acid secretion.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastric Acid; Gastric Mucosa; Histamine Antagonists; Histamine H1 Antagonists; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Male; Omeprazole; Pentagastrin; Perfusion; Pyrilamine; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 1998 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 37-1998. A 41-year-old woman with anemia and severe thrombocytopenia.
Topics: Adult; Anemia, Iron-Deficiency; Anti-Ulcer Agents; Diagnosis, Differential; Female; Humans; Omeprazole; Ranitidine; Thrombocytopenia | 1998 |
Histamine H2-receptor antagonism of T-593, an anti-ulcer agent: studies on aminopyrine accumulation in isolated canine gastric mucosal cells.
Topics: Aminopyrine; Animals; Anti-Ulcer Agents; Bucladesine; Carbachol; Carbon Radioisotopes; Cholinergic Agonists; Dogs; Dose-Response Relationship, Drug; Famotidine; Gastric Acid; Gastric Mucosa; Guanidines; Histamine; Histamine H2 Antagonists; Omeprazole; Pentagastrin; Pirenzepine; Ranitidine; Sulfones | 1998 |
Cost effectiveness of treatment for gastro-oesophageal reflux.
Topics: Anti-Ulcer Agents; Cisapride; Cost-Benefit Analysis; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine | 1998 |
New model of cytoprotection/adaptive cytoprotection in rats: endogenous small irritants, antiulcer agents and indomethacin.
Topics: Amino Acid Sequence; Anastomosis, Surgical; Animals; Anti-Ulcer Agents; Atropine; Cyclooxygenase Inhibitors; Cytoprotection; Dose-Response Relationship, Drug; Ethanol; Gastric Mucosa; Indomethacin; Irritants; Jejunum; Male; Molecular Sequence Data; Omeprazole; Peptic Ulcer; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Stomach | 1999 |
Developmental regulation of gastric somatostatin secretion in the sheep.
Topics: Aging; Animals; Animals, Newborn; Drug Combinations; Embryonic and Fetal Development; Female; Fetus; Gastric Mucosa; Gastrins; Histamine; Male; Omeprazole; Pentagastrin; Ranitidine; Sheep; Somatostatin; Stomach; Time Factors | 1999 |
Stress ulcer prevention and histamine-2-receptor antagonists: leaps of faith or back to the drawing board?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Histamine H2 Antagonists; Humans; Intensive Care Units; Lansoprazole; Omeprazole; Peptic Ulcer; Ranitidine; Stress, Physiological | 1999 |
Effect of omeprazole, lansoprazole, and ranitidine on the DNA synthesis of mononuclear cells.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Critical Care; DNA; Histamine H2 Antagonists; Humans; Immunity, Cellular; Lansoprazole; Leukocytes, Mononuclear; Male; Omeprazole; Proton Pump Inhibitors; Radionuclide Imaging; Radiopharmaceuticals; Ranitidine; Stomach Ulcer; Thymidine; Tritium | 1999 |
Effects of different antisecretory drugs on gastric potential difference in the rat: comparison with sucralfate.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Drug Interactions; Gastric Acid; Lansoprazole; Male; Nizatidine; Omeprazole; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Sucralfate | 1998 |
Clinical and economic factors in the selection of drugs for gastroesophageal reflux disease.
Topics: Cimetidine; Cost-Benefit Analysis; Endoscopy; Gastroesophageal Reflux; Humans; Omeprazole; Ranitidine; Treatment Outcome | 1993 |
Resolution of thrombocytopenia after treatment for Helicobacter pylori: a case report.
Topics: Amoxicillin; Anti-Ulcer Agents; Autoimmune Diseases; B-Lymphocytes; Gastric Mucosa; Gastritis; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Peptic Ulcer Hemorrhage; Purpura, Thrombocytopenic, Idiopathic; Ranitidine; Splenectomy; Stomach Ulcer | 1999 |
Characterization of antisecretory and antiulcer activity of CR 2945, a new potent and selective gastrin/CCK(B) receptor antagonist.
Topics: Animals; Anti-Anxiety Agents; Anti-Ulcer Agents; Benzodiazepines; Benzodiazepinones; Calcium; Cats; Chronic Disease; Cysteamine; Dose-Response Relationship, Drug; Ethanol; Gastric Acid; Gastric Fistula; Gastric Mucosa; Gastrins; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Parietal Cells, Gastric; Pentagastrin; Perfusion; Phenylurea Compounds; Rabbits; Ranitidine; Rats; Receptors, Cholecystokinin; Stomach; Stomach Ulcer | 1999 |
Secondary prevention of upper gastrointestinal bleeding associated with maintenance acid-suppressing treatment in patients with peptic ulcer bleed.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cimetidine; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Male; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Risk Factors; Secondary Prevention | 1999 |
Long-term extracorporeal bilirubin elimination: A case report on cascade resin plasmaperfusion.
Topics: Acute Kidney Injury; Bile Acids and Salts; Charcoal; Chemical and Drug Induced Liver Injury; Cholestasis; Disseminated Intravascular Coagulation; Doxycycline; Epilepsy, Generalized; Erythromycin; Extracorporeal Circulation; Fatal Outcome; Hematoma, Subdural; Hepatic Encephalopathy; Humans; Hyperbilirubinemia; Liver Failure; Omeprazole; Pneumonia; Ranitidine; Resins, Plant; Shock, Septic; Thrombophlebitis | 1998 |
Helicobacter pylori infection and persistent hyperemesis gravidarum.
Topics: Adolescent; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Famotidine; Female; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Hyperemesis Gravidarum; Omeprazole; Penicillins; Peptic Ulcer; Pregnancy; Pregnancy Complications, Infectious; Proton Pump Inhibitors; Ranitidine | 1999 |
The treatment and prophylaxis of nonsteroidal anti-inflammatory drug (NSAID)-associated ulcers and erosions.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Controlled Clinical Trials as Topic; Gastric Mucosa; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Treatment Outcome | 1999 |
Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes.
Topics: Abnormalities, Drug-Induced; Anti-Ulcer Agents; Cimetidine; Cohort Studies; Female; Humans; Infant, Newborn; Italy; Omeprazole; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pregnancy Trimester, First; Ranitidine; Risk; United Kingdom | 1999 |
Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Antigens, Bacterial; Bismuth; Breath Tests; Feces; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Omeprazole; Organometallic Compounds; Ranitidine; Salicylates; Sensitivity and Specificity; Urea | 1999 |
Treatment of Helicobacter pylori: where are we now? What are the key questions?
Topics: Anti-Ulcer Agents; Bismuth; Duodenal Ulcer; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Treatment Outcome; United Kingdom | 1999 |
Laryngeal contact granuloma.
Topics: Adult; Aged; Anti-Dyskinesia Agents; Botulinum Toxins; Female; Granuloma; Histamine H2 Antagonists; Humans; Laryngeal Neoplasms; Levamisole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 1999 |
Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease.
Topics: Anti-Ulcer Agents; Double-Blind Method; Female; Heartburn; Histamine H2 Antagonists; Humans; Male; Middle Aged; Multicenter Studies as Topic; Omeprazole; Quality of Life; Randomized Controlled Trials as Topic; Ranitidine | 1999 |
Prevention and healing of experimental indomethacin-induced gastric lesions: effects of ebrotidine, omeprazole and ranitidine.
Topics: Animals; Anti-Ulcer Agents; Benzenesulfonates; Disease Models, Animal; Gastric Juice; Histamine H2 Antagonists; Indomethacin; Male; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Thiazoles | 2000 |
H2-blocker modulates heart rate variability.
Topics: Aged; Analysis of Variance; Anti-Ulcer Agents; Arrhythmias, Cardiac; Circadian Rhythm; Diterpenes; Electrocardiography; Fatty Alcohols; Female; Heart Rate; Histamine H2 Antagonists; Humans; Male; Omeprazole; Ranitidine; Stomach Ulcer | 1999 |
A new mechanism for anti-inflammatory actions of proton pump inhibitors--inhibitory effects on neutrophil-endothelial cell interactions.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Cell Adhesion; Cell Adhesion Molecules; Cell Communication; Cell Culture Techniques; Endothelium; Enzyme Inhibitors; Famotidine; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Lansoprazole; Neutrophils; Omeprazole; Proton Pump Inhibitors; Ranitidine; Stomach Ulcer | 2000 |
Optimal acid suppression therapy in critically ill patients.
Topics: Anti-Ulcer Agents; Gastrointestinal Hemorrhage; Histamine H2 Antagonists; Humans; Omeprazole; Ranitidine; Stomach Ulcer; Sucralfate | 2000 |
Influence of age on the steady state disposition of drugs commonly used for the eradication of Helicobacter pylori.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Age Factors; Aged; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Creatinine; Female; Helicobacter Infections; Helicobacter pylori; Humans; Kidney; Lansoprazole; Male; Metronidazole; Middle Aged; Omeprazole; Penicillins; Ranitidine | 2000 |
Role of gastric acid secretion in progression of acute gastric erosions induced by ischemia-reperfusion into gastric ulcers.
Topics: Acute Disease; Animals; Anti-Ulcer Agents; Blood Flow Velocity; Disease Progression; Gastric Acid; Gastric Mucosa; Gastrins; Gene Expression Regulation; Histamine; Histidine Decarboxylase; Interleukin-1; Male; Omeprazole; Polymerase Chain Reaction; Ranitidine; Rats; Rats, Wistar; Reperfusion Injury; RNA, Messenger; Stomach; Stomach Diseases; Stomach Ulcer; Time Factors | 2000 |
Concordance between use of proton pump inhibitors and prescribing guidelines.
Topics: Antacids; Anti-Ulcer Agents; Critical Care; Drug Prescriptions; Drug Utilization; Enzyme Inhibitors; Histamine H2 Antagonists; Humans; Omeprazole; Peptic Ulcer; Practice Guidelines as Topic; Proton Pump Inhibitors; Queensland; Ranitidine | 2000 |
Acid suppression and upper GI bleeding.
Topics: Anti-Ulcer Agents; Drug Administration Schedule; Gastric Acid; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Omeprazole; Ranitidine; Time Factors | 2000 |
Melatonin protects against stress-induced gastric lesions by scavenging the hydroxyl radical.
Topics: Animals; Anti-Ulcer Agents; Antioxidants; Cold Temperature; Dose-Response Relationship, Drug; Free Radical Scavengers; Hydroxyl Radical; Indomethacin; Lipid Peroxidation; Melatonin; Omeprazole; Peptic Ulcer; Ranitidine; Rats; Rats, Wistar; Stress, Physiological | 2000 |
[Upgrading efficiency and safety of combined antihelicobacterial treatment of ulcer patients using modern clinicopharmacological approaches].
Topics: Adult; Anti-Bacterial Agents; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Peptic Ulcer; Ranitidine; Treatment Outcome | 2000 |
[Economic evaluation of the use of diclofenac/misoprostol in the treatment of osteoarticular diseases].
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Arthritis, Rheumatoid; Cost-Benefit Analysis; Decision Trees; Diclofenac; Gastrointestinal Diseases; Humans; Misoprostol; Omeprazole; Osteoarthritis; Ranitidine | 2000 |
The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis.
Topics: Antacids; Barrett Esophagus; Cimetidine; Drug Prescriptions; Endoscopy; Esophagitis; Female; Humans; Male; Middle Aged; Omeprazole; Practice Patterns, Physicians'; Ranitidine | 2001 |
Current approaches to reducing gastrointestinal toxicity of low-dose aspirin.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Aspirin; Gastrointestinal Hemorrhage; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine | 2001 |
Cost effectiveness of rabeprazole versus generic ranitidine for symptom resolution in patients with erosive esophagitis.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Cost-Benefit Analysis; Decision Trees; Drug Costs; Drugs, Generic; Enzyme Inhibitors; Esophagitis, Peptic; Gastroesophageal Reflux; Health Care Costs; Histamine H2 Antagonists; Humans; Managed Care Programs; Omeprazole; Proton Pump Inhibitors; Rabeprazole; Ranitidine; United States | 2000 |
Haloperidol-stomach lesions attenuation by pentadecapeptide BPC 157, omeprazole, bromocriptine, but not atropine, lansoprazole, pantoprazole, ranitidine, cimetidine and misoprostol in mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Atropine; Benzimidazoles; Bromocriptine; Cimetidine; Disease Models, Animal; Domperidone; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indomethacin; Lansoprazole; Male; Mice; Mice, Inbred Strains; Misoprostol; Omeprazole; Pantoprazole; Peptide Fragments; Proteins; Ranitidine; Stomach Diseases; Sulfoxides | 2001 |
Treatment of gastroesophageal reflux disease: to step or not to step.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Gastroesophageal Reflux; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2001 |
Seriate histomorphometry of whole rat stomach: an accurate and reliable method for quantitative analysis of mucosal damage.
Topics: Animals; Anti-Ulcer Agents; Disease Models, Animal; Ethanol; Gastric Mucosa; Indomethacin; Male; Misoprostol; Omeprazole; Ranitidine; Rats; Rats, Wistar; Shock, Hemorrhagic; Stomach Diseases | 2001 |
[Current principles of the use of laparoscopic surgery in gastroduodenal ulcer].
Topics: Antacids; Anti-Bacterial Agents; Anti-Ulcer Agents; Clarithromycin; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Gastrectomy; Helicobacter Infections; Helicobacter pylori; Humans; Laparoscopy; Metronidazole; Omeprazole; Organometallic Compounds; Peptic Ulcer; Postoperative Complications; Ranitidine; Recurrence; Stomach Ulcer; Tetracycline; Time Factors | 2001 |
Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults.
Topics: Adult; Amoxicillin; Anti-Ulcer Agents; Bangladesh; Body Mass Index; Breath Tests; Carbon Isotopes; Developing Countries; Female; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Omeprazole; Organometallic Compounds; Patient Compliance; Peptic Ulcer; Ranitidine; Recurrence; Tinidazole; Urea | 2001 |
What is the best pharmacologic approach to managing moderate to severe heartburn?
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Double-Blind Method; Female; Heartburn; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Multicenter Studies as Topic; Omeprazole; Proton Pump Inhibitors; Ranitidine; Reproducibility of Results; Treatment Outcome | 2001 |
Diagnostic methods for detecting forms and strains of Helicobacter pylori and evaluation of its eradication.
Topics: Adolescent; Adult; Aged; Antibodies, Bacterial; Bismuth; DNA Fingerprinting; Duodenal Ulcer; Female; Flagellin; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Immunoglobulin G; Male; Middle Aged; Omeprazole; Polymerase Chain Reaction; Ranitidine; Recurrence; Restriction Mapping; Species Specificity; Time Factors; Urease | 2001 |
In support of "step-up therapy" for gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Omeprazole; Prospective Studies; Ranitidine; Treatment Outcome | 2002 |
Drugs for bleeding peptic ulcer.
Topics: Anti-Ulcer Agents; Histamine H2 Antagonists; Humans; Injections, Intravenous; Meta-Analysis as Topic; Omeprazole; Peptic Ulcer Hemorrhage; Proton Pump Inhibitors; Ranitidine | 2002 |
Critical effect of Helicobacter pylori infection on the effectiveness of omeprazole for prevention of gastric or duodenal ulcers among chronic NSAID users.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Clinical Trials as Topic; Helicobacter Infections; Helicobacter pylori; Humans; Misoprostol; Omeprazole; Peptic Ulcer; Ranitidine; Recurrence; Treatment Outcome | 2002 |
Gastroprotective activity of solidagenone on experimentally-induced gastric lesions in rats.
Topics: Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Furans; Male; Naphthalenes; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach Ulcer | 2002 |
Gastroprotective activity of oleanolic acid derivatives on experimentally induced gastric lesions in rats and mice.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Aspirin; Dose-Response Relationship, Drug; Ethanol; Hydrochloric Acid; Lansoprazole; Ligation; Male; Mice; Molecular Structure; Oleanolic Acid; Omeprazole; Phytotherapy; Pylorus; Ranitidine; Rats; Rats, Sprague-Dawley; Solanaceae; Stomach Ulcer; Toxicity Tests, Acute | 2002 |
[The gastric mucigenous function in the treatment of patients with ulcer with various antisecretory preparations].
Topics: Adult; Anti-Ulcer Agents; Duodenal Ulcer; Enzyme Inhibitors; Famotidine; Female; Gastric Acidity Determination; Histamine H2 Antagonists; Humans; Male; Middle Aged; Mucins; Muscarinic Antagonists; Omeprazole; Pirenzepine; Proton Pump Inhibitors; Ranitidine; Receptor, Muscarinic M1; Receptors, Muscarinic; Stomach Ulcer | 2002 |
Melatonin protects against gastric ulceration and increases the efficacy of ranitidine and omeprazole in reducing gastric damage.
Topics: Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Free Radical Scavengers; Gastric Mucosa; Hydroxyl Radical; Melatonin; Mitochondria; Omeprazole; Peptic Ulcer; Peroxidase; Ranitidine; Rats; Rats, Wistar; Superoxide Dismutase | 2002 |
Relative contribution of mucosal injury and Helicobacter pylori in the development of gastroduodenal lesions in patients taking non-steroidal anti-inflammatory drugs.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Cohort Studies; Duodenal Ulcer; Female; Gastric Mucosa; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Multivariate Analysis; Omeprazole; Ranitidine; Recurrence; Risk Factors; Stomach Ulcer; Treatment Failure | 2002 |
Influence of sex and Helicobacter pylori on development and healing of gastroduodenal lesions in non-steroidal anti-inflammatory drug users.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Disease Susceptibility; Duodenal Ulcer; Endoscopy, Digestive System; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Misoprostol; Multivariate Analysis; Omeprazole; Ranitidine; Sex Factors; Stomach Ulcer; Treatment Outcome; Wound Healing | 2002 |
[Ranitidine-bismuth citrate versus omeprazole plus two antibiotics for seven days for the eradication of Helicobacter pylori: a non-concluding clinical essay].
Topics: Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Ranitidine | 2002 |
Impact of safety alerts upon prescribing of cisapride to children in New Zealand.
Topics: Adolescent; Child; Child, Preschool; Cisapride; Drug Prescriptions; Drug Utilization; Humans; Infant; New Zealand; Omeprazole; Practice Patterns, Physicians'; Ranitidine; Safety Management | 2002 |
[Results of pre- and postoperative treatment of complicated duodenal ulcers with proton pump inhibitors ].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Drug Therapy, Combination; Duodenal Ulcer; Follow-Up Studies; Humans; Lansoprazole; Omeprazole; Peptic Ulcer Hemorrhage; Peptic Ulcer Perforation; Postoperative Care; Proton Pump Inhibitors; Ranitidine; Time Factors | 2002 |
Facial swelling and eosinophilia in a 44-year-old woman.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Angioedema; Cefuroxime; Cetirizine; Diagnosis, Differential; Drug Hypersensitivity; Edema; Eosinophilia; Face; Fatigue; Female; Humans; Hypereosinophilic Syndrome; Indoles; Lansoprazole; Methylprednisolone; Methylprednisolone Acetate; Omeprazole; Penicillins; Phenylcarbamates; Prednisone; Ranitidine; Recurrence; Sulfonamides; Syndrome; Terfenadine; Tosyl Compounds | 2002 |
Esophageal Crohn disease in children: a clinical spectrum.
Topics: Child; Child, Preschool; Colonoscopy; Crohn Disease; Endoscopy, Digestive System; Esophagitis; Esophagus; Female; Humans; Infant; Male; Omeprazole; Radiography; Ranitidine | 2003 |
Oesophageal acid-peptic strictures in the histamine H2 receptor antagonist and proton pump inhibitor era.
Topics: Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Catheterization; Esophageal Stenosis; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Incidence; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2003 |
[Pharmacotherapy in complex treatment of ulcerous stenosis].
Topics: Amoxicillin; Antacids; Anti-Infective Agents; Anti-Ulcer Agents; Cimetidine; Drug Therapy, Combination; Duodenal Ulcer; Enzyme Inhibitors; Follow-Up Studies; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Metronidazole; Omeprazole; Pyloric Stenosis; Ranitidine; Time Factors | 2003 |
Submucosal microinfusion of endothelin and adrenaline mobilizes ECL-cell histamine in rat stomach, and causes mucosal damage: a microdialysis study.
Topics: Animals; Cells, Cultured; Endothelins; Enterochromaffin-like Cells; Epinephrine; Female; Gastric Mucosa; Gastrins; Histamine; Histamine Release; Histidine Decarboxylase; Infusions, Parenteral; Male; Methylhistidines; Microdialysis; Microinjections; Misoprostol; Omeprazole; Parietal Cells, Gastric; Pyrilamine; Ranitidine; Rats; Rats, Sprague-Dawley; Somatostatin; Time Factors | 2003 |
Different effect of antiulcer agents on rat cysteamine-induced duodenal ulcer after sialoadenectomy, but not gastrectomy.
Topics: Animals; Anti-Ulcer Agents; Atropine; Cysteamine; Duodenal Ulcer; Female; Gastrectomy; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Submandibular Gland | 2003 |
Study of Mimusops elengi bark in experimental gastric ulcers.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Animals; Anti-Ulcer Agents; Benzimidazoles; Ethanol; Female; Gastric Acid; Injections, Intraperitoneal; Male; Mimusops; Omeprazole; Pantoprazole; Plant Bark; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer; Sulfoxides | 2003 |
Health-related quality of life improves with treatment-related GERD symptom resolution after adjusting for baseline severity.
Topics: Adult; Anti-Ulcer Agents; Clinical Trials as Topic; Data Interpretation, Statistical; Female; Gastroesophageal Reflux; Health Status; Heartburn; Humans; Male; Middle Aged; Omeprazole; Psychometrics; Quality of Life; Ranitidine; Reproducibility of Results; Severity of Illness Index; Surveys and Questionnaires; United States | 2003 |
Symptomatic and endoscopic outcome of heartburn 3-4.5 years after starting lansoprazole therapy: a prospective study of 142 patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Endoscopy, Gastrointestinal; Esophagitis; Female; Heartburn; Humans; Lansoprazole; Male; Middle Aged; Omeprazole; Prospective Studies; Proton Pump Inhibitors; Ranitidine; Treatment Outcome | 2003 |
Childhood Helicobacter pylori infection, clinical presentations, endoscopic, histologic features and results of treatment.
Topics: Adolescent; Amoxicillin; Child; Child, Preschool; Drug Therapy, Combination; Female; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Infant; Male; Metronidazole; Omeprazole; Ranitidine; Retrospective Studies; Treatment Outcome | 2003 |
Flavor and taste of lansoprazole strawberry-flavored delayed-release oral suspension preferred over ranitidine peppermint-flavored oral syrup: in children aged between 5-11 years.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Child; Child, Preschool; Consumer Behavior; Delayed-Action Preparations; Female; Flavoring Agents; Forecasting; Fragaria; Humans; Lansoprazole; Male; Mentha piperita; Omeprazole; Prospective Studies; Ranitidine; Suspensions; Taste | 2004 |
Effects of omeprazole, famotidine, and ranitidine on the enzyme activities of carbonic anhydrase from bovine stomach in vitro and rat erythrocytes in vivo.
Topics: Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cattle; Erythrocytes; Esterases; Famotidine; In Vitro Techniques; Omeprazole; Ranitidine; Rats; Rats, Sprague-Dawley; Stomach | 2004 |
[The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Amoxicillin; Anti-Ulcer Agents; Benzimidazoles; Breath Tests; Cisapride; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Middle Aged; Omeprazole; Pantoprazole; Quality of Life; Ranitidine; Reproducibility of Results; Sulfoxides; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2004 |
A pharmacokinetic interaction study between omeprazole and the H2-receptor antagonist ranitidine.
Topics: Adult; Anti-Ulcer Agents; Biological Availability; Chromatography, High Pressure Liquid; Drug Interactions; Histamine H2 Antagonists; Humans; Male; Omeprazole; Ranitidine | 2004 |
Localization of gastrinomas by selective intra-arterial calcium injection in patients on proton pump inhibitor or H2 receptor antagonist therapy.
Topics: Adult; Blood Specimen Collection; Calcium Gluconate; Female; Gastrinoma; Hepatic Veins; Histamine H2 Antagonists; Humans; Injections, Intra-Arterial; Intestinal Perforation; Liver; Male; Middle Aged; Omeprazole; Pancreas; Pancreatic Neoplasms; Proton Pump Inhibitors; Ranitidine; Stimulation, Chemical | 2005 |
Effects of ranitidine, famotidine, pantoprazole, and omeprazole on intragastric pH in dogs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Analysis of Variance; Animals; Benzimidazoles; Dogs; Dose-Response Relationship, Drug; Famotidine; Food Deprivation; Gastric Acidity Determination; Gastric Juice; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine; Reference Values; Sulfoxides | 2005 |
Mechanisms of action of leptin in preventing gastric ulcer.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Lansoprazole; Leptin; Nitric Oxide; Omeprazole; Prostaglandin-Endoperoxide Synthases; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer | 2005 |
Nasal pain disrupting sleep as a presenting symptom of extraesophageal acid reflux in children.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Child, Preschool; Diet; Gastroesophageal Reflux; Histamine H2 Antagonists; Hoarseness; Humans; Lansoprazole; Life Style; Male; Nasal Cavity; Omeprazole; Pain; Proton Pump Inhibitors; Ranitidine; Sleep Initiation and Maintenance Disorders; Snoring | 2005 |
"Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Cost-Benefit Analysis; Decision Support Techniques; Esophagitis, Peptic; Histamine H2 Antagonists; Humans; Japan; Lansoprazole; Models, Statistical; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2005 |
Efficacy of a proton pump inhibitor given in the early postoperative period to relieve symptoms of hiatal hernia after open heart surgery.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Benzimidazoles; Cardiac Surgical Procedures; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gastroesophageal Reflux; Gastrointestinal Hemorrhage; Hernia, Hiatal; Humans; Male; Middle Aged; Omeprazole; Patient Satisfaction; Postoperative Care; Probability; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Risk Assessment; Treatment Outcome | 2006 |
Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials.
Topics: Adolescent; Adult; Aged; Anti-Ulcer Agents; Anxiety; Child; Child, Preschool; Endoscopy, Gastrointestinal; Female; Follow-Up Studies; Heartburn; Humans; Infant; Infant, Newborn; Male; Middle Aged; Omeprazole; Quality of Life; Randomized Controlled Trials as Topic; Ranitidine; Treatment Outcome | 2006 |
Helicobacter pylori eradication in peptic dyspepsia.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Bismuth; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Dyspepsia; Helicobacter Infections; Helicobacter pylori; Humans; Omeprazole; Peptic Ulcer; Proton Pump Inhibitors; Ranitidine | 2005 |
Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Topics: Achlorhydria; Acute Disease; Anti-Ulcer Agents; Child, Preschool; Community-Acquired Infections; Gastroenteritis; Gastroesophageal Reflux; Histamine H2 Antagonists; Humans; Infant; Omeprazole; Pneumonia; Proton Pump Inhibitors; Ranitidine; Risk Factors | 2006 |
Letter to the Editor regarding pediatric postcricoid masses.
Topics: Anti-Ulcer Agents; Child; Cricoid Cartilage; Humans; Laryngeal Diseases; Laryngoscopy; Omeprazole; Prolapse; Ranitidine; Respiratory Sounds | 2006 |
Severe laryngeal hyperkeratosis secondaryto laryngopharyngeal reflux.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Drug Therapy, Combination; Gastroesophageal Reflux; Hoarseness; Humans; Keratosis; Laryngeal Diseases; Laryngeal Mucosa; Laryngoscopy; Male; Middle Aged; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Proton Pumps; Ranitidine; Respiratory Tract Infections; Sulfoxides | 2006 |
Effect of acid secretion blockade on acute gastric mucosal lesions induced by Tityus serrulatus scorpion toxin in anaesthetized rats.
Topics: Acute Disease; Anesthesia; Animals; Atropine; Cimetidine; Dose-Response Relationship, Drug; Drug Antagonism; Enzyme Inhibitors; Gastric Acid; Gastric Mucosa; Gastrointestinal Agents; Male; Neurotoxins; Octreotide; Omeprazole; Pepsin A; Ranitidine; Rats; Scorpion Venoms; Stomach Diseases | 2006 |
Ecabet sodium prevents esophageal lesions induced by the reflux of gastric juice in rats.
Topics: Abietanes; Animals; Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Esophageal Diseases; Esophagus; Gastric Juice; Gastroesophageal Reflux; Male; Mucous Membrane; Omeprazole; Pepsin A; Ranitidine; Rats; Rats, Sprague-Dawley | 2007 |
[Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Anti-Ulcer Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Famotidine; Health Care Costs; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Peptic Ulcer; Rabeprazole; Ranitidine; Russia | 2007 |
[The clinical effectiveness of rabeprazole in patients with acid-related gastric and duodenal diseases with various sensitivity of different types of parietal gastric cell receptors].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Female; Gastric Acid; Gastric Acidity Determination; Gastritis; Histamine H2 Antagonists; Humans; Lansoprazole; Male; Muscarinic Antagonists; Omeprazole; Parietal Cells, Gastric; Pirenzepine; Proton Pump Inhibitors; Rabeprazole; Ranitidine; Receptors, Histamine H2; Receptors, Muscarinic | 2007 |
[Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Biomarkers; Drug Therapy, Combination; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Misoprostol; Omeprazole; Pirenzepine; Ranitidine; Stomach Diseases; Treatment Outcome | 2007 |
14-day quadruple therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure in Thailand.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Bismuth; Chi-Square Distribution; Drug Administration Schedule; Drug Therapy, Combination; Female; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Omeprazole; Rabeprazole; Ranitidine; Tetracycline; Treatment Failure | 2006 |
Treatment interruptus: the need for withdrawal.
Topics: Anti-Ulcer Agents; Child; Esophagitis, Peptic; Gastroesophageal Reflux; Humans; Omeprazole; Ranitidine | 2007 |
[Evidence based treatment strategy for dyspeptic symptoms].
Topics: Dyspepsia; Evidence-Based Medicine; Gastritis; Histamine H2 Antagonists; Humans; Omeprazole; Proton Pump Inhibitors; Ranitidine | 2007 |
Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice.
Topics: Analysis of Variance; Animals; Anti-Ulcer Agents; Blotting, Western; Comet Assay; DNA Damage; Helicobacter Infections; Helicobacter pylori; Male; Mice; Mice, Inbred C57BL; Omeprazole; Ranitidine; Reverse Transcriptase Polymerase Chain Reaction; Statistics, Nonparametric | 2007 |
Interaction between methotrexate and omeprazole in an adolescent with leukemia: a case report.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Ulcer Agents; Antimetabolites, Antineoplastic; Humans; Male; Methotrexate; Omeprazole; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Ranitidine; Stomach Ulcer | 2008 |
Therapy for unhealed gastrocutaneous fistulas in rats as a model for analogous healing of persistent skin wounds and persistent gastric ulcers: stable gastric pentadecapeptide BPC 157, atropine, ranitidine, and omeprazole.
Topics: Adrenal Cortex Hormones; Animals; Anti-Ulcer Agents; Atropine; Cutaneous Fistula; Disease Models, Animal; Gastric Fistula; Gastric Mucosa; Male; Omeprazole; Peptide Fragments; Proteins; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer; Wound Healing | 2009 |
Effects of a one-week treatment with acid gastric inhibitors on Helicobacter pylori-infected mice.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Mice; Omeprazole; Ranitidine; Treatment Outcome | 2008 |
Antiulcerogenic and anti-inflammatory activities of the essential oil from Pterodon emarginatus seeds.
Topics: Administration, Oral; Alkyl and Aryl Transferases; Animals; Anti-Inflammatory Agents; Anti-Ulcer Agents; Brazil; Carrageenan; Disease Models, Animal; Dose-Response Relationship, Drug; Ethanol; Fabaceae; Indomethacin; Interleukin-1alpha; Male; Medicine, Traditional; Mice; Monocyclic Sesquiterpenes; Nitric Oxide; Oils, Volatile; Omeprazole; Peptic Ulcer; Pleurisy; Polycyclic Sesquiterpenes; Ranitidine; Seeds; Sesquiterpenes; Tumor Necrosis Factor-alpha | 2009 |
Postoperative pneumonia in elderly patients receiving acid suppressants: a retrospective cohort analysis.
Topics: Aged; Antacids; Elective Surgical Procedures; Female; Humans; Male; Omeprazole; Pneumonia; Postoperative Complications; Ranitidine; Retrospective Studies; Risk Assessment; Risk Factors | 2010 |
Modification of gastric pH in the fasted dog.
Topics: Animals; Buffers; Dogs; Fasting; Gastric Emptying; Glycine; Hydrochloric Acid; Hydrogen-Ion Concentration; Injections, Intravenous; Jejunum; Male; Models, Animal; Omeprazole; Pentagastrin; Potassium Chloride; Ranitidine; Stomach; Time Factors | 2010 |
Novel approaches to inhibition of gastric acid secretion.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Enzyme Inhibitors; Gastric Acid; Gastroesophageal Reflux; Histamine Antagonists; Histamine H2 Antagonists; Humans; Hydrogen-Ion Concentration; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Ranitidine | 2010 |
De novo erosive esophagitis in duodenal ulcer patients related to pre-existing reflux symptoms, smoking, and patient age, but not to Helicobacter pylori eradication: a one-year follow-up study.
Topics: Adult; Age Factors; Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Clarithromycin; Data Interpretation, Statistical; Drug Therapy, Combination; Duodenal Ulcer; Esophagitis; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Male; Metronidazole; Middle Aged; Multivariate Analysis; Omeprazole; Prognosis; Ranitidine; Smoking; Stomach; Time Factors | 2010 |
Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats.
Topics: Animals; Anti-Ulcer Agents; Bismuth; Cyclooxygenase Inhibitors; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Female; Hematologic Tests; Indomethacin; Male; Misoprostol; Omeprazole; Ranitidine; Rats; Rats, Wistar; Stomach Ulcer | 2012 |
Long-term follow-up of a child with primary lymph node gastrinoma and Zollinger-Ellison syndrome.
Topics: Abdominal Pain; Anti-Ulcer Agents; Child; Combined Modality Therapy; Diarrhea; Duodenal Ulcer; Follow-Up Studies; Gastric Bypass; Gastric Outlet Obstruction; Gastrinoma; Humans; Lymph Nodes; Lymphatic Diseases; Male; Omeprazole; Peptic Ulcer Perforation; Peritonitis; Pneumoperitoneum; Postoperative Complications; Pylorus; Ranitidine; Vagotomy, Truncal; Zollinger-Ellison Syndrome | 2011 |
In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Ascorbic Acid; Cimetidine; Erythrocytes; Famotidine; Hemolysis; Histamine H2 Antagonists; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lansoprazole; Lovastatin; Nizatidine; Omeprazole; Pantoprazole; Pravastatin; Proton Pump Inhibitors; Ranitidine; Ultraviolet Rays | 2012 |
Bacterial infections in cirrhosis: role of proton pump inhibitors and intestinal permeability.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Animals; Bacteria; Bacterial Infections; Cohort Studies; Female; Humans; Jejunum; Liver Cirrhosis; Male; Middle Aged; Models, Animal; Netherlands; Omeprazole; Pantoprazole; Peritonitis; Permeability; Polyethylene Glycols; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Risk Factors | 2012 |
An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.
Topics: Anti-Ulcer Agents; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Clinical Trials, Phase III as Topic; Disease-Free Survival; Double-Blind Method; Drug Interactions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Omeprazole; Proton Pump Inhibitors; Quinazolines; Randomized Controlled Trials as Topic; Ranitidine; Retrospective Studies; Stomach Ulcer; Treatment Outcome | 2013 |
Mucosal protective agents prevent exacerbation of NSAID-induced small intestinal lesions caused by antisecretory drugs in rats.
Topics: Alanine; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Diclofenac; Dose-Response Relationship, Drug; Gastric Mucins; Gastrointestinal Agents; Intestinal Diseases; Intestinal Mucosa; Intestine, Small; Male; Misoprostol; Mucus; Omeprazole; Protective Agents; Proton Pump Inhibitors; Quinolones; Ranitidine; Rats; Rats, Wistar; Sus scrofa; Triazines | 2014 |
Incidence of postoperative dyspepsia is not associated with prophylactic use of drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anesthesia Recovery Period; Anesthesia, General; Dyspepsia; Female; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Postoperative Complications; Proton Pump Inhibitors; Ranitidine; Treatment Outcome; Young Adult | 2014 |
Granulomatous tubulointerstitial nephritis secondary to omeprazole.
Topics: Acute Kidney Injury; Anti-Inflammatory Agents; Diagnosis, Differential; Female; Humans; Middle Aged; Nephritis, Interstitial; Omeprazole; Prednisone; Proton Pump Inhibitors; Ranitidine; Renal Dialysis | 2014 |
Disposition of the anti-ulcer medications ranitidine, cimetidine, and omeprazole following administration of multiple doses to exercised Thoroughbred horses.
Topics: Administration, Oral; Animals; Anti-Ulcer Agents; Cimetidine; Drug Administration Schedule; Female; Half-Life; Horses; Male; Omeprazole; Physical Conditioning, Animal; Ranitidine | 2017 |
Overdose in young children treated with anti-reflux medications: Poisons enquiry evidence of excess 10-fold dosing errors with ranitidine.
Topics: Age Factors; Child, Preschool; Chlorpheniramine; Databases, Factual; Domperidone; Drug Compounding; Drug Overdose; Female; Gastrointestinal Agents; Humans; Incidence; Infant; Male; Metoclopramide; Omeprazole; Poison Control Centers; Ranitidine; Risk Factors; United Kingdom | 2018 |
Occupational contact allergy to omeprazole and ranitidine.
Topics: Dermatitis, Occupational; Eczema; Exanthema; Histamine H2 Antagonists; Humans; Male; Middle Aged; Omeprazole; Patch Tests; Proton Pump Inhibitors; Ranitidine | 2017 |
Rethinking the laryngopharyngeal reflux treatment algorithm: Evaluating an alternate empiric dosing regimen and considering up-front, pH-impedance, and manometry testing to minimize cost in treating suspect laryngopharyngeal reflux disease.
Topics: Algorithms; Anti-Ulcer Agents; Cost-Benefit Analysis; Drug Administration Schedule; Drug Therapy, Combination; Electric Impedance; Esophageal pH Monitoring; Female; Humans; Laryngopharyngeal Reflux; Male; Manometry; Middle Aged; Omeprazole; Proton Pump Inhibitors; Ranitidine; Retrospective Studies; Treatment Outcome | 2017 |
Treatment of reflux disease during pregnancy and lactation.
Topics: Alginates; Antacids; Female; Gastroesophageal Reflux; Glucuronic Acid; Hexuronic Acids; Humans; Lactation; Omeprazole; Pregnancy; Pregnancy Complications; Proton Pump Inhibitors; Ranitidine; Sucralfate | 2017 |
Use of Point-of-Care Gastric pH Testing to Assess the Efficacy of Acid Suppression Therapy in the Neonatal Intensive Care Unit.
Topics: Anti-Ulcer Agents; Critical Care; Enteral Nutrition; Female; Gastric Acid; Gastric Acidity Determination; Humans; Hydrogen-Ion Concentration; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Intubation, Gastrointestinal; Male; Omeprazole; Point-of-Care Testing; Ranitidine; Retrospective Studies | 2020 |
Effect of Hydrotalcite on Indometacin-Induced Gastric Injury in Rats.
Topics: Aluminum Hydroxide; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Dinoprostone; Disease Models, Animal; Epidermal Growth Factor; Female; Gastric Mucosa; Indomethacin; Magnesium Hydroxide; Male; Membrane Proteins; Omeprazole; Ranitidine; Rats; Rats, Wistar; Stomach; Stomach Ulcer | 2019 |
Vanishing gastric hyperplastic polyps.
Topics: Aged; Anti-Ulcer Agents; Drug Substitution; Gastroesophageal Reflux; Humans; Male; Omeprazole; Polyps; Ranitidine; Stomach Diseases | 2019 |
Acute Anisakiasis: Pharmacological Evaluation of Various Drugs in an Animal Model.
Topics: Acute Disease; Animals; Anisakiasis; Anthelmintics; Anti-Ulcer Agents; Antinematodal Agents; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Fishes; Gastrointestinal Tract; Mebendazole; Omeprazole; Ranitidine; Rats; Rats, Wistar; Sucralfate | 2021 |
Consistent gastric pH-dependent effects of suppressors of gastric acid secretion on the antihypertensive responses to oral nitrite.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Gastric Acid; Gastric Mucosa; Histamine H2 Antagonists; Hydrogen-Ion Concentration; Hypertension; Male; Nitrates; Nitric Oxide; Nitrites; Omeprazole; Proton Pump Inhibitors; Ranitidine; Rats; Rats, Wistar; Sodium Nitrite; Treatment Outcome | 2020 |
In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
Topics: Biological Transport; Boron Compounds; Calcium; Calcium Channel Blockers; Cell Line; Chemokine CCL26; Diltiazem; Egtazic Acid; Eosinophilic Esophagitis; Epithelial Cells; Esophageal Mucosa; Famotidine; Female; H(+)-K(+)-Exchanging ATPase; Histamine H2 Antagonists; Humans; Interleukin-4 Receptor alpha Subunit; Male; Omeprazole; Primary Cell Culture; Proton Pump Inhibitors; Proton Pumps; Ranitidine; RNA, Messenger; Signal Transduction; Th2 Cells; Verapamil | 2021 |
No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies.
Topics: Animals; Famotidine; Gastroesophageal Reflux; Gastrointestinal Neoplasms; Humans; Omeprazole; Ranitidine; United States | 2021 |